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ABSTRACT 
NOVEL METHODS FOR REDUCING BREAST DOSE DURING 
COMPUTED TOMOGRAPHY SCANS 
by 
Kelsey Boitnott Mathieu 
Pediatric female and young adult female patients who undergo computed 
tomography (CT) scanning may be at higher risk for developing radiation-induced 
breast cancer later in life. Thus, the purpose of this thesis was to both accurately 
quantify dose and explore new strategies for CT breast dose reduction. In order 
to determine dose reduction, dose quantification was first assessed through the 
development and validation of an empirical model for describing attenuation in 
CT and second through evaluation of the precision of dosimetry-related 
measurements obtained using three different models of CT scanners. Breast 
dose-savings was evaluated using CT dose index phantoms, anthropomorphic 
phantoms, and Monte Carlo computer modeling. Modifications to current 
scanning procedures, such as proper patient centering and beginning data 
acquisition with the x-ray tube facing a patient's posterior, were shown to 
minimize breast dose. Novel techniques, including varying the x-ray tube voltage 
during scanning and incorporation of a dynamic x-ray beam filter over the 
breasts, were also found to successfully reduce breast dose. 
ACKNOWLEDGEMENTS 
I would first like to thank my advisor Dr. Dianna Cody for the invaluable 
guidance and assistance she has provided in helping me formulate this thesis. 
Second, I would like to thank my thesis committee members Dr. Michael McNitt-
Gray, Dr. Antonios Mikos, Dr. Rebecca Richards-Kortum, and Dr. Dennis Cox for 
their time and feedback. 
Additionally, I would like to thank the following faculty and stuff of MD 
Anderson, UCLA, and Rice University: Dr. Cheenu Kappadath, Dr. John Rong, 
Dr. Allen White, Dr. Nancy Fitzgerald, Dr. Philip Tchou, Mr. Joseph Meier, 
Ms.Kathy Prentice, Ms. Georgeanne Moore., Dr. Chris Cagnon, Dr. Grace Kim, 
Mr. Adam Turner, Mr. Di Zhang, Ms. Maryam Khatonabadi, Dr. Neely Atkinson 
and Ms. Gayle Schroeder. Finally, I would like to thank Dr. Adam Chandler and 
Dr. Jiang Hsieh of General Electric Healthcare. 
Dedicated to my husband, Jacques, for being my support system, personal 
assistant, and alarm clock ... 
To my parents for teaching me "where there's a will there's a way" ... 
perhaps too well 
To my dogs, Link and Lady, for providing comic relief and keeping me company 
during my all-nighters 
Finally, to my brother, Josh, a cancer survivor, who makes me believe in the 
importance of this research 
iv 
TABLE OF CONTENTS 
CHAPTER 1: INTRODUCTION AND BACKGROUND .. ............................... 1 
1.1. INTRODUCTION ........................................................................................... 1 
1.2. FUNDAMENTALS OF COMPUTED TOMOGRAPHY ............................................ .4 
1.2.1. X-ray Production ................................................................................ 5 
1.2.2. X-ray Interactions in CT ................................................................... 10 
1.2.3. X-ray Detection ................................................................................ 11 
1.2.4. Image Reconstruction ...................................................................... 13 
1.2.5. Modern CT ...................................................................................... 18 
1.3. RADIATION DOSE ...................................................................................... 23 
1.3.1. Radiation-induced Cancer ............................................................... 26 
1.3.2. Dose Quantification ......................................................................... 31 
1.3.2.1. CTDI Phantoms ........................................................................ 32 
1.3.2.2. Anthropomorphic Phantoms ..................................................... 35 
1.3.2.3. Monte Carlo Dose Estimates .................................................... 36 
1.3.3. CT Dose Reduction Strategies ........................................................ 39 
1.3.3.1. Tube Current Modulation ......................................................... .40 
1.3.3.2. In-plane Organ Shielding ......................................................... .43 
1.4. FORWARD TO THESiS ............................................................................... .44 
CHAPTER 2: AN EMPIRICAL MODEL OF CT ATTENUATION UNDER 
NARROW-BEAM GEOMETRy ....... ................................... .................... 46 
2.1. INTRODUCTION ......................................................................................... 47 
2.2. MATERIALS AND METHODS ........................................................................ 51 
2.2.1. Data Collection ................................................................................ 51 
2.2.2. Data Analysis .................................................................................. 56 
2.2.2.1. Validation of Lambert W model ................................................. 56 
2.2.2.2. HVL and QVL Estimation .......................................................... 60 
2.3. RESULTS ................................................................................................. 65 
2.3.1. Validation of Lambert W Equation ................................................... 65 
2.3.2. HVL and QVL Estimation ................................................................. 70 
2.4. DiSCUSSiON ............................................................................................. 76 
2.5. CONCLUSION ........................................................................................... 81 
CHAPTER 3: PRECISION OF DOSIMETRY-RELATED MEASUREMENTS 
OBTAINED ON CURRENT MDCT SCANNERS ........................................ 83 
3.1. INTRODUCTION ......................................................................................... 84 
3.2. MATERIALS AND METHODS ........................................................................ 87 
3.2.1. Radiation Dosimetry Measurements ................................................ 87 
3.2.1.1. Calculated CTDI1Qo, air Values .................................................... 90 
3.2.1.2. Calculated HVL and QVL .......................................................... 94 
3.2.1.3. Calculated CTDlw ...................................................................... 96 
3.2.2. Statistical Analysis ........................................................................... 98 
3.3. RESULTS ............................................................................................... 100 
3.4. DlsCUSSION ........................................................................................... 1 07 
3.5. CONCLUSION ......................................................................................... 110 
CHAPTER 4: RADIATION DOSE PENALTY IN AXIAL MODE CT ............. 111 
4.1. INTRODUCTION ....................................................................................... 112 
4.2. MATERIALS AND METHODS ...................................................................... 115 
4.2.1. Phantom Measurements ............................................................... 115 
4.2.1.1. CTDI Phantoms at Isocenter ................................................... 117 
4.2.1.2. CTDI Phantoms Off-center ...................................................... 119 
4.2.2. Computer Simulation ..................................................................... 122 
4.3. RESULTS ............................................................................................... 123 
4.3.1. CTDI Phantoms at Isocenter ......................................................... 123 
4.3.2. CTDI Phantoms Off-center ............................................................ 126 
4.3.3. Computer Simulation ..................................................................... 129 
4.4. DiSCUSSiON ........................................................................................... 132 
vii 
4.5. CONCLUSiON ......................................................................................... 135 
CHAPTER 5: VARYING KVP AS A MEANS OF REDUCING CT BREAST 
DOSE TO PEDIATRIC PATIENTS •••.........•.••••.•.............••..................... 136 
5.1. INTRODUCTION ....................................................................................... 137 
5.2. MATERIALS AND METHODS ...................................................................... 141 
5.2.1. Measured Data .............................................................................. 141 
5.2.1.1. CTDI ....................................................................................... 141 
5.2.1.2. Anthropomorphic Phantoms ................................................... 143 
5.2.2. Monte Carlo Dose Estimates ......................................................... 147 
5.2.2.1. Voxelized Models .................................................................... 148 
5.2.2.2. Simulations ............................................................................. 148 
5.3. RESULTS ............................................................................................... 158 
5.3.1. Measured Data .............................................................................. 158 
5.3.1.1. CTDI ........................................................................................ 158 
5.3.1.2. Anthropomorphic Phantoms .................................................... 160 
5.3.2. Monte Carlo Dose Estimates ......................................................... 162 
5.4. DiSCUSSiON ........................................................................................... 166 
5.5. CONCLUSiON ......................................................................................... 170 
CHAPTER 6: ORGAN-BASED BEAM FILTRATION: A NOVEL APPROACH TO 
REDUCING CT BREAST DOSE .......................................................... 171 
6.1. INTRODUCTION ....................................................................................... 173 
6.2. MATERIALS AND METHODS ...................................................................... 178 
6.2.1. Phantoms and CT scanners .......................................................... 178 
6.2.2. Scanning techniques ..................................................................... 179 
6.2.3. Unshielding scanning .................................................................... 181 
6.2.4. In-plane bismuth breast shielding .................................................. 181 
6.2.5. Organ-based beam filtration .......................................................... 182 
6.2.5.1. Transmission measurement .................................................... 184 
6.2.5.2. Copper foil filtration .................................................................. 184 
6.2.5.3. Lead foil filtration ..................................................................... 184 
viii 
6.2.6. Dose analysis ................................................................................ 185 
6.2.7. Image quality analysis ................................................................... 187 
6.3. RESULTS ............................................................................................... 189 
6.3.1. Transmission measurements ..................................................... 189 
6.3.2. Dose analysis ............................................................................. 190 
6.3.3. Image quality analysis ................................................................ 193 
6.4. DiSCUSSiON ........................................................................................... 203 
6.5. CONCLUSION ......................................................................................... 209 
CHAPTER 7: SUMMARY AND FUTURE WORK ..................................... 21 0 
7.1. SUMMARy .............................................................................................. 210 
7.2. FUTURE WORK ....................................................................................... 211 
CHAPTER 8: APPENDICES ............................................................... 217 
8.1. ApPENDIX A: DERIVATION OF EQ. (2.5) .................................................... 217 
8.2. ApPENDIX B: EQUATIONS FOR CALCULATING HVL AND QVL. ..................... 218 
ix 
LIST OF FIGURES 
FIGURE 1.1. Basic components of an x-ray tube .................................................... 7 
FIGURE 1.2. The unfiltered spectrum of a 100 kVp x-ray beam and the same 
spectrum after applying filtration ........................................................................... 9 
FIGURE 1.3. SDCT versus MDCT. ........................................................................ 12 
FIGURE 1.4. Image matrix .................................................................................... 14 
FIGURE 1.5. CT Image reconstruction .................................................................. 15 
FIGURE 1.6. CT Image reconstruction .................................................................. 17 
FIGURE 1.7. The basic components of a modern CT scanner gantry ................... 19 
FIGURE 1.8. The beam profiles "traced" around a patient during axial and helical 
scanning .............................................................................................................. 22 
FIGURE 1.9. The two sizes of CTDI phantoms ..................................................... 33 
Figure 1.10. TCM schemes for two patients ....................................................... .42 
FIGURE 2.1. HVL setups ...................................................................................... 53 
FIGURE 2.2. Lambert W validation scatter plots ................................................... 58 
FIGURE 2.4. Lambert W best-fit curves ............................................................... 66 
FIGURE 2.5. Residual plots .................................................................................. 67 
FIGURE 2.6. RPD bar graphs ............................................................................... 71 
FIGURE 3.1. Setup for free-in-air exposure measurements .................................. 91 
FIGURE 3.2. HVL and QVL setups ........................................................................ 94 
FIGURE 3.3. CTDI phantom setups ...................................................................... 96 
FIGURE 4.1. CTDI phantoms .............................................................................. 117 
FIGURE 4.2. The 32-cm CTDI phantom was scanned using various tube start 
acquisition angles; a start angle of 45° is shown in this illustration ................... 118 
FIGURE 4.3. Vertical and emulated horizontal off-centering in a 32-cm CTDI 
phantom ............................................................................................................ 121 
FIGURE 4.4. CTD1100, 12:00 versus start acquisition angle ..................................... 125 
FIGURE 4.5. CTD1100, 12:00 and CTD1100, 9:00 versus start acquisition angle .......... 127 
Figure 4.6. Results of the computer model simulation ...................................... 131 
FIGURE 5.1. kVp splitting ................................................................................... 140 
FIGURE 5.3. Anthropomorphic phantoms .......................................................... 143 
FIGURE 5.4. Stationary scans to emulate kVp splitting ....................................... 145 
FIGURE 5.2. Voxelized patient models ............................................................... 149 
FIGURE 5.5. Breast tissue coverage ................................................................... 154 
FIGURE 5.6. z-axis coverage .............................................................................. 155 
FIGURE 5.7. Plot showing the TCM scheme ....................................................... 156 
FIGURE 5.8. CT images of anthropomorphic phantoms ..................................... 163 
FIGURE 5.9. (a) Anteroposterior and/or (b) lateral views could be used to identify a 
patient's breast tissue coverage, which could then be used to determine the (c) 
tube angles and patient table positions over which to apply kVp splitting ......... 170 
FIGURE 6.1. The entrance beam versus the exit beam for an anteroposterior 
projection through a patient. .............................................................................. 176 
FIGURE 6.2. Organ-based beam filtration ........................................................... 177 
FIGURE 6.3. Phantoms were centered within the scanners' bores using the built-in 
laser lights ......................................................................................................... 178 
FIGURE 6.4. Localizer (scout) images of anthropomorphic phantoms ................ 180 
FIGURE 6.5. Placement of appropriately-sized bismuth breast shields on the 
phantoms .......................................................................................................... 182 
FIGURE 6.6. Lead and copper foil over the Mylar window .................................. 183 
FIGURE 6.7. Breast shield angular coverage ...................................................... 183 
FIGURE 6.8. AnthropomorphiC phantoms ........................................................... 186 
xi 
FIGURE 6.9. ROls ............................................................................................... 188 
FIGURE 6.10. CT images of the 5-year-old phantom scanned on a GE 
LightSpeed VCT scanner .................................................................................. 197 
FIGURE 6.11. CT images of the 10-year-old phantom a GE LightSpeed VCT 
scanner ............................................................................................................. 198 
FIGURE 6.12. CT images of the (female) adult phantom on aGE LightSpeed VCT 
scanner ............................................................................................................. 199 
FIGURE 6.13. CT images of the 5-year-old phantom on a GE Discovery CT750 
HD scanner ....................................................................................................... 200 
FIGURE6.14. CT images of the 10-year-old on a GE Discovery CT750 HD 
scanner ............................................................................................................. 201 
FIGURE 6.15. CT imagesof the (female) adult phantom on a GE Discovery CT750 
HD scanner ....................................................................................................... 202 
FIGURE 6.16. The anteroposterior scout of the adult anthropomorphic phantom, 
which has the breast tissue outlined ................................................................. 208 
FIGURE 7.1. A CT image of one of the 25 pediatric female patients used to 
construct voxelized patient models, .................................................................. 213 
FIGURE 7.2. The localizer image of one of the pediatric patients, whose CT 
images were used to construct voxelized patient models, shows the patient 
holding a bean bag toy during scanning ............................................................ 213 
FIGURE 7.3. CT images showing the difference in the amount of glandular breast 
tissue across patients ........................................................................................ 215 
xii 
LIST OF TABLES 
TABLE 1.1. The most recent tissue weighting factors (WT) published in a 2007 
report by the ICRP.38 The sum of all wTvalues is 1.0 ......................................... 24 
TABLE 1.2. Average effective dose for various radiographic examinations, 
including CT.40 Note that the CT doses are (for the most part) higher than those 
of other radiographic imaging modalities ............................................................. 25 
TABLE 1.3. Example of the type of look-up table used when assigning photon 
energies, which range from 1 keV to the specified kVp, based on a random 
number generated by the MC model. .................................................................. 38 
TABLE 2.1. Details of the experimental conditions under which exposure versus 
attenuator thickness data were collected using two experimental setups on a GE 
LightSpeed Qx/i CT scanner .............................................................................. 55 
TABLE 2.2. Results of the nonlinear regression analysis used to validate the 
Lambert W model and to compare its performance to the Yu et aI., Bjarngard and 
Shackford, and Lambert-Beer attenuation models .............................................. 68 
TABLE 2.3. Results of the HVL and QVL estimation analysis. For each 
interpolation method, the fraction (in parentheses) and percentage of acceptable 
interpolation pairs (i.e., pairs with RPDs ::; 5%) for estimating the HVL (only), QVL 
(only), and both the HVL and QVL Uointly) is shown; each fraction's denominator 
is equal to the number of interpolation pairs and RPDs calculated for that data 
set. The mean and range (in parentheses) of RPDs across all interpolation pairs 
for each data set is also shown ........................................................................... 72 
TABLE 3.1. Schedule of weekly and quarterly (on Siemens scanners at site B) or 
triannual (on GE scanners at site A) data collection on all nine CT scanner units. 
".!''' indicates that a measurement session was performed on that unit at that 
relative time period, while "_" indicates that no session was performed. Some 
cells are grouped to illustrate the data sampling used to calculate between-run 
(weekly) (cells grouped with dashed oval), between-run (triannual) (cells shaded 
gray), and between-scanner (cells grouped with solid oval) individual %CV 
values .................................................................................................................. 89 
TABLE 3.2. Techniques used on each make and model of scanner to obtain 20 
repeated free-in-air CTDI measurements using a 10-cm pencil ionization 
chamber suspended at isocenter. All scans were performed in axial mode; 
nominal beam width can be calculated by multiplying the number of channels by 
the channel width ................................................................................................ 92 
TABLE 3.3. kVp, type of bowtie filter, and collimation variations used on each 
make and model of scanner to gather free-in-air CTDI measurements; axial scan 
mode and 1-s exposure times were used for all techniques. A total of 21, 12, and 
seven techniques were tested on each of the three GE LightSpeed VCT, GE 
LightSpeed 16, and Siemens Sensation 64 units, respectively ........................... 93 
TABLE 3.4. HVLs and QVLs were found for various kVps and types of bowties on 
each make and model of scanner; axial scan mode and 1-s exposure times were 
used for all techniques. Six, five, and four techniques were tested on each of the 
three GE LightSpeed VCT, GE LightSpeed 16, and Siemens Sensation 64 units, 
respectively ......................................................................................................... 95 
TABLE 3.5. Techniques employed by each make and model of scanner for CDTI 
phantom measurements; axial scan mode and 1-s exposure times were used for 
all techniques. All technical factors, except for the bowtie filter used by the GE 
scanners, were consistent between the 16-cm and 32-cm phantoms. Four 
techniques were tested per CTDI phantom using each scanner make and model, 
with the exception of the GE LightSpeed VCT, where two bowties and thus a 
total of eight techniques were tested for the 16-cm CTDI phantom ..................... 97 
TABLE 3.6. Mean and standard deviation, in parentheses, of CTDI 1oo, air calculated 
values; "_" indicates the scanner either does not offer that bowtie option or that 
beam width. CTDI1QO air values were normalized to 100 mAs to account for 
differences in scanning protocols used on the different scanner makes and 
models .............................................................................................................. 101 
TABLE 3.7. Median and range, in parentheses, of measurement precision of 
CTDI1Qo, air, HVL, QVL, and CTDlw (for a 16-cm and 32-cm CTDI phantom) 
calculated values. Within-run precision was only evaluated for CTDI1Qo, air data 
(collected using the techniques that appear in Table 3.2), thus "- " is shown for all 
other dosimetry metrics. Between-run and between-scanner individual %CVs 
were calculated from data collected at a given technique (shown in Table 3.3, 
3.4, and 3.5 for CTDI1Qo, air, HVL and QVL, and CTDlw, respectively) on the same 
make and model of scanner .............................................................................. 102 
TABLE 3.8. Mean and standard deviation, in parentheses, of the calculated HVLs 
and QVLs (in mm of aluminum); "_" indicates that the scanner does not offer that 
bowtie option ..................................................................................................... 1 04 
xiv 
TABLE 3.9. Mean and standard deviation, in parentheses, of calculated CTDlw 
values for a 16-cm and 32-cm CTDI phantom; "-" indicates that the scanner does 
not offer that bowtie option. CTDlw values were normalized to 100 mAs to 
account for differences in scanning protocols used on the different scanner 
models .............................................................................................................. 106 
TABLE 4.1. Each CTDI phantom was scanned (in service mode) for a single axial 
rotation using the following technique(s) ........................................................... 119 
TABLE 4.2. The ratio of CTDls in a 32-cm CTDI phantom when the phantom was 
positioned at isocenter to when the phantom was moved below isocenter (for a 
given peripheral dose measurement location). To provide a source of comparison 
for our results, the results of a study by Li et al. 155 are also shown ................... 129 
TABLE 5.1. Techniques used to scan a small, medium, and large pediatric patient 
on a GE Discovery STE PETtCT scanner, which contains a 16-slice CT scanner . 
.......................................................................................................................... 150 
TABLE 5.2. Techniques used in the MC simulations to assess the effectiveness of 
kVp splitting for the small, medium, and large patients; all simulations were 
performed using a GE LightSpeed VCT scanner .............................................. 157 
TABLE 5.3. Exponents of kVp calculated using Eq. (5.1) and the measured 
exposures collected free-in-air or at the 12:00 chamber position in the CTDI 
phantoms; exponents were only determined relative to 100 kVp for the 16-cm 
CTDI phantom or 120 kVp for the 32-cm phantom. The ratio of kVps can be 
raised to these powers to determine how to scale the tube current across 
different kVps for scans with kVp splitting ......................................................... 159 
TABLE 5.4. Percentage of dose savings from using kVp splitting in 
anthropomorphic phantoms representing a 5-year-old, 10-year-old, and adult 
relative to a full scan at a fixed 100 kVp (for the pediatric phantoms) or 120 kVp 
(for the adult phantom); negative values (bold-faced) indicate dose savings. The 
currents were scaled across kVps using the exponents listed in Table 5.3, which 
were calculated from CTDI1oo, air or CTDI at the 12:00 chamber position in a 16-
cm CTDI phantom (for the pediatric phantoms) or 32-cm CTDI phantom (for the 
adult phantom) .................................................................................................. 161 
TABLE 5.5. Breast and lung dose absorbed by three pediatric patients as 
estimated through MC computer modeling. For static kVp scans, a single tube 
current was used and thus a single dose is reported in both columns in the table. 
For scans with kVp splitting, different currents were used for the anterior and 
posterior tube angles (the posterior currents were calculated using the CTDI10o, air 
xv 
or CT01100, 12:00 scaling factors listed in Table 5.3 and thus two dose estimates 
were obtained; the CT01100, 12:00 scaling factors were determined in a 16-cm CTOI 
phantom for the small and medium patients and in a 32-cm CTOI phantom for the 
large patient). In parentheses below the dose estimates, dose savings is given 
for the kVp splitting scans relative to a fixed kVp scan; negative values indicate 
dose savings ..................................................................................................... 165 
TABLE 6.1. The TCM protocols used when scanning the pediatric and adult 
anthropomorphic phantoms; 40-mm beam coverage, 2.5-mm helical image 
thickness, 0.984 pitch, and O.4-s rotation times were used for all scans ........... 180 
TABLE 6.2. Percentages of exposure transmitted through bismuth breast shields 
and foil filtration. The transmission percentages were calculated relative to 
exposure measured for an unattenuated beam ................................................ 189 
TABLE 6.3. Calculated dose estimates (in mGy) and the corresponding 
percentages of dose savings (in parentheses) for all three phantoms, across all 
shielding conditions, on both scanners; all scans used the clinical TCM and ASiR 
protocols listed in Table 6.1. Oose savings for each phantom and measurement 
location were calculated relative to the scan without filtration, shielding, or ASiR; 
therefore, the percentage of dose savings is not listed for the "No shielding 
(TCM)" scan ...................................................................................................... 191 
TABLE 6.4. CT numbers (HU) and noise (shown in parentheses) measured in the 
CT images of the three anthropomorphic phantoms for ROls drawn at the 
sternum, left breast, and in the posterior soft tissue near the spine. The specific 
location of each ROI can be seen in Figure 6.9 ................................................ 194 
xvi 
AIC 
ALARA 
A5iR 
CT 
CTDI 
CTDI100 
CTD1100, 9:00 
CTD1100, 12:00 
CTD1100, air 
CTD1100, central 
CTD1100, peripheral 
CTDlw 
CV 
EM 
FDA 
FOV 
GE 
Gy 
HU 
HVL 
ICRP 
ISO 
keV 
kVp 
LNT 
rnA 
rnA's 
MC 
MDCT 
MIRD 
MRI 
rns 
NI 
PMMA 
QA 
QVL 
R 
R2 
LIST OF ABBREVIATIONS 
Akaike's information criterion 
As low as reasonably achievable 
Adaptive iterative statistical iterative reconstruction 
Computed tomography 
Computed tomography dose index 
CTDI calculated from exposure detected by a 100-mm 
pencil ionization chamber 
CTDI1QO detected at the 9:00 peripheral chamber hole in a 
CTDI phantom 
CTDI100 detected at the 12:00 peripheral chamber hole in a 
CTDI phantom 
Free-in-air CTDI 
CTDI 100 detected at the central chamber hole in a CTDI 
phantom 
CTDI1QO detected at one of the peripheral chamber holes in 
a CTDI phantom 
Weighted CTDI 
Coefficient of variation 
Electromagnetic 
Food and Drug Administration 
Field of view 
General Electric 
Gray 
Hounsfield unit 
Half-value layer 
International Commission of Radiological Protection 
International Organization for Standardization 
Kiloelectron volts 
Peak kilovoltage 
Linear no-threshold 
Milliamperes; units of x-ray tube current 
Current-exposure time product 
Monte Carlo 
Multidetector CT 
Medical Internal Radiation Dose 
Magnetic resonance imaging 
millisecond 
Noise index 
Polymethylmelacralate 
Quality assurance 
Quarter-value layer 
Roentgen 
Coefficient of determination 
ROI 
RPD 
5 
SDCT 
SFOV 
SSE 
Sv 
TCM 
TLD 
Region of interest 
Relative percent difference 
Seconds; units of x-ray tube rotation time or exposure time 
Single detector CT 
Scan field of view 
Sum of squares error 
Sievert 
Tube current modulation 
Thermoluminescent dosimeter 
xviii 
CHAPTER 1 
INTRODUCTION AND BACKGROUND 
1.1. INTRODUCTION 
The number of computed tomography (CT) scans performed annually in the 
United States grew from 3 million in 1980 to 62 million by 2006. 1 Based on an 
estimated rate of 10% increase per year, approximately 100 million CT scans will 
be performed in the U.S. in 2011.2 For certain clinical applications, CT use has 
increased at an even faster rate; for instance, the number of annual CT scans 
performed in the emergency department reportedly increased by approximately 
16% per year between 1995 and 2007.3 Additionally, the percentage of CT scans 
performed on pediatric patients (15 years or younger) increased from 4% of all 
CT scans in 19894 to 11% by 1999.5 Use of CT has continually increased 
because CT images have notably improved soft tissue contrast compared to 
conventional x-ray images6 and enhanced spatial resolution compared to 
magnetic resonance imaging (MRI);7 increased speed of imaging provides 
another advantage of CT over MRI. Because CT imaging can depict both soft 
tissue and bone details within seconds, it has broad clinical applications, ranging 
from cancer diagnosis and treatment planning to assessing emergency room 
trauma patients.8 
Although CT scans are being prescribed at an increasing rate, until recently 
the potential risk of radiation-induced cancer associated with these scans was 
1 
given little attention. According to a 2004 study, only 9% of emergency 
department physicians and 47% of radiologists surveyed at one hospital believed 
that there was an increased risk of cancer from CT.9 Furthermore, only 22% of 
the emergency department physicians and 15% of the radiologists were able to 
accurately quantify the amount of radiation dose estimated for the hospital's 
abdominopelvic CT protocols relative to the dose received from a chest 
radiograph. Awareness of the potential risks of exposure to medical radiation 
among physicians and the general public alike has increased with media 
coverage of recent incidents across the United States that have resulted in 
hundreds of patients receiving excessive levels of medical radiation, causing 
radiation burns and hair loss.10. 11 While guidelines and regulations exist for 
monitoring radiation exposure to nuclear industry workers and healthcare 
providers, such regulations do not exist for exposed patients. A study that 
reviewed the health insurance records of almost 1 million Americans estimated 
that over 1800 of the study participants received very high levels of radiation, 
which were estimated to exceed the annual limit for nuclear power plant 
workers. 12 Although CT use is currently not federally regulated and instead 
voluntary programs provide the standards of care (e.g., accreditation though the 
American College of Radiology), recent overdose incidents have prompted the 
Food and Drug Administration (FDA) to launch an initiative aimed at preventing 
unjustified CT examinations and unnecessarily high levels of radiation 
exposure. 13 Upon investigation of radiation overdoses during CT brain perfusion 
examinations, the FDA discovered that improper use of CT scanners, rather than 
2 
equipment malfunction, was responsible for the incidents; these findings were 
summarized in a press release issued in November of 2010. 14 The press release 
also stated that the FDA is currently working with CT scanner manufacturers to 
make scanners safer by adding alerts to warn the CT technologists performing 
the examinations, many of whom are inadequately trained on radiation 
protection, 15 when the prescribed dose is considered to be too high. 16 
Although the exact cancer risk to patients undergoing CT examinations is 
uncertain, it is the responsibility of medical professionals to minimize this risk by 
preventing overdose incidents and by developing and implementing strategies to 
lower patient doses. Furthermore, when patient dose is of concern (e.g., when 
scanning pregnant women or young children), non-ionizing imaging modalities, 
such as MRI or ultrasound, should be considered as alternatives to CT.+ A 2009 
study suggested that 3 - 77% of CT scans performed on young patients (under 
35 years) were unjustified or could be replaced by a non-ionizing imaging 
modality.17 While there is uncertainty regarding cancer risks associated with CT, 
medical professionals agree that it is important to consider radiation exposure to 
individual tissues given that carcinogenesis is often organ-specific. Many 
epidemiological studies have associated exposure to ionizing radiation, including 
medical sources of radiation (e.g., CT), with increased breast cancer risk.18, 19 
Recent data indicates that 1 out of every 8 American women will be diagnosed 
with breast cancer during her lifetime, making it the most common cancer in 
women (excluding nonmelanoma skin cancer).20, 21 The risk of developing 
radiation-induced breast cancer is especially high when radiation exposure 
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occurs during childhood. 18,22 Although most CT scans are performed on adults, 
children with cancer often receive high levels of radiation exposure from 
recurrent CT scans, as well as radiation therapy. Such exposure incurs a lifelong 
risk to these patients; in fact, statistically significant rates of secondary cancer 
have been reported throughout the lifespan of childhood cancer survivors.23, 24 
Although childhood cancer is rare «1% of cancer diagnosis), an estimated 
10,700 new cases of childhood cancer (among children 0 - 14 years old) were 
expected in 2010. 21 Furthermore, the percentage of childhood cancer survivors 
is increasing, and based on the 5-year survival rate of 77.9% for these 
patients,21, 25 over 8,000 children a year may be at risk for secondary cancer; 
thus, it is important to consider levels of radiation dose to this patient population. 
The combination of high breast cancer incidence, radiation sensitivity of 
breast tissue (especially in pediatric cancer patients), and increasing use of CT 
provides motivation for development of breast dose reduction strategies. Thus, 
the goal of this thesis was to develop new strategies for reducing breast dose to 
pediatric and young adult female patients during CT scanning. 
1.2. FUNDAMENTALS OF COMPUTED TOMOGRAPHY 
The invention of computers allowed for the development of computed 
tomography - a medical imaging technology capable of producing a three-
dimensional view of the human body's internal anatomy.s In 1971, the first clinical 
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CT scanner (developed by Godfrey Newbold Hounsfield) was installed at 
Atkinson-Morley's Hospital in London and its clinical potential was immediately 
apparent. Initially, CT was used to image the brain by passing a pencil-like beam 
of x-rays through the head from multiple angles around its periphery. The x-rays 
that were transmitted through the head were measured on the other side by a 
detector and relayed to a computer which reconstructed a cross-sectional image 
of the scanned region.6 Within 10 years of introduction into clinical practice, CT 
use rapidly increased and many technological advances were made, including 
development of a body scanner.+ Furthermore, the number of images acquired 
during modern scanning has increased dramatically from early CT examinations 
during which only 20 - 50 images were acquired.26 While modern CT scanners 
differ greatly from the brain scanner initially developed by G.N. Hounsfield, the 
basic principles of operation remain the same. 
1.2.1. X-RAY PRODUCTION 
In Hounsfield's original prototype, the radioactive isotope Americium 95, 
which emits gamma rays, was used. Both x-rays and gamma rays are types of 
electromagnetic (EM) radiation, or energy that travels through space or matter, 
and can be described both as waves and as particles. When considered to 
behave as a wave, EM radiation is characterized in terms of wavelength and 
frequency and appears as such in the EM spectrum. Gamma rays and x-rays are 
both on the high-frequency end of the spectrum and thus are ionizing. Ionizing 
radiation interacts with matter by removing bound electrons from the electron 
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shell of an atom. From a particle perspective, EM radiation behaves as photons, 
or quanta of energy. Although gamma rays and x-rays are both forms of EM 
radiation, they are produced differently. X-rays are produced outside the nucleus, 
while gamma rays are produced within the nucleus of a radioactive atom. 
Therefore, production of x-rays can be controlled, while gamma ray production is 
dictated by the decay time of the radioactive isotope emitting the gamma 
radiation (e.g., Americium 95). Because the time required to generate enough 
gamma rays to form an image resulted in extremely long scan times, Hounsfield 
soon replaced the isotope source with an x-ray tube to generate ionizing 
radiation in CT.7 
X-rays are produced inside an x-ray tube by energy conversion. A fast-
moving stream of electrons is generated at the filament, which is part of the 
cathode, and is directed towards the anode by applying a high potential 
difference. When an electron in the stream interacts with a specific target area on 
the anode, its kinetic energy is either lost in the form of heat (>99% of 
interactions) or in photon generation. Because such a large amount of heat is 
generated during this process, rotating anodes are employed to minimize heat 
loading by allowing for heat distribution over a larger target area. Additionally, the 
anode target is typically made of tungsten because it has a high atomic number, 
which allows for efficient x-ray conversion, and a high melting point. 6 Figure 1.1 
shows the basic components of the x-ray tubes used in CT. 
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FIGURE 1.1. Basic components of an x-ray tube. In CT, the x-ray beam emitted 
from the tube is filtered before exposing patients. 
Two types of interaction are responsible for x-ray generation in an x-ray 
tube: bremsstrahlung and characteristic x-rays. Bremsstrahlung radiation 
constitutes the majority of the x-ray beam and is produced when an electron 
comes in the proximity of the nucleus of a tungsten atom on the anode target 
region. 6 Electrical attractions between the electron and the positively-charged 
tungsten nucleus pull the electron off course, causing it to decelerate. A photon , 
whose energy corresponds to the kinetic energy lost by the electron during 
deceleration, is emitted; the amount of kinetic energy lost depends on the 
distance between the electron and the nucleus. When an electron collides with 
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the nucleus, which occurs only rarely, all of its kinetic energy is transferred to the 
emitted photon. Characteristic x-rays are a result of the photoelectric effect. The 
photoelectric effect occurs when an electron in the stream strikes an inner-shell 
electron of the tungsten atoms that compose the anode target, uses some of its 
energy to remove the electron from the electron shell, and then transfers the 
remainder of its energy to the ejected electron. When this happens, there is a 
vacancy in an inner-electron shell, which the atom attempts to fill through an 
electron cascade that moves electrons from outer to inner shells. Energy equal to 
the difference in the binding energies of the inner and outer shells is released 
during the cascade as a characteristic x-ray or is transferred to an Auger 
electron, which is an outer-shell electron that is ejected from the atom but does 
not produce x-rays. 
The amount of current that is allowed to flow through the filament is 
measured in units of milliamperes (mA) and determines the number of electrons 
that flow from the cathode to the anode. Therefore, the x-ray tube current also 
determines the intensity (quantity) of x-rays produced. The exposure time 
(typically expressed in seconds [s]) determines how long current is flowing and x-
rays are being produced. Energy (quality) of the x-rays is controlled by the 
potential difference across the x-ray tube, which pulsates between a minimum 
and maximum voltage (known as voltage ripple); the maximum voltage is called 
peak kilovoltage (kVp). Instantaneous voltage at the time of flow dictates the 
kinetic energy of each electron and is expressed in units of kiloelectron volts 
(keV). Varying kinetic energies of electrons in the electron stream, along with 
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differences in the amounts of energy transferred from the electrons to the emitted 
photons, causes the x-ray beam to be composed of photon of a spectrum of 
energies. Spikes from the contribution of characteristic x-rays appear at specific 
keYs in the spectrum, which are related to the binding energies of electrons in 
the shells of tungsten atoms. The energies of photons in the spectrum range 
from approximately 0 keY (in an unfiltered spectrum) to the kVp. Filtration 
increases the minimum energy and narrows the range of energies in the 
spectrum by preferentially removing the low-energy photons. CT scanners have 
a constant amount of inherent filtration, which is shown in Figure 1.1. An example 
of an unfiltered spectrum and the same spectrum after passing through filtration 
appears in Figure 1.2. 
c:i 
z 
Unfiltered 
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/ x-rays 
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FIGURE 1.2. The unfiltered spectrum of a 100 kVp x-ray beam and the same 
spectrum after applying filtration. 
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1.2.2. X-RAY INTERACTIONS IN CT 
Interactions of the x-ray beam produced by a CT scanner's x-ray tube as it 
passes through a patient are necessary for producing CT images. When 
traversing matter (e.g., the human body), x-ray photons will either penetrate 
through the matter unchanged or interact with the matter. Whether or not a 
photon is able to ionize matter is determined by both the photon' energy and 
matter's physical properties (e.g., density and atomic number).8 
Attenuation is the interaction and consequent reduction in intensity of an 
x-ray beam as it passes through matter. Before an x-ray beam passes through a 
patient, it is attenuated as it travels through the x-ray tube's output port and beam 
filtration, which affects both the number and energy of photons in the beam. 
Attenuated photons are removed from the primary x-ray beam by either 
absorption or scattering. In the case of absorption, interacting photons lose all of 
their energy and are stopped inside the matter. Alternatively, scattered photons 
are deflected off their original course during the interaction and may lose of some 
their energy as a result. 
In diagnostic CT imaging, three primary attenuation interactions occur 
between the x-ray beam and the human body: coherent scattering, Compton 
scattering, and the photoelectric effect, which was described in 1.2.1. Coherent 
(Rayleigh) scattering is the only non-ionizing interaction and occurs when a 
photon is scattered but its energy does not change. In Compton (incoherent) 
scattering, a photon is deflected after striking and ejecting an outer-shell electron 
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from an atom; some of the photon's original energy is transferred to the ejected 
electron, which then interacts with surrounding atoms. Of these three 
interactions, the contribution of coherent scattering is often less than 5%. The 
relative contributions of Compton scattering and the photoelectric effect vary 
based on photon energy and physical properties of the interacting matter. 
However, in the energy range used for diagnostic CT, Compton scattering is the 
dominant interaction in both soft tissues and bone.6 
1.2.3. X-RAY DETECTION 
X-rays that penetrate through the patient and reach an array of detectors 
(mounted directly across from the x-ray tube) are recorded and used to create 
CT images. The number and energy of photons varies across detectors in the 
detector array according to differences in attenuation in the anatomical regions 
that different photons pass through; different tissues in the body interact with x-
rays differently. For example, bone readily attenuates x-rays and, as a result, few 
photons reach the detector; on the other hand, air in the lungs attenuates very 
few x-rays and thus many photons are transmitted and detected. 
Modern scanners incorporate multiple rows of detectors placed side-by-
side. This is referred to as multidetector CT (MDCT) and can be contrasted with 
single detector CT (SDCT), which features a single row of detectors. In SDCT, 
only one image can be reconstructed for each rotation of the x-ray tube; on the 
other hand, MDCT allows for multiple planar sections of a patient to be acquired 
concurrently. Figure 1.3 highlights the difference between SDCT and MDCT. The 
11 
advantages of MDCT over SDCT are that there are more options for the slice 
(image) thickness and more anatomy can be imaged during each rotation, which 
correlates to faster imaging times, particularly when acquiring submillimeter 
images, allowing small anatomic details to be resolved. 27 
Single 
Detector 
Array 
Multiple 
Detector 
Array 
FIGURE 1.3. SDCT only allows for acquisition of one image per rotation, and thus 
has been replaced by MDCT, which allows multiple images to be captured per 
rotation. The MDCT scenario shown here has four rows of detectors, which 
translates to reconstruction of up to four images per rotation. 
The slice capability of MDCT scanners (i.e., the number of detector rows 
and the nominal beam width) is continuously increasing. Currently, 64-slice 
MDCT scanners are able to capture a 40-mm thick region of a patient in one 
rotation. 28 The region of coverage (e.g., 40 mm) is called the nominal x-ray beam 
width and equals the number of images acquired multiplied by the thickness of 
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each image.29 Because each row in the detector array in MDCT can acquire data 
for (at most) a single image, the thickness of each image is dependent on the 
width of each detector row. The number of images that can be simultaneously 
captured depends on the total number of detector rows. Thus, a 40-mm coverage 
region for a 0.625-mm detector width can be subdivided into 64 0.625-mm 
images. Data acquired from multiple detector rows can be combined, either 
before or after scanning, to form images that are thicker than the width of 
individual rows.28 For example, 32 1.25-mm thick images can be reconstructed 
from 64 0.625-mm thick images by combining the raw data from pairs of 
neighboring detector rows. Likewise, 10 3.75-mm thick images can be generated 
by binning together groups of six rows of 0.625-mm detectors prior to acquisition. 
However, when detector rows are binned before scanning, they are treated as a 
single detector row; thus, the detected signal cannot be retrospectively separated 
across individual rows and reconstructing the data into thinner slices is 
impossible. 
1.2.4. IMAGE RECONSTRUCTION 
Data is collected by the detector array many times during each rotation 
around a patient, generating different projections, or views, of the patient. The 
data collected by the detectors is transferred to a computer for processing, and 
subsequently a cross-section of the patient is reconstructed into an image by 
filling in an empty matrix (illustrated in Fig.1.4) with the data. The profiles of 
photon detection across detector elements in the array are sent through the 
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image matrix in the opposite direction from which they were originally received by 
the detector array; this process is known as back projection. For each angular 
position of the x-ray tube where data was sampled, the corresponding profile is 
back projected into the image matrix; Figure 1.5 shows the profile across the 
detector array for two angular positions of the x-ray tube. Each transmission 
profile is back projected into the image matrix such that the value detected by 
each detector element is filled in across an entire row or column in the image 
matrix. Once profiles from every angular position that was sampled have been 
back projected into the matrix, an image can be resolved. Overlap between 
profiles occurs and different regions of the image matrix appear either dark or 
light according to the x-ray interactions that occurred at the corresponding 
anatomical location. For instance, bone appears white in CT images, while air 
appears black. 
FIGURE 1.4. The cross-sectional anatomy of a patient is converted into an image 
by filling in an empty image matrix. The thickness of each image (shown in this 
figure as the z-dimension) is determined by the single or the binned detector row 
width. 
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FIGURE 1.5. An image is produced by detecting transmission of x-rays through a 
patient at many angular positions of the x-ray tube as it rotates with detector 
array around the patient. The detected transmission profiles are then back 
projected into an image matrix and the overlap in profiles eventually forms an 
image. Note that the shading in this figure is opposite of what would be observed 
in the actual CT image. In reality, fewers photons would reach the detectors 
when traveling through the patient than through air and the patient would 
consequently appear lighter/brighter than air in the CT image. 
While two-dimensional images are displayed on the scanner console , the 
image matrix is actually three-dimensional. Therefore, the elements in the matrix 
that appear as two-dimensional pixels are, in reality, volume elements called 
voxels; the numerical value of each voxel is determined during back projection. 
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All voxels in the matrix have the same dimensions, where each voxel is square in 
the x- and y-dimensions and sized according to thickness of the cross-section 
imaged in the z-dimension (see Fig. 1.4). The size of the image matrix is called 
the field of view (FOV) and is defined as the voxel size in the x- or y-dimension 
multiplied by the number of voxels per row or column, respectively. Because the 
image matrix is square, the FOV is the same for both the x- and y-dimensions. 
The two-dimensional views shown in each image provide three-dimensional 
views of patient anatomy when multiple images are viewed together. 8 
Voxels in the image matrix are assigned a numerical value according to 
their level of attenuation; tissues in the body attenuate x-rays to varying degrees 
depending on their density and atomic number. For each detector, the left side of 
the following equation is calculated: 
-In (t) = /lX, (1.1 ) 
where 1 is the intensity of photons transmitted through an attenuating material of 
thickness x and 10 is the intensity with no attenuating material as measured by a 
reference detector. Because x is the same for every voxel, it cancels out of the 
calculation, and thus the calculated values for /1, which are known as the linear 
coefficients, are filled into voxels in the image matrix. Figure 1.6(a) shows a 
projection through one row in the image matrix, Figure 1.6(b) shows how voxels 
in a 2 x 2 image matrix would be filled in with data from two projections. The 
calculated /1 value is scaled according to the following equation and displayed as 
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such in the patient images: 
CT(x,y) = 1000. ~(x,y)- ~water, 
~water 
(1.2) 
where CT(x,y) is called the CT number and is the value assigned to each voxel in 
the CT image in Hounsfield units (HU), /l(x,y) is the /l value for the given voxel 
determined through back projection, and /lwater is the linear attenuation coefficient 
ofwater.8 
(b) 
FIGURE 1.6. (a) Transmission through one row in an image matrix for one 
projection angle; (b) shows a 2x2 matrix using transmission profiles from two 
projections. 
Images generated through back projection are blurry, and so the 
transmission profiles are filtered before being back projected; this is known as 
filtered back projection. Modern scanners offer several filtering algorithms, which 
are designed to enhance specific details of the image (e.g., bone or soft tissue). 
Besides using filtered back projection to reconstruct CT images, iterative 
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reconstruction methods have also been developed. Iterative reconstruction is 
capable of producing CT images with less noise (when scanning the same object 
for the same x-ray tube exposure) than those generated by filtered back 
projection; however, long reconstruction times have historically limited this 
method's use. Recently, more efficient iterative reconstruction techniques have 
been developed and various forms of iterative reconstruction (known by the trade 
names ASiR, iDose, IRIS, AIDR) have been implemented across CT scanner 
manufacturers. The strategy developed by General Electric (GE) Healthcare is 
called adaptive statistical iterative reconstruction (ASiR) and combines iterative 
reconstruction with filtered back projection to shorten reconstruction times while 
reducing image noise. Although, an unfamiliar, pixelated appearance has been 
reported by some radiologists in images reconstructed with ASiR, who are 
accustomed to seeing images reconstructed from pure filtered back projection, it 
has not been shown to affect the diagnostic quality of the CT images.3D 
1.2.5. MODERN CT 
Modern CT scanning begins with patients being positioned (either head-
first or feet-first) on a table inside the bore (opening) of the CT scanner gantry 
(framework), as shown in Figure 1.7. Patients are then centered by a CT 
technologist within the bore using a laser-based guidance system; the patient 
table position is fixed in the horizontal plane, but can be vertically adjusted. The 
CT technologist leaves the patient room and performs a localizer scan, which is 
similar to a low-resolution chest radiograph, to help plan the examination. After 
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the localizer is reviewed, if the CT technologist is dissatisfied with the patient's 
centering, the patient's position can be adjusted and additional localizers can be 
acquired. However, the process of centering and re-centering the patient is time-
consuming and demands are placed on technologists to increase patient 
throughput. As a result, patients are often improperly centered. At one hospital, it 
was reported that 95% of patients undergoing chest and abdominal CT 
examinations were off-center by more than 5 mm. 31 
y }-x 
z 
FIGURE 1.7. The basic components of a modern CT scanner gantry. The 
reference axes and tube angles shown are used by GE Healthcare CT scanners, 
which were the primary scanners involved in the research described in this 
thesis. 
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After using the localizer to determine the patient table positions (along the 
z-axis) where the scan should start and end to capture the desired image length, 
the technologist enters the scan parameters (e.g., kVp, mA, detector 
configuration, etc.) on the scanner console. The patient is then scanned 
according to the parameters specified. Once the scan begins, the patient is 
exposed to x-rays as the x-ray tube rotates (in the x-y plane) around the patient's 
body. Modern CT scanners use a fan beam of x-rays coupled to an array of 
detectors, rather than a pencil beam coupled to one or two detectors, as in 
Hounsfield's original CT scanner. The fan beam of x-rays is produced by an x-ray 
tube mounted inside the CT scanner gantry. The detector array is mounted on 
the opposite side of the scanner gantry and rotates synchronously with the x-ray 
tube. Since portions of the fan beam outside the detection region do not 
contribute to the images, width of the fan beam is collimated at the output of the 
x-ray tube to match that of the detector array. The shape of the fan beam is also 
controlled using a bowtie-shaped filter (see Fig. 1.1). The bowtie filter is used in 
addition to inherent filtration to further filter the spectrum and shape the beam to 
reflect the cylindrical shape of most patients by preferentially filtering the outer 
edge of the fan beam which exposes the relatively thinner regions of the 
patients.7 Many scanner models offer several bowtie options which can be 
selected to best match individual patient size. 
To image different sections of the patient's anatomy, the patient table is 
moved along the z-axis through the scanner bore. In early CT, the x-ray tube 
rotated around one section of the patient while the patient table was stationary. 
20 
Then, the patient table was moved either forward or backward and another 
rotation was performed to image the next section of the patient. This method of 
scanning is known as axial, or "step-and-shoot." Because exams performed in 
axial scan mode consist of sections of a patient being successively imaged, it 
can take several minutes to scan over a large region of the patient. Because 
axial scanning is time-consuming it creates clinical disadvantages. For example, 
patients are typically asked to hold their breath for as long as possible during 
examinations over the trunk region because patient motion results in the blurring 
of anatomy in the CT images. Thus, the length of time a patient is able to hold his 
or her breath, which is typically less than 30 seconds, determines the number of 
consecutive images that are not degraded by respiratory motion; this issue is 
particularly important in thoracic imaging.32 The need for shorter scan times to 
capture larger regions of a patient's anatomy within a single breath-hold 
motivated development of continuous acquisition scanners, which emerged in the 
early 1990s.33, 34 Continuous CT acquisitions are performed in what is known as 
helical, or spiral, scan mode. Helical scanning allows the x-ray tube to 
continuously rotate as the patient table simultaneously moves through the 
scanner bore at a constant speed. Development of helical scan mode has 
resulted in faster scan times compared to axial scanning because table 
movement does not require additional scan time. Although both axial and helical 
scan modes are available on modern CT scanners, most patient examinations 
are performed in helical mode because of the time-saving advantages that helical 
scanning offers.29 
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When scanning in helical mode, technologists must specify a pitch, which 
is defined as the length the patient table travels per rotation of the x-ray tube 
divided by the nominal beam width.35 A helical scan with a pitch of 1 is equivalent 
to an axial scan in that the beam profiles from each rotation are contiguous; a 
pitch less than 1 results in beam overlap and a pitch greater than 1 results in 
gaps between the beam profiles from consecutive rotations. Figure 1.8 shows the 
beam profiles for axial and helical scanning (at different pitches). Although a 
spiral path is traced around a patient when scanning in helical mode, the 
acquired data can be reconstructed into consecutive planar images (like those 
acquired in axial mode) by first interpolating between data points in the z-
direction.36 Longer image reconstruction times, due to the additional processing 
time required for interpolation of helical data, are compensated for by shorter 
data acquisition time compared to axial scanning.? 
Helical 
(pitch = 1) 
Helical 
(pitch> 1) 
Helical 
(pitch < 1) 
Axial 
FIGURE 1.8. The beam profiles "traced" around a patient during axial and helical 
scanning (for various pitches). 
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1.3. RADIATION DOSE 
The intensity and energy of radiation emitted by a CT scanner is affected 
by the spectra of the x-ray beam, as well as other scanning factors. Output of a 
CT scanner is expressed as exposure, which is the ability of x-rays to ionize air. 
The unit of exposure is the roentgen (R), where 1 R produces 2.58 . 10-4 
coulombs of ionizing radiation per kilogram of air at standard temperature and 
pressure. Exposure measured in air can be converted to absorbed dose, which is 
the energy deposited to matter (e.g. the body), using appropriate conversion 
factors. 8 Absorbed dose is expressed in units of gray (Gy) or rad, where 1 Gy 
equals 1 joule per kilogram and 1 rad equals 10 mGy. Compared to other 
radiographic imaging modalities, absorbed dose in CT imaging tends to be much 
higher. 37 
Tissues in the body are not equally sensitive to the effects of ionizing 
radiation, thus the International Commission of Radiological Protection (ICRP) 
has assigned tissue weighting factors to tissues and organs based on their 
relative radiosensitivities; the most recent tissue weighting factors appear in 
Table 1.1.38 Because most CT scans do not expose the entire body to radiation, 
but rather irradiate a specific anatomic region (e.g., chest, head, abdomen) and 
the organs within that region, effective dose is calculated as the weighted 
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average of the dose absorbed by the irradiated organs:39 
Effective dose = L WT • WR • DT,R , (1.3) 
where WT is the tissue weighting factor, WR is the radiation weighing coefficient, 
and DT,R is the tissue absorbed dose. Units of effective dose are the sievert (Sv). 
Because WR equals 1 for x-rays, absorbed and effective dose have the same 
units and therefore 1 Sv equals 1 Gy.8 
TABLE 1.1. The most recent tissue weighting factors (WT) published in a 2007 
report by the ICRP.38 The sum of all wTvalues is 1.0. 
Tissue 
Breast 
Colon 
Lung 
Red bone marrow 
Stomach 
Gonads 
Bladder 
Esophagus 
Liver 
Thyroid 
Bone surface 
Brain 
Salivary glands 
Skin 
Remainder (Adrenals, etc.) 
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Tissue weighting factor 
(wr) 
0.12 
0.12 
0.12 
0.12 
0.12 
0.08 
0.04 
0.04 
0.04 
0.04 
0.01 
0.01 
0.01 
0.01 
0.12 
Average effective doses for various radiographic imaging examinations 
are listed in Table 1.2.40 These values can be compared to the mean effective 
dose to adults living in areas of normal background radiation, which is estimated 
to be 3 mSv/year.41 Background radiation comes from natural sources, including 
cosmic radiation from the sun and radioactive nuclides in the earth's crust and in 
the air; therefore, levels of background radiation vary across geographical 
regions. 42 
TABLE 1.2. Average effective dose for various radiographic examinations, 
including CT. 40 Note that the CT doses are (for the most part) higher than those 
of other radiographic imaging modalities. 
Radiographic examination 
Intraoral radiograph (dental) 
Posteroanterior chest radiograph 
Cervical spine film 
Mammogram 
Head CT 
Pelvic CT 
Chest CT 
Abdominal CT 
Tumor C8F-FDG) (Nuclear medicine [PET]) 
Coronary angiography (CT) 
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Average effective dose 
(mSv) 
0.005 
0.02 
0.2 
0.4 
2 
6 
7 
8 
14.1 
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1.3.1. RADIATION-INDUCED CANCER 
While CT scans are useful diagnostic tools, they may put patients at risk 
for subsequently developing radiation-induced cancer.43 Specifically, it has been 
estimated that 1.5 - 2% of all cancers in the United States can be attributed to 
CT and that 1 out of every 500 children or 2,000 adults who receive a scan will 
develop fatal cancer.44,45 These rates can be compared to the estimate that 1 out 
of 4.7 deaths in the U.S. is due to cancer (for all causes).25 The estimated 
incidence of fatal cancer in exposed children is higher because sensitivity to 
radiation is inversely related to age.43 Children are more radiosensitive than 
adults because their cells divide more rapidly, making their DNA more vulnerable 
to damage, and because they have longer life expectancies over which to 
express this damage.46 Additionally, cancer risk from radiation exposure varies 
across gender and CT examinations. A study of atomic bomb survivors reported 
that women experience about twice the risk compared to men.47 Furthermore, a 
study of the health insurance records of 952,420 Americans reported that a 
higher percentage of women than men underwent at least one radiographic 
imaging procedure over a three-year period (78.7% versus 57.9%)? 
When examined concurrently, age and gender risk differentials appear 
even higher; lifetime cancer incidence estimates attributable to CT coronary 
angiography examinations indicate that a 20-year-old woman has 23 times the 
risk of an 80-year-old man, while a 20-year-old man only has 5 times the risk.48 
One study estimated that a 20-year-old woman has 23 times the lifetime risk of 
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cancer attributable to CT coronary angiography compared to an 80-year-old man, 
while a 20-year-old man only has 5 times the risk.48 
The CT examination type, which affects the amount of radiation exposure 
and which organs are exposed, also affects cancer risk. For example, a CT scan 
of the heart (coronary angiography) may lead to cancer in 1 out of every 150 
women (aged 20 years), while routine head CT carries a lower risk of 1 cancer 
per 4,360 women.49 Effective dose is often used to estimate cancer risk; 
however, the tissue weighting factors used to calculate effective dose are 
constant regardless of a patient's age or gender. Also, because effective dose 
combines dose for all organs into a single value, it has limited value in predicting 
cancer risk. For example, a CT scan of the pelvis with an effective dose of 50 
mSv carries a lower risk of breast cancer than a chest CT scan with an effective 
dose of 5 mSv because, even though the effective dose is higher, breast tissue is 
not directly exposed during a pelvic scan. 
Interactions between ionizing radiation (x-rays) and atoms and molecules 
inside the human body are necessary for the generation of CT images. However, 
exposure to ionizing radiation is a risk factor for cancer because of the damage it 
may cause to cellular components during these interactions, resulting in 
chromosome breakage, cell death, and oncogenic transformation. Absorption of 
radiation by water molecules is the primary source of cellular damage because 
the human body is predominantly composed of water. Interactions between water 
and ionizing radiation form free radicals, which are highly reactive and can 
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damage DNA and RNA. Many types of DNA damage can occur after exposure to 
ionizing radiation; double-strand breaks are the most lethal. 5o Once DNA is 
damaged, specific molecular sensors activate damage processing (i.e., DNA 
damage response). Outcomes of the DNA damage response include successful 
repair (and restoration to full functionality), partial repair (resulting in an increased 
risk of mutagenesis and carcinogenesis), or cell death.51 Carcinogenesis is a late 
(long-term) stochastic effect, thus the probability of developing cancer increases 
with exposure to increasing levels of radiation, but the severity of the cancer is 
independent of the level of exposure. 52 Radiation-induced cancer is only 
perceived after a latent period (e.g., 10 years for breast cancer)43 and cannot be 
differentiated from cancer caused by other carcinogens.8 Early effects of 
radiation exposure include erythema (skin burns) and epilation (hair loss).53 
Several studies have provided justification for a linear, no-threshold (LNT) 
relationship between the amount and duration of exposure to ionizing radiation 
and the likelihood of developing cancer. 54, 55 A no-threshold effect means that 
any level of exposure (e.g., a single CT scan) incurs a risk to patients. Based on 
the census population and the estimated number of annual scans, one study 
calculated that 1 out of every 4.4 people received a CT scan in 2004;56 however, 
this statistic overestimates the true proportion because it did not account for 
patients receiving multiple scans within a year. Skeptics of the LNT model, who 
have cast doubt on the model's biological basis and validation, believe that it 
overestimates risk from doses lower than 10 mSv.57 Thus, from this opposing 
perspective, patients receiving single CT scans have a very minimal (if any) 
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increased cancer risk. The LNT model also assumes that risk accumulates 
linearly with each scan performed. Therefore, lifetime attributable risk must be 
considered for patients who receive multiple lifetime scans.58 The medical 
records of over 30,000 patients revealed that (over a 22-year period) 33% of the 
study's patients underwent five or more CT scans and 5% of patients underwent 
between 22 and 132 CT scans.59 However, the percentage of patients who 
received multiple scans reported in this study is likely higher than among the 
general patient population because many of the participants were adult cancer 
patients (who typically undergo regular CT scans). A chart review of 355,088 
children (younger than 18 years) found that 7.9% received at least one CT scan 
and 1.1 % received three or more scans during the 3-year study period.50 
The estimated cancer risks attributable to radiation exposure are largely 
based on epidemiological studies of atomic bomb survivors. From 1950 to 1997, 
86,572 atomic bomb survivors from Hiroshima and Nagasaki were followed;47 
during this period, 36.8% and 10.8% of the survivors died of non-cancer diseases 
and solid cancer, respectively.47 Of the solid cancer deaths, 5% were attributed 
to radiation exposure; 14.7% of the 272 breast cancer deaths reported were 
considered to be radiation-induced. 47 Breast tissue is especially susceptible to 
the carcinogenic effects of radiation because, compared to other organs, breast 
tissue has a heightened radiosensitivity. 18 When the atomic bomb survivors were 
also pooled across age groups, it was observed that young children incurred the 
highest risk. 
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Breast cancer incidence varies by race and nationality, and because 
Japan has lower breast cancer incidence than the United States, it is unclear 
whether the results from studies of Japanese atomic bomb survivors translate to 
American women. 61 , 62 Therefore, epidemiological studies have been conducted 
in North America with medical sources of radiation to further characterize breast 
cancer risk.63 In a multicenter study of 6,068 childhood cancer survivors (in the 
United States and Canada), a statistically significant excess in the number of 
cancer cases were observed; 24.7 times more cases of breast cancer were 
reported among this patient population than would have been expected among 
the general public.64 In another study, a chart review of 5,573 female scoliosis 
patients (under the age of 20 at the time of diagnosis) in the United States was 
performed to estimate their cumulative radiation dose; many patients received 
frequent radiographic examinations to monitor the condition of their spine.65 
Because the latent period for radiation-induced breast cancer is at least 10 years, 
patients were tracked for an average of 40 years.43 Patients in the cohort were 
estimated to have experienced 1.69 times higher breast cancer incidence than in 
women who were exposed to background radiation only. Breast cancer incidence 
was increased by 3.4-fold in women first exposed between the ages of 10 and 11 
years old, which is consistent with the belief that the breast tissue of 
prepubescent girls and girls who are beginning menstruation is most susceptible 
to radiation damage.66 Other studies suggest that women over 50 years at the 
time of exposure experience a minimal increase in breast cancer risk from 
diagnostic levels of radiation exposure. 18 Additionally, higher incidences of breast 
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cancer have been observed in exposed patients that have a family history of 
cancer;54, 57 this may be because women that inherit deleterious BRCA 1 or 
BRCA2 mutations are more radiosensitive due to deficiencies in DNA repair. 58 
1.3.2. DOSE QUANTIFICATION 
Absorbed dose to patients undergoing CT scanning is difficult to 
accurately quantify because organ dose cannot be directly measured, except 
perhaps in the case of cadaver studies. While dosimeters can be placed on a 
patient's surface to give an indication of entrance or skin dose, it is difficult to 
quantify the dose effect using different techniques or scan parameters in patient 
studies as this would require scanning the patient multiple times and needlessly 
exposing them to harmful radiation. Therefore, effective dose is typically 
quantified using both phantom measurements and/or computational modeling. 
Two categories of test phantoms have been designed to approximate the 
attenuation of x-rays through a patient; the first represents the most basic 
simplification of human anatomy, while the second attempts to accurately 
represent the size and shape of the human body, internal anatomy, and 
differences in attenuation across different organs. Dose is estimated through 
computational modeling by mathematically simulating a CT scan, including 
radiation transport through a patient. Both phantoms and computational modeling 
can be used to quantify effective dose; however, phantoms measurements 
cannot accurately estimate organ dose for all of the tissue listed in Table 1.1. 
Furthermore, while modeling is capable of producing more accurate organ dose 
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estimates than phantoms (particularly for individual patients), this approach is 
only available to a few experimental research groups. 
1.3.2.1. eTCI PHANTOMS 
CT dose index (CTDI) is the primary and accepted means of estimating 
dose in CT. CTDI is quantified through exposure detected inside cylindrical 
polymethylmelacralate (PMMA) phantoms, which are standardized by the FDA.59 
The phantoms used to measure CTDI are known as CTDI phantoms and are 
commercially available in several sizes. The most common sizes have 16 cm and 
32 cm diameters and are used to represent the head and body of teenage and 
adult patients, respectively; the 16-cm phantom is used to represent both the 
head and body of pediatric patients.7o Both sizes of CTDI phantoms are 15-cm 
long. Holes are predrilled along the length of the phantoms (at the center and 
around the periphery) and a 10-cm long pencil ionization chamber is placed 
inside the holes to measure exposure. The ionization chamber, which is a 
standard air-filled radiation detector, is connected to an electrometer that 
displays the exposure. B, 71 Locations of the peripheral chamber holes (1 cm 
below the surface) are identified in the same manner as the face of a clock: 3:00, 
6:00, 9:00, and 12:00. Both CTDI phantoms are shown in Figure 1.9 along with 
their respective chamber hole locations. Because typically only one ionization 
chamber is used at a time, solid PMMA filler rods are placed in the empty 
chamber holes. 
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FIGURE 1.9. The two sizes of CTDI phantoms (32-cm and 16-cm) typically used to 
estimate adult patient dose received from a (a) body and (b) head scan, 
respectively. 
Exposure is measured inside the CTDI phantoms for a single axial rotation 
(i.e., stationary patient table) and converted to CTDI1Qo, which is defined as the 
radiation dose (normalized to the beam width) measured for 100 mm along the 
length of the ionization chamber, using the following equation: 72 
CTDI = r·C·E·L (1.4) 
100 N.T' 
where f converts in-air exposure to dose and equals 0.87 rad/R for dose to the 
air-filled chamber, C is the calibration factor of the exposure meter connected to 
the ionization chamber, E is the detected exposure value in units of R, L is the 
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active detection length of the chamber (100 mm), and N· T is the nominal beam 
width in mm (N is the number of active detective rows and T is the detector row 
thickness). Detected exposure, and thus the calculated CTDI 100 values, may vary 
across the phantom's chamber holes; for instance, exposure measured at the 
peripheral chamber holes in a 32-cm CTDI phantom is typically around twice 
what is measured at the central chamber hole. Therefore, an average, or 
weighted, CTDI (CTDlw) is calculated as follows: 72 
1 2 
CTDIw = '3 CTDI100, central + '3 CTDI100, peripheral, (1.5) 
where CTDI 100, central is the CTDI 100 value calculated from exposure measured at 
the central chamber hole and CTDI1oo, peripheral is the CTDI100 value calculated 
from exposure measured at one of the peripheral chamber holes. For the 16-cm 
phantom, exposure measured at the peripheral and central chamber holes is 
relatively consistent. 
CTDI 100 has been shown to underestimate dose deposited in CTDI 
phantoms by 10% - 37% because the 10-cm long pencil chamber can only detect 
dose for 10 cm in a 15-cm long phantom.73 It has been shown that a Farmer 
chamber, which is a small ionization chamber with a volume of 0.6 mm3 , can be 
used to yield more accurate dose estimates.74, 75 In addition to issues with using 
CTDI1oo, dose measured in CTDI phantoms, which have a circular cross-section 
and lack internal organs or tissue differentiation, does not accurately reflect dose 
to patients. Furthermore, the CTDI values across two patients scanned with the 
same protocol parameter settings will the equal although the absorbed dose will 
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vary across these patients, even when the patients of very similar in size. Despite 
these limitations, CTDI is the standard metric because it provides a simple way of 
quantifying scanner output and can be used to compare dose estimates obtained 
across scan parameters. Thus, in the future, the FDA may require CT scanner 
manufacturers to display CTDI calculated values on the scanner console to 
increased awareness of dose among CT technologists with the intention of 
preventing overdose incidents. 
1.3.2.2. ANTHROPOMORPHIC PHANTOMS 
Human-like anthropomorphic phantoms more accurately represent 
anatomy and tissue attenuation than CTDI phantoms. Anthropomorphic 
phantoms are commercially available in a variety of shapes, patient sizes, and 
anatomical complexities. These phantoms contain internal holes where point 
dose detectors can be placed to measure organ dose; thermoluminescent 
dosimeters (TLDs) are commonly used for this purpose. Unlike an ionization 
chamber, which detects dose within a volume, TLDs are so small that they are 
considered to detect dose at a single point. TLDs must be processed and read by 
trained personnel in order to obtain dose information.76 Additionally, large 
variations in detected exposure across TLDs (for a constant level of scanner 
output and at constant location on the phantom) are possible because of their 
point-dose nature.77 Therefore, despite the advantages of using anthropomorphic 
phantoms compared to CTDI phantoms (i.e., better representation of patient 
anatomy and the ability to estimate effective dose), limitations also exist. 
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1.3.2.3. MONTE CARLO DOSE ESTIMATES 
Although a method for calculating effective dose has been established 
(Eq. 1.3), it relies on knowledge of the absorbed dose to each organ. Dose 
absorbed by each organ must be estimated because there is currently no way of 
directly measuring organ dose inside patients. Monte Carlo (MC) modeling seeks 
to improve upon the limitations of effective dose quantification in phantoms by 
providing organ dose information for humans of varying sizes scanned using 
varying protocols. Monte Carlo techniques may be used to estimate dose by 
mathematically simulating the passage of x-ray photons through a patient. 76 
There are two approaches currently used to model a patient, mathematical and 
voxel-based. 78 The first approach simplifies human anatomy by using 
geometrical shapes to represent organs and tissues. These models were first 
developed at the Oak Ridge National Laboratory based on a "Reference Man" 
created by the ICRP to represent an average-sized male and are known as 
Medical Internal Radiation Dose (MIRD) models.79 MIRD models are not 
anatomically realistic but are more accessible than voxelized models of actual 
patients because each voxel in a patient image must be identified as belonging to 
a specific organ or tissue through a process known as segmentation. Although 
segmentation can be semi-automated, some organs, and particularly organ 
boundaries, must be identified manually. This process can be time-consuming 
and requires extensive anatomical knowledge. For this reason, a limited 
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database of voxelized models exists, especially for full-body patient models with 
each organ identified. Some of the most widely-used voxelized patient models 
were developed by the Gesellschaft fOr Strahlen- und Umweltforschung (GSF) -
National Research Centre for Environment and Health. Because internal 
anatomy varies greatly among individuals and organ dose estimates obtained in 
voxelized models are specific to the patient modeled, they do not reflect dose to 
a different patient undergoing the exact same scan. Nevertheless, Monte Carlo 
modeling's ability to estimate absorbed dose to an entire organ provides an 
advantage compared to dose measurements obtained in phantoms.8o 
To estimate dose absorbed by specific organs, passage of individual photons 
through the patient is simulated. To do so, the kVp is input and a spectra is 
generated based on the scanner type. The spectra is divided into 1 keV bins from 
1 to the kVp. Each bin is given a weight based on the likelihood of occurrence, 
which is determined from the spectra. The number of photons at each keV is 
normalized to the total number of photons in the spectrum such that the 
contributions at each keV will sum to 1.0. Then each keV is assigned to a range 
of numbers on a number line from 0 to 1.0 based on their relative contribution. A 
value from 0 to 1.0 is randomly generated by the MC model and then assigned a 
keV according to that number. Random numbers do not have the same likelihood 
of being assigned to each keV as demonstrated in Table 1.3. The shape and 
unequal energy distribution of photons in an x-ray spectra is taken into account in 
the MC model in this way because it is more likely to generate a number 
assigned to 60 keV than 1 keV. Because 106 or more photons are followed 
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through the model, the energy spectrum of the beam can be accurately 
represented. However, because single photons are followed individually the Me 
model cannot directly incorporate or account for the current-exposure time 
product (mAs). 
TABLE 1.3. Example of the type of look-up table used when assigning photon 
energies, which range from 1 keV to the specified kVp, based on a random 
number generated by the Me model. 
Random number generated 
0-0.005 
0.005 - 0.010 
0.300 - 0.500 
0.600 - 0.700 
keV value assigned 
1 
2 
60 
70 
After a simulation is performed, output of the Me model is in units of 
mGy/photon and is converted to dose in units of mGy/mAs by multiplying output 
by a normalization factor. 81 The normalization factor is the ratio of free-in-air 
exposure measured using a pencil ionization chamber on the same as scanner 
simulated to the free-in-air exposure simulated by the Me model for the same 
scan parameters. Finally, dose in mGy/mAs can be multiplied by the desired 
mAs. 
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CT Dose Reduction Strategies 
During CT scanning, it is important to minimize patient dose while 
maintaining adequate image quality. However, since reductions in radiation dose 
are typically accompanied by degradations in image quality, the "as low as 
reasonably achievable" (ALARA) principle should be followed to minimize dose 
while maintaining diagnostic image quality.82 This is particularly important for 
pediatric patients, who incur the greatest risk of future long-term effects and 
receive about 11 % of CT scans in the United States. 5, 83-85 In 2002, the FDA 
issued a public health notification entitled "Reducing radiation risk from computed 
tomography for pediatric and small adult patients," which advised radiologists 
and medical physicists to prescribe CT sparingly to young children and to adjust 
scan parameters appropriately.86 Although other forms of medical doses (e.g., 
pharmaceuticals) are adjusted for children, prior to this notification, pediatric 
patients were frequently scanned using the same exam protocols as for adult 
patients.87 Release of the notification has led to increased awareness and to 
lower doses in pediatric scanning.88 In 2007, the Image Gently campaign was 
started to raise awareness and change practice such that lower doses are used 
when scanning pediatric patients and has outlined steps to consider when 
scanning pediatric patients.8g, gO In addition to modifying protocols to reduce 
dose, several strategies have emerged in recent years, including tube current 
modulation (TCM), in-plane organ shielding, and new iterative reconstruction 
techniques (discussed in 1.2.4). 
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When considering ALARA for pediatric patients, it is important to keep in 
mind that if dose is too low there is the risk of missing a diagnosis.91 Thus, 
therapeutic or imaging goals (e.g., obtaining a diagnosis in cancer patients or 
assessing injury in emergency department/room patients) dictate the acceptable 
levels of dose reduction. In additional, image quality is affected by the size of the 
patient (the same protocol will give very different image quality across patient 
sizes and should be adjusted according to the patient's size). Specifically, 
children tend to have a lack of visceral fat, which affects attenuation of radiation 
in the body, thus effecting both image quality and dose. 92 
The effective doses listed in Table 1.2 represent averages, but because of 
the differences in imaging needs, dose calculated for different CT exam types 
has been shown to vary by a factor of 13 within and across hospitals.49 While 
variation in dose across hospitals due to differences in imaging needs is positive 
in terms of showing patient specification, it is important to ensure consistency in 
how scans are performed at a given hospital. In another study at a different 
hospital, compliance rates (i.e., technologists following the prescribed protocols) 
of up to 88% (but as low as 59%) were reported. 93 Compliance ensures that the 
low-dose protocols are used, which helps to prevent overdose incidents. 
1.3.2.4. TUBE CURRENT MODULATION 
Tube current modulation is a dose-reduction technology that has emerged 
in recent years as a result of the advanced capabilities of modern CT scanners. 
TCM is the CT version of automatic exposure control, which has traditionally 
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been used in conventional radiography systems as a means of preventing image 
overexposure. The delay in implementing such technology into CT was likely due 
to the fact that overexposure in CT actually improves image quality (which is not 
the case in conventional radiography). Thus, automatic exposure control is used 
in CT for regulating patient dose. TCM lowers dose by vary the x-ray tube current 
within a scan according to the patient's anatomy;94 specifically, current, and thus 
radiation dose, is decreased when smaller or thinner parts of the patient's body 
(e.g., the neck) are scanned and is increased when larger or thicker parts (e.g., 
across the shoulders) are scanned. Although multiple factors control the amount 
of radiation output by the CT scanner, the tube current is the easiest to modify 
and has the most predictable behavior.95 
TCM promotes ALARA by enabling patient specificity between exams; the 
specificity of TCM across patients is demonstrated in Figure 1.10. Both angular 
(within the xy-plane) and longitudinal (along the z-axis) approaches to TCM have 
been developed and are typically combined (i.e., xyz modulation) in modern CT 
scanners to maximize dose-savings.96, 97 However, each CT scanner vendor has 
a unique approach to accomplishing TCM.98 
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Figure 1.10. TCM schemes (superimposed on the patients' localization 
projection images) used when scanning two 8 year old female patients. Although 
both patients are very similar in size (the patient shown in [a] was 127 em tall and 
weighed 22.0 kg at the time of scanning, while patient [b] was 128 em tall and 
weighed 24.7 kg), they had noticeably different TCM patterns. The above images 
were collected as part of an IRB approved study. 
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Prior to the development of TCM, the x-ray tube current was constant 
(static) throughout the exam regardless of variations in patients' anatomy. 
Compared to scans with a static mA, dose reductions of up to 40% have been 
observed (without a significant increase in noise) from applying angular TCM in 
simulations, phantom measurements, and cadaver studies.99 Similar results were 
also observed in a study comparing pediatric patients scanned with and without 
TCM.100, 101 
1.3.2.5. IN-PLANE ORGAN SHIELDING 
Radiation protection garments have been placed over patients undergoing 
radiological procedures for years (e.g., lead aprons for conventional and dental 
radiography). These garments are designed to protect the body from radiation 
and are used in CT to specifically shield superficial radiosensitive organs (i.e., 
the eye, breast, thyroid, and testes). Shielding the patient has the same effect as 
adding filtration to the x-ray beam, which is the preferential removal of low energy 
photons that are unlikely to penetrate through a patient and are instead likely to 
be attenuated upon entrance.6 Therefore, removing these photons from the x-ray 
beam, which are thought not to contribute to improved image quality, reduces 
patient dose. Lead shielding has been shown to reduce fetal dose during CT 
scanning in pregnant patients; 102 another study also showed dose reduction of 
87% to the male gonads during abdominopelvic MDCT.103 
While protective garments have historically been lead-based, most 
garments used in CT are now bismuth-based, because they conform better to the 
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body and are lighter-weight. 104, 105 Bismuth garments were first introduced into 
CT in the 1990s and have since been approved by the FDA. Dose reductions 
ranging from 41 - 57% to the breast (as measured with TLDs placed on the 
patients' skin surface) have been observed in patients scanned with bismuth 
breast shields in place.106, 107 Similarly, dose reductions of 18 - 48% to the lens of 
the eye have been observed in patients and phantoms from using bismuth 
shields.108-110 Furthermore, bismuth shielding has also been shown to reduce 
dose to the testes and the thyroid. 106, 109 Although dose-savings has consistently 
been reported with in-plane organ shielding, some studies have observed a 
negative effect on image quality.111-113 
1.4. FORWARD TO THESIS 
The aim of this thesis was two-fold: (1) to accurately quantify dose and (2) 
to develop new strategies to reduce breast dose to pediatric and young adult 
female patients during CT scanning. These patient populations experience one of 
the highest risks related to secondary cancers due to their increased radiation 
exposure that is part of diagnosis and treatment of cancer in the patients at MD 
Anderson Cancer Center - the facility where this research was conducted. 
In order to evaluate success of novel breast dose reduction strategies, the 
ability to accurately quantify relative dose is important. Thus, the first part of this 
thesis (i.e., Chapters 2 and 3) focused on quantifying dose in terms of both 
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physical measurement precision and gathering data for Monte Carlo modeling. 
The second part of the thesis (i.e., Chapters 4 - 6) focused on strategies for 
reducing breast dose. Initially, measurements in CTDI phantom were used 
evaluate dose penalties (to regions of the phantom that best represent breast 
dose [i.e., the peripheral 12:00 chamber position]) associated with particular 
scanning techniques and protocols (i.e., axial versus helical acquisitions). After 
considering the dose effect of current scanning protocols and procedures, this 
thesis explored the efficacy of novel approaches (i.e., strategies not available on 
current scanners), including tube voltage modulation and built-in breast shielding, 
for reducing radiation dose delivered to the breast tissue of female young adult 
and pediatric patients undergoing CT scans. Both anthropomorphic phantoms 
and MC modeling were employed to estimate the amount of radiation dose 
deposited to the breast tissue before and after implementation of the novel 
techniques. Given the relationship between increased radiation exposure and 
cancer incidence, reducing breast dose in girls and young women will in turn 
decrease the rate of radiation-induced breast cancer in adult women who 
received CT scans as children or young adults. 
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CHAPTER 2 
AN EMPIRICAL MODEL OF CT ATTENUATION UNDER 
NARROW-BEAM GEOMETRY 
PURPOSE: The purpose of this study was to develop and validate a mathematical 
model to describe narrow-beam attenuation of kilovoltage x-ray beams for the 
intended applications of half-value layer (HVL) and quarter-value layer (QVL) 
estimation, patient organ shielding, and computer modeling. 
METHODS: An empirical model, which uses the Lambert W function and 
represents a generalized Lambert-Beer law, was developed. To validate this 
model, transmission of diagnostic energy x-ray beams was measured over a 
wide range of attenuator thicknesses (0.49 mm AI to 34.00 mm) on a CT 
scanner. Exposure measurements were acquired under narrow-beam geometry 
using standard methods, including the appropriate ionization chamber. Nonlinear 
regression was used to find the best-fit curve of the proposed Lambert W model 
to each measured transmission versus attenuator thickness data set. In addition 
to validating the Lambert W model, we also assessed the performance of two-
point Lambert W interpolation compared to traditional methods for estimating the 
HVL and QVL (i.e., semilogarithmic [exponential] and linear interpolation). 
RESULTS: The Lambert W model was validated for modeling attenuation versus 
attenuator thickness with respect to the data collected in this study (R2>0.99). 
Furthermore, Lambert W interpolation was more accurate and less sensitive to 
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the choice of interpolation points used to estimate the HVL and/or QVL than the 
traditional methods of semilogarithmic and linear interpolation. 
CONCLUSION: The proposed Lambert W model accurately describes attenuation 
of both monoenergetic radiation and (kilovoltage) polyenergetic beams (under 
narrow-beam geometry). 
2.1. INTRODUCTION 
The Lambert-Beer law describes attenuation of a monoenergetic beam 
(composed of photons of a single energy) and is represented as 
(2.1 ) 
where 1 is the intensity of photons transmitted through an attenuating material of 
thickness x, f1 is the linear attenuation coefficient, and 10 is the unattenuated 
intensity. In a polyenergetic beam, the energy spectra of the photons changes as 
the beam passes through an attenuating material; as a result, the linear 
attenuation coefficient is not a constant value but rather varies with beam 
attenuation.8 Because x-rays are polyenergetic, attenuation of a clinical x-ray 
beam cannot be accurately modeled by Eq. (2.1). 
Development of an equation to describe x-ray beam attenuation may 
benefit several applications, one of which is HVL and QVL estimation. Quality of 
an x-ray beam is characterized by its spectra, which is difficult to measure 
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directly. The HVL, which is defined as the attenuator thickness that reduces the 
measured exposure to exactly one-half of the unattenuated exposure, is the 
metric most often used to describe the quality of an x-ray beam.114 Therefore, the 
HVL is routinely estimated during quality assurance (QA) testing.8 The QVL is 
defined as the attenuator thickness that reduces measured exposure to exactly 
one-quarter of the unattenuated exposure. Although estimation of the QVL is not 
as routine as that of the HVL, it is necessary for determining the homogeneity 
coefficient, which is used to characterize the polyenergetic nature of an x-ray 
beam.115 Additionally, some MC computer models use both the HVL and QVL to 
construct virtual CT scanners.116 Typically, two-point interpolation is performed to 
estimate the HVL or QVL from two measured data points [(XlI II), (X21 b)] 
bracketing the HVL or QVL; that is, with one thickness (Xl) less than and one 
thickness (X2) greater than the HVL or QVL. 117 Alternatively, two-point 
extrapolation uses two thicknesses (Xl and X2), which are both less than or both 
greater than the HVL or QVL. Traditionally, either two-point semilogarithmic (i.e., 
exponential) or linear interpolation has been used for HVL and QVL estimation, 
despite the fact that neither function accurately describe attenuation in 
radiographic imaging. The measurements used to estimate the HVL or QVL are 
gathered under narrow-beam geometry, which refers to detection of photons 
from the primary beam and does not take into account the contribution of scatter; 
conversely, broad-beam geometry refers to radiation that is outside the primary 
beam (i.e., scatter).115 
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Four mathematical models for describing attenuation of megavoltage x-ray 
beams (two of which were evaluated in this study) were discussed by 
Kleinschmidt, who suggested that a function (p.) can be written to describe the 
mean attenuation coefficient of a polyenergetic beam.118 The model that 
Kleinschmidt determined to be optimal was excluded from our analysis because 
it contained three unknown variables and thus conflicted with the objective of this 
study, which was to develop an attenuation model that could be used to estimate 
the HVL and QVL by two-point interpolation. The first of the two mean 
attenuation coefficient functions (p.) discussed by Kleinschmidt and considered in 
our analysis was developed by Bjarngard and Shackford as: 119 
p. = /10 - AX, (2.2) 
where 110 and A are unknown parameters. The second function we considered 
was proposed by Yu et al. as an alternative to Eq. (2.2),120 
- /10 
/1 = l+ilx' (2.3) 
with all variables defined as above. 
Because Eqs. (2.2) and (2.3) were intended for use in describing high-
energy (megavoltage) photon beams, an empirical model for p. was proposed for 
diagnostic-energy (kilovoltage) x-ray beams with the intent that the model be 
utilized to describe narrow-beam attenuation through homogeneous aluminum, 
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which is typically used for HVL and QVL estimation: 
(2.4) 
Replacing constant p by function Ji (i.e., Eq. [2.4]), Eq. (2.1) can be rewritten as 
(see Appendix A for derivation [Chapter 8]): 
(2.5) 
where /, x, and 10 are defined as in Eq. (2.1) and W refers to the Lambert W 
function. The Lambert W function has been shown to have several applications 
in physics 121 and is defined as the multivalued inverse of the function 
W(z)eW(Z) = z, (2.6) 
where z is a complex number.122 By L'Hopital's rule, Eq. (2.5) is reduced to Eq. 
(2.1) when used to model attenuation of a monoenergetic beam (po = p and A = 
0). Therefore, Eq. (2.5) represents a more general form of the Lambert-Beer law 
(Eq. [2.1]). 
Although Eqs. (2.2) and (2.3) were not originally developed for or validated 
under the conditions of this study (i.e., kilovoltage x-ray beam attenuation), there 
were no constraints included in the publications describing their derivation that 
would specifically exclude them from being applied to this type of data. 
Therefore, the following attenuation models (Eqs. [2.7] and [2.8]) were derived (in 
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the same manner as Eq. [2.5]) by substituting Eqs. (2.2) and (2.3), respectively, 
in to Eq. (2.1): 
(2.7) 
(2.8) 
The purpose of this study was to validate the proposed Lambert W model 
(Eq. [2.5]) using transmitted exposure versus attenuator thickness data obtained 
(under narrow-beam geometry) on a CT scanner. Versatility of the proposed 
model was evaluated by collecting data over a range of conditions, including two 
kVps and two experimental setups. After validating the Lambert W model over a 
broad range of conditions, we evaluated the accuracy of using two-point Lambert 
W interpolation to estimate the HVLs and QVLs compared to accepted methods 
(i.e., semilogarithmic and linear interpolation) and also to interpolations based on 
the models described by Yu et al. and Bjarngard and Shackford. 
2.2. MATERIALS AND METHODS 
2.2.1. DATA COLLECTION 
Exposure measurements were collected through varying thicknesses of 
type 1100 aluminum alloy (AI 1100), which were measured using a digital caliper 
(with 0.01-mm accuracy). Two unattenuated exposure measurements (10) were 
initially collected and averaged for every data set. Data points were recorded as 
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measured exposure (I) versus attenuator thickness (A). Exposure was detected 
(under narrow-beam geometry) using an exposure meter (RadCal Corporation, 
Monrovia, CA) connected to a RadCal ionization chamber (either a 3-cm3 pencil 
chamber or 0.6-cm3 Farmer chamber). 
Two experimental setups (shown in Figure 2.1) were used to gather 
exposure versus attenuator thickness data on a LightSpeed QXli CT scanner 
(GE Healthcare, Waukesha, WI) so that the proposed Lambert W attenuation 
model could be evaluated using a traditionally-accepted method, as well as a 
more recent approach.74, 123 Exposure readings were measured at 80 kVp and 
120 kVp (20-mm nominal beam width, large focal spot size, and "body" scan 
FOV [SFOVD using a 10-cm pencil ionization chamber in the first (traditional) 
approach and a Farmer chamber in the second (more recent) approach. In both 
cases, the chambers were positioned free-in-air at gantry isocenter. Additionally, 
the x-ray tube was positioned at the bottom of the scanner gantry and held 
stationary at that location throughout testing; sheets of AI 1100 were placed at 
the bottom of the gantry so that they directly covered the x-ray tube output port. 
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FIGURE 2.1. Two experimental setups were used to collect data on a GE 
LightSpeed QXli CT scanner. With the x-ray tube held stationary at the bottom of 
the gantry, varying thicknesses of AI 1100 filters (indicated by the arrows) were 
placed over the x-ray tube output port and transmitted exposure was detected 
with either (a) a 10-cm pencil ionization chamber (circled) or (b) a Farmer 
chamber (circled). Lead collimation was added at the bottom of the gantry for the 
Farmer chamber setup and the AI 1100 attenuators were placed directly over the 
lead collimators. 
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In the second setup, the Farmer chamber was suspended from a hole 
(with roughly the same diameter as the chamber) drilled into the side of a long, 
narrow foam block such that the inactive region of the chamber remained inside 
the hole to secure the chamber in place. The foam block was positioned on the 
patient table with the active volume of the chamber suspended free-in-air. Using 
the scanner's built-in laser lights, the length of the chamber was aligned along 
the x-axis (rather than the z-axis, as was the case for the pencil chamber) and its 
midpoint was aligned at the intersection of the y- and z-axes (see Fig. 2.1 b for 
orientation of the chamber and the axes). The Farmer chamber was suspended 
in this manner (orientation) because its length exceeded the widest beam 
available for the Qx/i scanner and we wanted to ensure that the entire active 
detection region of the chamber was exposed. To avoid detection of scattered 
photons, the fan beam was physically collimated (along the x-axis) to match the 
length of the chamber. Collimation was achieved by placing two 1.5-mm thick 
sheets of lead at the bottom of the gantry and two foam blocks (cut to the length 
of the active detection region of the chamber) in between the lead sheets on 
each side of the x-ray tube output port. A plumb-bob was hung from the chamber 
to ensure that the opening between the lead sheets was properly aligned with the 
chamber. Upon alignment confirmation, the foam and lead were taped in place to 
maintain a constant opening throughout testing, during which the AI 1100 
attenuators were placed directly on top of the lead collimators. 
The thicknesses of added aluminum, along with other information related 
to the methods, appear in Table 2.1. 
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TABLE 2.1. Details of the experimental conditions under which exposure versus 
attenuator thickness data were collected using two experimental setups on a GE 
LightSpeed Qx/i CT scanner. 
Range of attenuator No. of data 
Experimental setup * kVp thicknesses t points 
(mm) collected 
Pencil chamber 80 0.49 - 20.28 41 
120 0.49 - 33.03 68 
Farmer chamber 80 0.49 - 34.00 70 
120 0.49 - 34.00 70 
Both setups used to collect the CT data are shown in Figure 2.1. The setup which used 
a 10-cm pencil ionization chamber did not feature any additional beam collimation, while 
the x-ray beam was collimated in the Farmer ionization chamber setup, using two 1.5-
mm thick lead sheets, to match the length of the chamber (along the x-axis). 
t For all data sets, average unattenuated exposure (10) was first determined and then AI 
1100 filters were added in approximately 0.5-mm increments within the specified 
attenuator thickness range; the number of attenuator thicknesses tested within this 
range is equal to the number of exposure versus thickness data points collected. 
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2.2.2. DATA ANALYSIS 
The proposed Lambert W model (Eq. [2.5]) was validated (within the 
context of this study) as an acceptable means of modeling attenuation of 
diagnostic x-ray beams. Additionally, the model's fit to the measured 
transmission data was compared to that of the monoenergetic Lambert-Beer law 
(Eq. [2.1]) and also to that of the polyenergetic attenuation models described by 
Eqs. (2.7) and (2.8). After validating and comparing Eq. (2.5) to other attenuation 
models, the accuracy of using two-point interpolation based on the Lambert W 
function to estimate the HVL and QVL was assessed. The Lambert W estimates 
were compared to estimates from the traditional methods of semilogarithmic and 
linear interpolation and also to estimates from interpolations based on Eqs. (2.7) 
and (2.8). 
2.2.2.1. VALIDATION OF LAMBERT W MODEL 
Prior to validating the Lambert W model (Eq. [2.5]), we will justify the 
reasoning behind its development. Since Eq. (2.4) was used to derive Eq. (2.5) 
and thus is the basis of the Lambert W model, evidence in support of a linear 
relationship between ii and (t) (with slope A and y-intercept /10) could provide 
such justification. However, because ii was not quantified in this study, we could 
not directly test for the presence of such a linear relationship. Instead, we 
rearranged Eq. (8.8) (derived from the substitution of Eq. [2.4] into Eq. [2.1], as 
shown in the appendix) such that the right side of the equation matched that of 
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Eq. (2.4) and fi was replaced by a term which used the data at hand: 
-In (~) = + A (~). 
x 110 Io (2.9) 
For every data set, -In (k) versus (!-.) was plotted and goodness of fit was judged 
x 10 
through least squares linear regression; Figure 2.2 shows one such plot along 
with the corresponding regression analysis. However, because these plots were 
generated by transforming the data to create a linear graph, some assumptions 
of linear regression were violated. 124 Additionally, transmission (t), which was 
the dependent variable of the measured data, appears in both the independent 
and dependent variable terms in Eq. (2.9). Therefore, while it was inappropriate 
to interpret results of the linear regression analysis, the plots were used to 
visually assess the linear relationship described by Eq. (2.9) as a means of 
indirectly validating Eq. (2.4). 
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0.16 
0.14 
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0.0 0.2 0.4 0.6 0.8 1.0 
1/10 
FIGURE 2.2. Scatter plot of -In (~) versus (!...) for data collected at 80 kVp using 
x 10 
the Farmer chamber setup. The calculated R2 value of 0.97 indicates a close fit 
of the linear trendline (which has the following equation: -In (~) = 0.101 + 
x 
0.049 . (:0)) to the data, thus providing support in favor of Eq. (2.9) and indirectly 
justifying the validity of Eq. (2.4). Note that the R2 value and the estimates of j.1o 
and A listed here differ from those determined through nonlinear regression (for 
the reasons explained above) even though the same data was analyzed. Table 
2.2 lists the R2 value for this data set as 0.9999, as well as estimates of j.1o and A 
determined through nonlinear regression based on the Lambert W model (Eq. 
[2.5]). 
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Since the linear scatter plots provided justification for Eq. (2.4), proper 
analysis of the Lambert W model (Eq. [2.5]) was warranted. Hence, Eq. (2.5) was 
fit to the detected transmission (t) versus attenuator thickness (x) data in Matlab 
R2008b (MathWorks Inc., Natick, MA) by nonlinear least squares regression, 
which used an iterative search algorithm 125 to determine the best-fit values of 
unknown parameters 110 and A. For each data set, ninety-five percent confidence 
intervals for the best-fit parameters were calculated, as well as the coefficient of 
determination (R2) and the sum of squares error (SSE) of the best-fit curves. 
Additionally, the HVL and QVL were estimated by substituting the best-fit values 
of 110 and A into Eqs. (8.10 - 8.11) (shown in Appendix 8); the HVL and QVL were 
estimated for data set comparison purposes only and were not used in the 
analysis of two-point Lambert W interpolation for HVL and QVL estimation. The 
same nonlinear regression analysis was also performed for Eqs. (2.1), (2.7), and 
(2.8). 
Since the R2 values for all four models were (for the most part) very similar 
to one another, Akaike's information criterion (Ale) was used to provide another 
source of comparison by which to gauge the models' relative goodness of fit. 126 
For every data set, an Ale value was calculated for each of the four attenuation 
models (Eqs. [2.1], [2.5], [2.7], and [2.8]). The Ale values by themselves are 
meaningless, and so evidence ratios were used to compare the Ale values 
calculated for the models described by Eqs. (2.1), (2.7), and (2.8) to the Ale 
values calculated for the Lambert W model (Eq. [2.5]). The evidence ratios 
described the likelihood the Lambert W model was correct (e.g., an evidence 
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ratio of 10 indicated that the Lambert W model was 10 times more likely to be 
correct than the model it was being compared to) by computing the probability 
that it was correct divided by the probability that another model (i.e., Eqs. [2.1], 
[2.7] or [2.8]) was correct. 124 Rough rules of thumb used when interpreting the 
AIC values were that a difference between two AIC values of less than 2, which 
corresponds to an evidence ratio of less than 2.7, indicates substantial evidence 
for the other model, while a difference between 4 and 7 indicates considerably 
less support for the other model, and a difference greater than 10 (or an 
evidence ratio greater than 148) indicates essentially no support in favor of the 
other model. 127 
2.2.2.2. HVL AND QVL ESTIMATION 
Lambert W interpolation was compared to traditional methods 
(semilogarithmic and linear interpolation) for HVL and QVL estimation, as well as 
interpolations based on Eqs. (2.7) and (2.8). Each interpolation method was 
judged by the accuracy of its predictions, which was evaluated by comparing 
measured transmission to predicted transmission through the HVL or QVL 
nearest neighbor. Additionally, the methods were compared in terms of the 
sensitivity of their predictions to the choice of interpolated data points. Finally, 
although interpolation is typically used for HVL and QVL estimation, we also 
considered whether extrapolation could yield accurate estimates. 
The first step in obtaining our predictions was to divide the measured data 
pOints (except for unattenuated exposure, 10) into pairs and to calculate flo and A 
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for each pair using Eqs. (8.12 - 8.13) (see Appendix B [Chapter 8]). Although 110 
and A can be calculated using more than two data points, such as in 2.2.2.1 
where all of the collected data points were used to determine the best-fit values 
of 110 and A, typically only two data points (i.e., one pair) are experimentally 
collected for the purpose of HVL or QVL estimation. The number of pairs 
analyzed and thus the number of 110 and A values calculated depended on the 
number of data points collected for each data set (shown in Table 2.1); for 
example, 41 data points were recorded for the pencil chamber setup at 80 kVp, 
which translated to 780 pairs being analyzed. All analyzed pairs were 
categorized according to whether they bracketed (interpolation) or lay on one 
side of (extrapolation) the HVL or QVL. Furthermore, a subcategory of 
interpolation was considered by analyzing those pairs that bracketed both the 
HVL and QVL. 
The calculated values of /10 and A for each data pair and the HVL or QVL 
nearest neighbor (X nearest) for the data set that the pair came from were 
substituted into the Lambert W model (Eq. [2.5]) to predict transmission 
( Ipredicted) h h thO k t·· th h I 10 t roug IC ness Xnearest; ransmlsslon roug Xnearest was a so 
predicted by semilogarithmic and linear interpolation, and by interpolations based 
on the Bjarngard and Shackford (Eq. [2.7]) and Yu et al. (Eq. [2.8]) models. The 
measured data points nearest the HVL or QVL (i.e., Xnearest) were used to 
approximately represent these values since the HVL and QVL were not directly 
measured and therefore their true values were unknown. 
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the HVL ([X nearest, Inearest]); (2) group all other data points, except for (0, 1), into 
10 
pairs and separate the pairs according to whether they bracket (interpolation) or 
lay on one side of (extrapolation) the HVL; (3) calculate /10 and A for each pair 
(from Eqs. [8.12-8.13] in Appendix 8); (4) substitute Xnearest, /10, and A into Eq. 
(2.5) to calculate Ipredicted for each pair; (5) use Eq. (2.10) to calculated the RPD 
10 
I I d" t d between each nearest and pre IC e ; (6) calculate the mean and range of RPDs and 
10 10 
also the fraction of interpolation and extrapolation pairs that yielded RPDs :5 5%. 
Similar steps can be followed to evaluate the accuracy of QVL estimation, the 
other measured data sets, and the other four interpolation methods. 
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Sample calculation 
with interpolation 
pair [a, c] (Le. , 
[(4.3 mm AI, 0.58), 
(6.03 mm AI, 0.48)]) 
1 
2 
1.0 
• Measured data 
..... ~ 0.8 - Lambert W trendline 
......... 
..... 
t:~ 
0 
'(i) 
t/) 
'E 
t/) 
t: 
CO 
.... 
.... 
0.6 
0.4 
0.2 
0.0 
4 
HVL nearest neig hbor: 
(5.54 mm AI, 0.50) 
e 
5 6 7 
f 
Attenuator thickness, XI (mm AI) 
9 
8 
Interpolation pairs: 
[a , e] , [a, d] , ... , [b, g] 
Extrapolation pairs: 
[a , b], [e, d] , .. . , [f, g] 
4.3 . 0.58 . in(0.48) - 6.03 . 0.48 . in(0.58) 
J10 = 4.3 ' 6.03 ' (0.48 - 0.58) 
= r-I 0-.1-0-4-m-m-- 1--'1 
= 6.03 . in(0.58) - 4.3 . in(0.48) = I 4. - 1 I 
A 4.3 ' 6.03 . (0.48 _ 0.58) . 0.0 0 mm . 
Ipred icted W(0.040 . 5.54 . e - 0.104.5.54 ) I I 
.....:.....--- = = . 0.5028. 
10 0.040 . 5.54 
1
(0.5028 - 0.5017)1 
RPD = 0.5017 . 100% = 10.23% I 
6 Interpolation results: Extrapolation results: 
RPDs ~ 5% : 300/300 pairs RPDs ~ 5%: 470/480 pairs 
Mean RPD = 1.18% Mean RPD = 1.17% 
(Range: 0.11 - 3.37%) (Range: 0.00 - 22 .7%) 
FIGURE 2.3. Sample calculation using data collected with the pencil chamber at 
80 kVp. The following steps were performed to calculate the RPDs and related 
statistical analysis for this data set: (1) identify the measured data point closest to 
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2.3. RESULTS 
2.3.1. VALIDATION OF LAMBERT W EQUATION 
Plots of transmission versus attenuator thickness for all four data sets, 
along with the corresponding Lambert W best-fit curves, appear in Figure 2.4; 
results of the nonlinear regression analysis, including the R2 values, are shown 
below each plot. Because the HVL and QVL estimates calculated from the 
Lambert W best-fit lines for the Farmer chamber and pencil chamber data sets 
agreed within 5%, both setups were considered to be acceptable for estimating 
the HVL or QVL; we could not determine which setup was better since the true 
HVL and QVL were unknown. The residuals (i.e., differences between the 
measured transmissions and the transmission values predicted by the best-fit 
lines for the models described by Eqs. [2.1], [2.5], [2.7], and [2.8]) are plotted in 
Figure 2.5; additional details of the nonlinear regression analysis for all of the 
models can be found in Table 2.2. 
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Pencil chamber (80 kVp) 
• Measured data 
Lambert W trendline 
0.0+----.----.---.---.-
o 5 10 15 20 
Attenuator thickness (mm AI) 
A. = 0.052 ± 0.002, 110 = 0.097 ± 0.001 , R2 = 0.9999 
HVL = 5.64 mm AI , QVL = 12.63 mm AI 
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<:> 
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Farmer chamber (80 kVp) 
• Measured data 
Lambert W trendline 
~ l--.--~=:~~-0.0 
o 10 20 30 
Attenuator thickness (mm AI) 
A. = 0.053 ± 0.002, 110 = 0.101 ± 0.001 , R2 = 0.9999 
HVL = 5.43 mm AI , QVL = 12.14 mm AI 
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Pencil chamber (120 kVp) 
• Measured data 
Lambert W trendline 
0.0+-----,..----.----.-
o 10 20 30 
Attenuator thickness (mm AI) 
A. = 0.038 ± 0.001 , 110 = 0.068 ± 0.000, R2 = 1.0000 
HVL = 7.99 mm AI , QVL = 17.91 mm A I 
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-
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Farmer chamber (120 kVp) 
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Attenuator thickness (mm AI) 
A. = 0.037 ± 0.001 , 110 = 0.072 ± 0.000, R2 = 1.000 
HVL = 7.67 mm AI , QVL = 17.08 mm AI 
FIGURE 2.4. Lambert W best-fit curves for data collected on a GE QXli 
LightSpeed CT scanner at 80 and 120 kVp. Two experimental setups (shown in 
Fig . 2.1) were used to collect exposure measurements, which were detected by 
either a Farmer ionization chamber or a 10-cm long pencil ionization chamber. 
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The R2 values for the Lambert W model (Eq. [2.5]) ranged from 0.9999 to 
1.000 across all data sets, indicating a very close fit of the model to the data. 
When compared to other attenuation models, the Ale evidence ratios indicated 
that the Lambert W model ranged (across all four data sets) from 1.63 . 1040 to 
3.84· 10B2 , 3.41 .1014 _ 2.78.1046, and 1.61 . 10B- 2.29 . 103B times more likely 
to be the correct model compared to the Lambert-Beer (Eq. [2.1]), Bjarngard and 
Shackford (Eq. [2.7]), and Yu et al. (Eq. [2.8]) models, respectively. Because the 
Lambert W model was well over one-million times more likely to be the correct 
model, there was persuasive evidence in its favor. Furthermore, the Lambert W 
model featured higher R2 values, across all data sets, than the models described 
by Eqs. (2.1), (2.7), and (2.8). 
2.3.2. HVL AND QVL ESTIMATION 
Figure 2.6 shows the percentage of acceptable pairs (i.e., pairs with 
RPDs s 5%) for predicting transmission through either the HVL or QVL nearest 
neighbor by each interpolation method. Although Figure 2.6 does not specifically 
quantify accuracy of the predictions (beyond the criteria of 5%), it does indicate 
that (in general) Lambert W interpolation was the most versatile estimation 
method in terms of flexibility in the choice of interpolation data points. Table 2.3 
also lists the fraction and corresponding percentage of acceptable interpolation 
pairs, as well as the mean and range of RPDs for each interpolation method. 
70 
(a) Acceptable pairs for interpolating HVL 
Lambert W • Yu et a!. • Bjarngard and Shackford Semilogarithmic Linear 
80kVp 120 kVp 80kVp 120 kVp 
Pencil chamber Farmer chamber 
(b) Acceptable pairs for interpolating QVL 
Lambert W • Yu et a!. • Bjarngard and Shackford Semilogarithmic Linear 
80kVp 120 kVp 80kVp 120 kVp 
Pencil chamber Farmer chamber 
FIGURE 2.6. These bar graphs provide a visual representation of the Lambert W, 
Yu et aI., Bjarngard and Shackford, semilogarithmic and linear interpolation 
methods' respective sensitivities to the choice of interpolation points used to 
predict transmission through the attenuator thickness nearest the HVL or QVL 
(X nearest) for each data set. The RPDs between the predicted and measured 
transmissions through Xnearest were calculated and the percentage of acceptable 
interpolation pairs (i.e., pairs with RPDs S 5%) for estimating (a) HVL and (b) 
QVL is shown. 
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Lambert W interpolation was shown to be successful in all of the HVL 
cases analyzed (2440 out of 2440 pairs), regardless of the choice of data points 
interpolated, and in over 99.8% of the QVL cases analyzed (3744 out of 3750 
pairs). The mean and range of RPDs between the measured and predicted (by 
Lambert W interpolation) transmissions through the HVL nearest neighbor across 
all four data sets was 0.72% (0.00 - 4.05%); similarly, the mean and range of 
RPDs for the QVL nearest neighbor across the data sets was 0.64% (0.00 -
5.17%). Across all data sets and all interpolation pairs (HVL and QVL), the 
Lambert W interpolated predictions yielded RPDs ranging from 0.00% to 5.17% 
(99.9% of the 6190 pairs analyzed had RPDs :5 5%) with a mean RPD of 0.68%. 
These results can be compared to the mean and range of RPDs (across all 6190 
pairs) of 1.96% (0.00 - 13.1 %) for interpolation based on the Yu et al. model 
(90.8% of pairs had RPDs :5 5%), 2.74% (0.00 - 16.2%) for interpolation based 
on the Bjarngard and Shackford model (82.8% of pairs had RPDs :5 5%), 3.37% 
(0.00 - 15.4%) for semilogarithmic interpolation (74.7% of pairs had RPDs:5 5%), 
and 22.6% (0.01 - 147%) for linear interpolation (21.2% of pairs had RPDs :5 
5%). 
The special case of using Lambert W interpolation to estimate both the 
HVL and QVL from a single pair of two measured data points, as opposed to 
using two pairs (i.e., four data points) to interpolate HVL and QVL separately, 
had a 99.6% acceptance rate (across all data sets). This rate can be compared 
to 67.5%, 44.1 %, 38.7%, and 1.0% acceptance when using Yu et aI., Bjarngard 
75 
and Shackford, semilogarithmic, and linear interpolations, respectively, to jointly 
estimate HVL and QVL. 
Lambert W extrapolation was also evaluated and RPDs of less than or 
equal to 5% were achieved by approximately 91.4% of pairs (4842 out of 5243 
pairs and 3549 out of 3933 pairs used to predict transmission through the HVL 
and QVL nearest neighbors, respectively). Lambert W extrapolation was more 
versatile than Yu et aI., Bjarngard and Shackford, semilogarithmic, and linear 
extrapolations, which had acceptance rates of 81.3%, 75.0%, 62.8%, and 15.4%, 
respectively. However, the diminished success rate of Lambert W extrapolation 
compared to Lambert W interpolation (91.4% versus 99.9% acceptance) 
indicates that, based on our results, interpolation rather than extrapolation should 
be used to estimate the HVL or QVL. 
2.4. DISCUSSION 
In this study, we proposed an empirical model, which uses the Lambert W 
function, to describe narrow-beam attenuation of diagnostic x-ray beams through 
homogenous materials, and our analyses showed that the proposed model 
accurately describes such attenuation. Furthermore, accuracy of the Lambert W 
attenuation model (Eq. [2.5]) over the broad range of testing conditions 
considered (two kVps and two experimental setups) demonstrates the versatility 
of this model. 
76 
Although there is an established method for assessing attenuation under 
broad-beam geometry,129 this method does not necessarily hold true when 
describing attenuation of the primary beam (and vice versa) because the x-ray 
spectra are very different under these two geometries. Therefore, the focus of 
this study was on developing a narrow-beam attenuation model. While several 
such models have been developed for high-energy beams,119, 120 to the best of 
the authors' knowledge, no such model has been verified for determining narrow-
beam attenuation of diagnostic energy beams. 
The proposed Lambert W model appears to closely model narrow-beam 
attenuation of kilovoltage x-ray beams in light of the high R2 values computed in 
this study, which ranged from 0.9999 to 1.000. These promising results may 
motivate future development of the empirical Lambert W model which presently 
relies on experimental data and could be enhanced by generation of look-up 
tables for constants flo and A, similar to the National Institute of Standards and 
Technology (NIST) mass attenuation coefficient tables. If look-up tables were 
developed, parameters flo and A would be specified according to the kVp, 
attenuating material, inherent filtration, and possibly other factors that affect the 
polyenergetic beam spectra (e.g., the bowtie filter). Our data sets demonstrate 
the need for specification according to these factors. For example, the effect of 
kVp is apparent when comparing the flo and A values across data sets collected 
at 80 kVp versus120 kVp. Besides the expected differences in flo and A that we 
observed across data sets, unexpected (but possibility justified) inconsistencies 
in the best-fit parameters were also observed. Differences across the two setups 
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may explain the statistically-significant differences noted in /10 at the a = 0.05 
level (as indicated by the lack of overlap in the 95% confidence intervals). In 
order to develop generic (non-manufacturer specific) look-up tables, 
inconsistencies in /10 and A for data sets with the same attenuating material, kVp, 
and inherent filtration would need to be resolved and the stability of /10 and A 
across these data sets would need to be established. 
Two-point Lambert W interpolation was considered to be a successful 
means of predicting transmission through the HVL nearest neighbor, yielding 
RPDs of less than or equal to 5% across all data sets regardless of the choice of 
interpolation data points. In addition to showing less sensitivity to the choice of 
interpolation points compared to the other interpolation methods analyzed, 
Lambert W interpolation displayed a higher degree of accuracy in its predictions. 
Of the four other interpolation methods evaluated, linear interpolation had the 
weakest performance, while interpolations based on the Yu et al. model most 
closely matched the performance of the Lambert W model. Despite its diminished 
success compared to Lambert W based interpolation, linear interpolation was 
observed to yield accurate predictions (within 5%) as long as the interpolated 
data points were within ±30% of the HVL or ±15% of the QVL; similarly, 
semilogarithmic interpolation was observed to yield accurate predictions when 
the interpolated data points were within ±80% of the HVL or ±60% of the QVL. 
The Bjarngard and Shackford model was generally less versatile and yielded less 
accurate estimates of transmission through the HVL and QVL nearest neighbors 
compared to the other therapy-based model evaluated in this study (i.e., the Yu 
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et a!. model); furthermore, semilogarithmic interpolation was superior to 
interpolations based on the Bjarngard and Shackford model for some data sets. 
Although the Yu et a!. model had a higher overall RPD across all data sets 
(1.96% versus 0.68%), higher average and maximum RPDs (across most data 
sets), and was less versatile in its percentage of acceptable pairs than the 
Lambert W model, the Lambert W model's principal advantage was its 
usefulness for estimating both the HVL and QVL simultaneously. While the 
accuracy of HVL and QVL estimation was not directly evaluated in this study, we 
expect it to be roughly equivalent to the level of accuracy observed in the 
predicted transmissions through the HVL and/or QVL nearest neighbors. 
Therefore, we can assume that Lambert W interpolation allows for accurate 
estimation of both the HVL and QVL from the unattenuated exposure (/0) and two 
measured data points (e.g., exposure measured through 0.5 mm and 33 mm of 
AI 1100). Thus, it is feasible that two-point Lambert W interpolation could be 
implemented into QA practice. To estimate the HVL and/or QVL, the 
unattenuated exposure and two measured exposure versus attenuator thickness 
data points could be substituted into Eqs. (8.10 - 8.13) (in Appendix B), which 
could be incorporated in a spreadsheet as part of QA practice. Equations (8.10 -
8.13) are the appropriate forms to use when estimating the HVL and/or QVL 
because they describe attenuator thickness in terms of intensity (transmission) 
rather than Eq. (2.5), which expresses intensity as a function of attenuator 
thickness. 
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For all HVL or QVL estimation practices, the authors recommend that the 
attenuator thicknesses be measured with a digital caliper. Our findings indicated 
that the nominal thicknesses of AI 1100 differed from the measured thicknesses 
by up to 10%. Therefore, by not measuring the attenuator thicknesses, the HVL 
and QVL estimates could be misrepresented, for instance, by as much ±0.8 mm 
of aluminum and ±1.79 mm of aluminum, respectively, at 120 kVp. Additionally, 
constants flo and A would change if the nominal rather than the measured 
attenuator thicknesses were used to determine these values, potentially leading 
to further misrepresentation of the HVL and QVL estimates. Since the nominal 
attenuator thicknesses were only precise to ±10%, it is reasonable that the 
original acceptance criterion of 5% be adjusted accordingly. We can apply this 
adjustment to our data, despite the fact that we measured the attenuator 
thicknesses, because we assessed performance of the Lambert W model by 
comparing measured and predicted transmissions rather than by comparing the 
HVL and QVL estimates to their true values. Since all RPDs observed in this 
study (0.00 - 5.17%) met the adjusted acceptance criterion, we can conclude that 
Lambert W interpolation accurately estimated transmission through both the HVL 
and QVL regardless of the choice of interpolation data points. 
Besides using the proposed Lambert W model to estimate the HVL and 
QVL, Eq. (2.5) could also be applied for other purposes, such as empirically 
determining attenuation through a given thickness of radiation protective clothing 
(i.e., in-plane bismuth breast shields, lead aprons, etc.); the international 
standard lEG 61331-3 specifies that the lead-equivalent thickness of a material 
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used for radiation-shielding garments be measured under narrow-beam 
geometry.130 Additionally, Eq. (2.5) can be used in Me modeling, as well as in 
other computer simulations of attenuation of an x-ray beam through inherent, 
bowtie, or other filtration. However, in order to apply Eq. (2.5) in either of these 
circumstances, additional analysis would need to be performed to validate the 
Lambert W model under the specific conditions being tested or modeled. 
2.5. CONCLUSION 
The empirical model proposed in this study represents a generalized 
Lambert-Beer law that describes attenuation of both monoenergetic and 
polyenergetic radiation. In the case of monoenergetic radiation, the proposed 
Lambert W model mathematically reduces to the Lambert-Beer law. Applications 
of the Lambert W model relevant to polyenergetic radiation include HVL 
estimation and narrow-beam patient shielding (e.g., lead apron) calculations. 
HVL estimation is simplified by the Lambert W model because only two 
attenuator thicknesses need to be supplied (e.g., 2 mm and 30 mm of AI 1100). 
Additionally, the Lambert W model can be utilized to jointly interpolate both the 
HVL and QVL from the same two measured data points. Besides yielding more 
accurate estimates of the HVL and/or QVL compared to traditional methods (Le., 
semilogarithmic and linear interpolation), other advantages of using Lambert W 
interpolation are that it is less time-consuming (as it requires less guess-work 
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and fewer measurements) and less vulnerable to experimenter error (since it is 
relatively insensitive to the choice of interpolation points). 
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CHAPTER 3 
PRECISION OF DOSIMETRY-RELATED MEASUREMENTS 
OBTAINED ON CURRENT MDCT SCANNERS 
PURPOSE: CT intrascanner and interscanner variability has not been well 
characterized. Thus, the purpose of this study was to examine the within-run, 
between-run, and between-scanner precision of physical dosimetry-related 
measurements collected over the course of one year on three different makes 
and models of MDCT scanners. 
METHODS: Physical measurements were collected using nine CT scanners (three 
scanners each of: GE LightSpeed VCT, GE LightSpeed 16, and Siemens 
Sensation 64). Measurements were made using various combinations of 
technical factors, including kVp, type of bowtie filter, and x-ray beam collimation, 
for several dosimetry-related quantities, including: (a) free-in-air CTDI (CTDI1oo, 
air); (b) calculated HVLs and QVLs; and (c) CTDlw calculated from exposure 
measurements collected in both a 16-cm and 32-cm CTDI phantom. Data 
collection was repeated at several different time intervals, ranging from seconds 
(for CTDI10o. air values) to weekly for three weeks and then quarterly or triannually 
for one year. Precision of the data was quantified by the percent coefficient of 
variation (%CV). 
RESULTS: The maximum relative precision error (maximum %CV) across all 
dosimetry metrics, time periods, and scanners included in this study was 4.33%. 
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The median observed %CVs for CTDI1Oo, air ranged from 0.05% to 0.19% over 
several seconds, 0.12% - 0.52% over one week, and 0.58% - 2.31% over three 
to four months. For CTDlw for a 16-cm and 32-cm CTDI phantom, respectively, 
the range of median %CVs was 0.38% - 1.14% and 0.62% - 1.23% in data 
gathered weekly for three weeks and 1.32% - 2.79% and 0.84% - 2.47% in data 
gathered quarterly or tri-annually for one year. 
CONCLUSION: From a dosimetry perspective, the MDCT scanners tested in this 
study demonstrated a high degree of within-run, between-run, and between-
scanner precision (with relative precision errors typically well under 5%). 
3.1. INTRODUCTION 
Recent media attention regarding risk to patients receiving CT scans has 
prompted the need for more accurate patient radiation dose estimates.45 MC 
computer modeling is making fast progress in the area of CT dose estimation 
and is moving closer towards clinical use. One such advancement was the recent 
development of an equivalent source model, which uses physical data, including 
the HVL and QVL to construct virtual models of CT scanners.116 Equivalent 
source models are constructed for every combination of scanner make and 
model, kVp, and type of bowtie filter because a unique x-ray spectrum, which is 
energy-dependent and filtration-dependent, exists for each scanner. Once an 
equivalent source model has been constructed, free-in-air exposures are used in 
the calculation of normalization factors (described by DeMarco et al.) which 
convert output of the MC model to absolute dose (in mGy/mAs); a unique, 
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scanner-specific normalization factor exists for every combination of technical 
factors,81 including kVp, bowtie filter, and x-ray beam collimation. This study 
sought to expand the number of available equivalent source MC models by 
supplying the HVL, QVL, and CTDI 1oo, air at multiple techniques for three scanner 
models produced by two manufacturers. 
In order for MC models to be considered reliable or trustworthy, accuracy 
of the dose estimates obtained from the model must be verified by benchmarking 
the model. Benchmarking, or validating, a MC model entails comparing the 
output of the simulation with the same type of physical dose metric 
experimentally collected on the same type of CT scanner under the same 
conditions as simulated. Because the HVL and QVL are used to construct 
equivalent source models and CTDI10o, air values are used to convert MC output 
to dose, these quantities cannot be used for benchmarking purposes; instead, 
CTDlw values can be employed. Although most MC codes are validated with 
CTDlw data for only one kVp, CTDlw data were collected at several kVps in this 
study because validating a code at multiple energies demonstrates a more robust 
model and thus provides a stronger validation. 131 
Previous studies have shown that a MC model can yield dose estimates 
that agree within 3.5% to physical data collected in a 32-cm diameter CTDI 
phantom on a LightSpeed 16 CT scanner (GE Healthcare).81 Although 3.5% 
appears to indicate a high level of conformity, the data used to benchmark the 
model were obtained from a single scanner during a single measurement 
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session; such measurements could potentially vary between scanners and over 
the lifetime of a scanner. Additionally, the level of agreement between MC dose 
estimates and physical dose measurements necessary for validation of the 
model has not yet been established. Therefore, in order to develop "pass-fail" 
benchmarking criteria, it is important to gauge measurement precision, or the 
closeness of repeated measurements obtained from a given scanner or "sibling" 
scanners of the same model. Measurement precision is most commonly 
quantified through the %CV, which is defined as the standard deviation divided 
by the mean multiplied by 100%.132 Quantifying the accuracy (closeness of a 
measured value to the true value) of dosimetry data is difficult because there is 
often no gold standard. 
According to the International Organization for Standardization (ISO), 
measurement precision encompasses measurement repeatability, intermediate 
precision, and reproducibility.133 Repeatability, or within-run precision, refers to 
precision estimates obtained when tests are performed over a very short time 
period by the same experimenter using the same equipment on the same subject 
at the same location; in this study, within-run precision was characterized using 
CTDI 10o. air values calculated from repeated free-in-air exposure measurements. 
Intermediate precision, or within-laboratory reproducibility, refers to precision 
estimates obtained when measurements are made at one testing site on different 
days (between-run), by different experimenters (between-operator), or using 
different test equipment (between-scanner); between-run and between-scanner 
precision were evaluated in this study. Between-run precision was assessed for 
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two different between-run time periods by conducting both weekly and quarterly 
(every three months) or triannual (every four months) measurement sessions. 
Between-scanner variability was determined by comparing dosimetry values 
collected on sibling scanners of the same model. Reproducibility, which ISO 
refers to as between-laboratory precision, could not be assessed in this study 
due to lack of feasibility. Therefore, short-term and long-term intrascanner 
[within-run, between-run (weekly), and between-run (quarterly or triannual)] and 
interscanner (between-scanner) precision were characterized in this study. 
The purpose of this study was two-fold: first, to collect a series of 
dosimetry-related values (CTDI1Oo, air, HVL, QVL, and CTDlw) on different makes 
and models of MDCT scanners in order to develop and benchmark MC 
equivalent source models; and second, to facilitate the eventual formation of 
"pass-fail" benchmarking criteria by characterizing the short-term and long-term 
intrascanner and interscanner precision of the data collected. 
3.2. MATERIALS AND METHODS 
3.2.1. RADIATION DOSIMETRY MEASUREMENTS 
Exposure readings were measured using a 10-cm pencil ionization 
chamber and an electrometer (RadCal Corporation) on three LightSpeed VCT 
and three LightSpeed 16 CT scanners (GE Healthcare) at site A and three 
Sensation 64 CT scanners (Siemens Healthcare, Forchheim, Germany) at site B. 
87 
~~----------
Readings were collected on all nine scanners at various time intervals over the 
course of one year; the authors chose this time period because it was within the 
time frame of what is considered a long-term study (as specified by Bonnick and 
Lewis)134 and because it roughly reflected the average lifespan of the CT x-ray 
tubes at both sites. At the beginning of each measurement session, within-run 
precision was gauged by collecting repeated free-in-air exposure measurements 
using a constant technique. Subsequently, the remaining data (free-in-air 
exposure measurements using varying techniques, HVL, QVL, and CTDlw 
calculated values) were acquired on the scanner. To evaluate both between-run 
(weekly) and between-scanner variation, the entire set of measurements was 
repeated on each scanner at both one-week and two-week intervals after the 
original measurement session. Between-run (quarterly or triannual) variation was 
assessed by repeating the measurement sessions every three to four months 
after the original session for one year; quarterly or triannual measurements were 
collected on five of the scanners (one GE LightSpeed VeT, one GE LightSpeed 
16, and three Siemens Sensation 64 scanners). Table 3.1 summarizes the timing 
of all measurement sessions performed using each scanner. 
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3.2.1.1. CALCULATED CTDI1oo, air VALUES 
At the beginning of each measurement session, the active detection 
volume of the ionization chamber was suspended free-in-air at or above the 
geometrical center of the gantry bore as shown in Figure 3.1; the central hole of 
a 16-cm CTDI phantom, which was placed in the patient head holder, was used 
to suspend the chamber. After aligning the chamber, within-run precision was 
characterized by collecting 20 consecutive free-in-air exposure measurements 
over several minutes on each scanner using the techniques described in Table 
3.2 in axial scan mode. The delay between repeated exposures was a few 
seconds (the time necessary to acquire and record an individual reading). The 
free-in-air setup was maintained and exposures were collected using various 
bowties, kVps, and collimations; collimation encompasses both the number of 
active channels and the channel width. Measurements were collected at a fixed 
collimation while varying the kVp and at various collimations at a fixed kVp of 
120, as described in Table 3.3. All exposure measurements were converted to 
CTDI1oo, air using Eq. (1.4). 
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3.2.1.2. CALCULATED HVL AND QVL 
The free-in-air CTDI setup was maintained and this test was performed in 
service mode so that the x-ray tube could be held stationary (i.e., in a 
nonrotational mode with the x-ray tube positioned at a fixed angle) at 180°, which 
corresponds to the bottom of the gantry; this setup has been shown to be an 
appropriate method for determining HVL. 123 Next, sheets of type 1100 aluminum 
alloy were placed at the bottom of the gantry so that they directly covered the x-
ray tube output port, as shown in Figure 3.2. Finally, the measured-exposure 
versus aluminum-thickness data for each combination of technical factors 
described in Table 3.4 were interpolated (using Eqs. [8.10] - [8.13] in the 
appendix to calculate HVL and QVL). 
FIGURE 3.2. To determine HVL and QVL, an ionization chamber (circle) was 
suspended free-in-air at isocenter and sheets of 1100 aluminum alloy (arrow) 
were placed at the bottom of the scanner gantry covering the x-ray beam, which 
was held stationary at 180°. 
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3.2.1.3. CALCULATED CTD1w 
Exposure measurements were collected inside the two standard sizes of 
CTDI phantoms (i.e., 16-cm and 32-cm); the 16-cm phantom was placed in the 
patient head holder, while the 32-cm phantom was placed directly on the patient 
table top. Both phantoms were positioned such that their central and 12:00 
peripheral chamber locations were aligned with the scanner's sagittal and 
coronal laser lights (see Fig. 3.3). Following standard methods, exposure 
readings were recorded with the ionization chamber placed inside both the 
central and 12:00 peripheral chamber holes; PMMA filler rods were placed in the 
four empty chamber holes. 135, 136 All measurements were collected for a single 
axial rotation using the techniques described in Table 3.5. CTDlw was calculated 
for both CTDI phantoms from the peripheral and central exposure measurements 
using Eq. (1.5). 
FIGURE 3.3. The central chamber holes of both a (a) 16-cm and (b) 32-cm CTDI 
phantom were aligned to gantry isocenter using the scanner's laser positioning 
lights. Subsequently, measurements were collected at the central and 12:00 
peripheral chamber holes in both phantoms. 
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3.2.2. STATISTICAL ANALYSIS 
Precision of the dosimetry data was characterized by %CVs, which were 
calculated in a two-tier process. In the lower tier, data were grouped according to 
the type of precision being characterized [i.e., between-run (weekly) precision] 
and individual %CV values were calculated from this data. Table 3.1 shows the 
data grouping used to calculate individual %CV values for each type of precision; 
within-run precision is not shown in the table because individual %CV values 
were calculated from 20 repeated CTDI 1oo, air values, which were collected on a 
single scanner during a single session. Because scanner model and technical 
factors have a known effect on absolute exposure, individual %CV values were 
always calculated from measurements collected at the same technical factors 
(bowtie filter, kVp, and collimation) on the same make and model of scanner. 71 , 
137 In the upper tier, individual %CVs were pooled within each precision type [i.e., 
between-run (weekly) precision], scanner model, and dosimetry metric (i.e., 
CTDI1Qo, air) to calculate the median and range. The median and range of %CV 
values were reported rather than an average and confidence interval because 
the presence of potential outliers was detected within the pooled data sets. 138, 139 
The following example illustrates the process that was employed to 
calculate the %CV values reported in this study. Between-run (weekly) precision 
of CTDI 1oo, air values calculated from exposure measurements made on the GE 
LightSpeed 16 scanners was determined by computing individual %CV values 
from three CTDI 1oo, air data points collected at a given technique and each 
98 
gathered one week apart on a given scanner unit. Because data were collected 
for 12 techniques per scanner on three scanners, a total of 36 individual 
between-run (weekly) O/OCV values were calculated. These 36 O/OCV values were 
then pooled to determine the median and range of between run (weekly) 
precision of free-in-air CTDI values collected on GE LightSpeed 16 scanners. 
Similarly, between-run (quarterly and triannual) individual O/OCVs were calculated 
using five quarterly or four triannual dosimetry values and between-scanner 
individual O/OCVs were calculated from dosimetry values collected on three 
"sibling" scanners of the same model; individual O/OCVs were then pooled across 
technique and "sibling" scanners (for between-run precision) or measurement 
sessions (for between-scanner precision). 
Pooling data across techniques and either "sibling" scanners or 
measurement sessions better represents overall scanner performance than 
assessing the precision of data collected at one technique on one scanner during 
one session, which could overestimate or underestimate true performance. 134 
Additionally, pooling across these factors increases the degrees of freedom and 
thus the statistical validity of the results. Although precision error could potentially 
vary from technique-to-technique, scanner-to-scanner, and session-to-session, 
the purpose of this study was to characterize the general performance of the 
scanners over a broad range of conditions rather than to develop a precision 
profile. 
99 
3.3. RESULTS 
Over 850 individual %CV values were calculated, which ranged from 
0.00% to 4.33% across all dosimetry metrics, precision types, and scanners 
included in this study; over 95% of the calculated %CVs were less than 2.75%. 
Free-in-air CTDI calculated values and the corresponding precision 
results, respectively, appear in Table 3.6 and 3.7 for each scanner make and 
model; because different current-exposure time products were used across 
scanner types, all CTDI 10o. air values were normalized to 100 mAs. Table 3.6 
shows a large spread of CTDI1oo. air values (5.8 - 46.7 mGy/100 mAs), which 
were influenced by the scanner model and technical parameters selected. Table 
3.7 shows intrascanner and interscanner variation in CTDI100 air values to be 
extremely low, with all %CVs less than 5%. One subtle trend emerged from 
these results, which was that in most cases, the scanners displayed 
progressively worse intrascanner precision as the between-run time increased 
from a few seconds to a week to several months. 
100 
TABLE 3.6. Mean and standard deviation, in parentheses, of CTDI 10o, air calculated 
values; "-" indicates the scanner either does not offer that bowtie option or that 
beam width. CTDI 100 air values were normalized to 100 mAs to account for 
differences in scanning protocols used on the different scanner makes and 
models. 
CTDI10o, air (mGy/1 00 mA·s) 
kVp Beam width Bowtie GE GE Siemens (mmf UghtSpeed UghtSpeed Sensation 
VCT 16 64 
80 20,40 Small 12.4 (0.3) 11.4 (0.1) 
80 40 Medium 12.4 (0.3) 
80 20,28.8,40 Large 8.9 (0.2) 8.4(0.1) 5.8 (0.1) 
100 20,40 Small 20.4 (0.4) 19.1 (0.2) 
100 40 Medium 20.3 (0.4) 
100 20,28.8,40 Large 15.6 (0.2) 15.0 (0.2) 11.1 (0.3) 
120 5 Small 46.7 (1.4) 43.5 (0.9) 
120 10 Small 37.3 (0.7) 35.0 (0.5) 
120 20 Small 31.4 (0.4) 28.0 (0.4) 
120 40 Small 29.5 (0.5) 
120 5 Medium 46.7 (1.5) 
120 10 Medium 37.3 (0.8) 
120 20 Medium 31.4 (0.5) 
120 40 Medium 29.4 (0.5) 
120 5 Large 37.7 (1.2) 35.9 (0.7) 16.2 (0.3) 
120 10 Large 30.1 (0.5) 28.8 (0.4) 16.3 (0.3) 
120 19.2 Large 19.6 (0.3) 
120 20 Large 25.3 (0.3) 23.1 (0.3) 
120 28.8 Large 18.1 (0.3) 
120 40 Large 23.8 (0.3) 
140 20,40 Small 39.7 (0.6) 38.1 (0.5) 
140 40 Medium 39.6 (0.6) 
140 20,28.8,40 Large 33.1 (0.4) 32.4 (0.5) 27.2 (0.5) 
"At 80 kVp, 100 kVp, and 140 kVp, nominal beam widths of 20 mm, 28.8 mm, and 40 
mm were tested exclusively on the GE LightSpeed 16, Siemens Sensation 64, and GE 
LightSpeed VeT scanners, respectively. 
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3 
The calculated HVLs and QVLs and their precisions appear in Table 3.8 
and 3.7, respectively. As shown in Table 3.8, the mean HVLs ranged from 5.4 
mm to 9.7 mm of aluminum and the mean QVLs ranged from 12.0 mm to 21.1 
mm of aluminum, depending on the scanner model and technical factors tested. 
Table 3.7 shows extremely low short- and long-term intrascanner and 
interscanner variability in the HVLs and QVLs, with all median and individual 
%CVs less than or equal to 1.04% and 2.74%, respectively. 
TABLE 3.8. Mean and standard deviation, in parentheses, of the calculated HVLs 
and QVLs (in mm of aluminum); "_" indicates that the scanner does not offer that 
bowtie option. 
HVL (mm AI) 
kVp Bowtie GE LightSpeed GE LightSpeed Siemens 
VCT 16 Sensation 64 
80 Large 5.4 (0.09) 5.9 (0.07) 6.2 (0.08) 
100 Large 6.6 (0.05) 7.2 (0.05) 7.6 (0.08) 
120 Small 6.6 (0.03) 7.2 (0.06) 
120 Medium 6.6 (0.01) 
120 Large 7.7 (0.05) 8.3 (0.09) 8.7 (0.09) 
140 Large 8.6 (0.14) 9.2 (0.04) 9.7(0.10) 
QVL (mm AI) 
80 Large 12.0 (0.10) 13.0 (0.10) 13.6 (0.11) 
100 Large 15.0 (0.11) 16.0 (0.11) 16.5(0.13) 
120 Small 15.4 (0.11) 16.6 (0.09) 
120 Medium 15.5 (0.08) 
120 Large 17.5(0.10) 18.5 (0.10) 18.9 (0.14) 
140 Large 19.8 (0.13) 20.7 (0.08) 21.1 (0.15) 
104 
The calculated CTDlw values (normalized to 100 mAs) for the 16-cm and 
32-cm CTDI phantoms and their relative precision errors appear in Table 3.9 and 
3.7, respectively. Table 3.9 shows the range of CTDlw values obtained from both 
the 16-cm (3.9 - 28.2 mGy/100 mAs) and 32-cm (1.7 - 12.7 mGy/100 mAs) 
CTDI phantoms. Table 3.7 shows that, with a few exceptions, the median %CV 
values (0.38 - 2.79%) were slightly higher compared to the other dosimetry 
metrics (CTDI10o, air, HVL, and QVL). Despite the slightly higher (in general) 
relative precision errors observed in this portion of the study, the results still 
demonstrated extremely low variability, with all %CV values below 5%. 
105 
TABLE 3.9. Mean and standard deviation, in parentheses, of calculated CTDlw 
values for a 16-cm and 32-cm CTDI phantom; "_" indicates that the scanner does 
not offer that bowtie option. CTDlw values were normalized to 100 mAs to 
account for differences in scanning protocols used on the different scanner 
models. 
CTDlw(mGy/100 mA·s) for a 16-cm CTDI phantom 
kVp Bowtie GE LightSpeed GE LightSpeed Siemens 
VCT 16 Sensation 64 
80 Small 6.6 (0.1) 6.4(0.1) 
80 Medium 7.6 (0.2) 
80 Large 3.9(0.1) 
100 Small 11.9 (0.2) 11.6 (0.2) 
100 Medium 13.5 (0.3) 
100 Large 8.0 (0.2) 
120 Small 18.1 (0.3) 17.7 (0.3) 
120 Medium 20.4 (0.4) 
120 Large 13.4 (0.3) 
140 Small 25.1 (0.3) 24.7 (0.4) 
140 Medium 28.2 (0.4) 
140 Large 20.3 (0.5) 
CTD1w (mGy/1 00 mA·s) for a 32-cm CTDI phantom 
80 Large 2.9 (0.1) 2.8 (0.0) 1.7 (0.0) 
100 Large 5.6 (0.1) 5.5 (0.1) 3.7 (0.1) 
120 Large 8.9 (0.1) 8.7 (0.2) 6.5 (0.1) 
140 Large 12.7 (0.2) 12.6 (0.2) 10.1 (0.2) 
106 
3.4. DISCUSSION 
The dosimetry data collected in this study yielded very high measurement 
precision across all conditions, time intervals, and scanners. The vast majority 
(over 95%) of the large amount of %CV values analyzed and reported in this 
study were below 2.75%, with only a few reaching 4%. Though not all existing 
MDCT scanners were tested, three different scanner models, which consisted of 
scanners from two manufacturers and two models from the same manufacturer, 
were evaluated. To further generalize the results of this study, two testing 
locations were included. In all scenarios, both intrascanner and interscanner 
relative precision errors were extremely low. 
This study's results indicate that dose estimates obtained from MC model 
simulations can be validated if they agree with physical data at a level of 5% or 
less; however, the level of acceptable mismatch is probably greater than 5% 
because measurement precision error is presumably not the only source of 
disagreement between the model and physical data. In order to develop more 
accurate validation criteria, several factors not addressed in this study should be 
considered. For example, inherent precision of the MC model, which can be 
affected by the number of photons simulated, should be taken into account 
during benchmarking experiments. Additionally, the dosimetry-related quantities 
considered in this study have different roles in MC equivalent source models 
which may influence error estimates. Specifically, HVL and QVL are parameters 
input into MC equivalent source models and therefore precision error in these 
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values propagates through the model. Precision error associated with the free-in-
air exposures, which convert MC output to dose, does not propagate through the 
model itself but does lead to variability in the absolute dose estimates obtained 
and thus error or uncertainty bars should be included with reported dose 
estimates. 
Dosimetry measurements are collected on CT scanners for various 
reasons other than for benchmarking MC dose estimates. For example, such 
results serve as a reference for CT facility management to show that, in light of 
the exceptional stability of modern CT scanners, frequent dosimetry testing is 
unnecessary for avoiding overexposure incidents. 14o Therefore, the results of this 
study also have implications for scanner compliance testing, as well as, any other 
applications that utilize scanner output (dosimetry) values. 
To the best of the authors' knowledge, no prior study has addressed the 
precision of measuring dose output from state-of-the-art MDCT scanners. 
Despite the strength of this study, sources of variation or error were present, 
including variation in scanner output, ionization chamber and electrometer 
imprecision, and setup variability between sessions and scanners. Scanner 
workloads varied from 160 to 164, 126 to 156, and 119 to 204 patients per week 
(on average over the time of the study) on the GE LightSpeed VCT, GE 
LightSpeed 16, and Siemens Sensation 64 scanners, respectively. Furthermore, 
at site B, one scanner had an x-ray tube change during the course of the study. 
At site A, a different ionization chamber and electrometer were used during the 
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third triannual measurement session on the GE LightSpeed VCT scanner. 
Additionally, at both sites, the ionization chambers and electrometers were 
calibrated prior to the study and were not recalibrated during the study and so 
drift was possible. Although the same experimenters were maintained at sites A 
and B throughout the course of the study, setup variability was unavoidable. To 
minimize setup variability at site A, centering of the ionization chamber and CTDI 
phantoms was verified by generating 1.25-mm thick images and then using a 
caliper tool to check the images for centering within at least 3 mm along both the 
x and y directions in the transverse plane (in the majority of cases, centering was 
within 1 mm). The scanners at Site B were unable to identify gantry isocenter on 
acquired CT images; therefore, only the scanners' built-in positioning laser lights 
were utilized to center the chamber and phantoms. 
Care should be taken when directly comparing the results reported in this 
study across scanner makes and models. When considering comparison of the 
%CV values, it is important to keep in mind the differences in testing locations 
and experimenters between sites A and B. Similarly, direct comparisons of 
system output (CTDI1Oo, air, HVL, QVL, and CTDlw values) across scanner models 
may be inappropriate. Although the same combination of technical factors 
resulted in measurable dose differences between scanner models, image quality 
was not assessed in this study and instead emphasis was placed on assessing 
precision. In order to properly characterize differences in dose performance 
between scanners, dose should be quantified while maintaining the same level of 
image quality across scanner models. 
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Despite the limitations of this study, the results revealed extremely low 
levels of variation in scanner output and dosimetry-related quantities across time 
and across "sibling" scanners of the same make and model. These results point 
to the exceptional similarity in "sibling" scanners and stability of the x-ray source 
output in the state-of-the-art MDCT scanners tested in this study over both very 
short periods of time and in time periods tested up to one year. 
3.5. CONCLUSION 
This study investigated the variability of CT scanner output across a range 
of time periods (from as short as a few seconds to as long as several months), 
technical parameters (kVp, bowtie filter, and x-ray beam collimation), and 
"sibling" scanners of three different makes and models. The results of this study 
demonstrated that across all conditions, the MDCT scanners tested produced 
dosimetry-related data that was precise (well within 5%) for all time periods 
tested over the course of one year. These results can be applied in MC modeling 
to improve upon and verify current MC models, thus improving the accuracy of 
patient dose estimates. 
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CHAPTER 4 
~~~~----------~~----------------~.----~~--~~ 
RADIATION DOSE PENALTY IN AXIAL MODE CT 
PURPOSE: A 10-millisecond (ms) rise and stabilization of the x-ray tube output 
occurs immediately prior to image acquisition on GE Healthcare CT scanners 
and is believed to contribute additional dose to anatomy facing the tube start 
acquisition angle. This dose penalty would presumably have a greater effect in 
axial scanning because the rise and stabilization time occurs for every 360 0 
rotation of the x-ray tube, whereas it only occurs at the beginning of each pass in 
helical scan mode. The purpose of this study was to characterize the dose 
penalty due to the rise and stabilization time in axial scan mode. 
METHODS: To quantify the dose penalty associated with rise and stabilization of 
the x-ray tube output, 10-cm, 16-cm, and 32-cm CTDI phantoms were scanned 
on a GE LightSpeed VCT scanner for a single axial rotation; a range of phantom 
sizes was used to account for possible variations in the dose penalty across 
patients of different sizes. Exposure was detected using a 10-cm pencil ionization 
chamber placed in the 12:00 peripheral chamber hole of each phantom. For 
various x-ray tube start acquisition angles, which were specified in scanner's 
service mode, exposure was recorded and then converted to CTDI. Additionally, 
scan factors, including phantom centering and rotation time, were varied to 
quantify their effect on the dose penalty. 
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RESULTS: In general, the dose penalty due to the 10-ms rise and stabilization 
time increased as the rotation time decreased and also as the ionization chamber 
was moved closer towards the top of the gantry (either by increasing the 
phantom diameter or by moving the phantom vertically off-center). For 1-s 
rotations, CTD1100, 12:00 was 1.0%, 1.6%, and 4.4% higher in the 10-cm, 16-cm, 
and 32-cm CTDI phantom, respectively, when a start angle of approximately 00 
was used versus a start angle of 270 0 • The dose penalty in the 32-cm CTDI 
phantom increased to 26% when using O.4-s rotations and moving the phantom 
vertically off-center by 12 cm. These observations were consistent with 
expectations based primarily on the geometry of the scanner and the setup was. 
CONCLUSION: In light of the dose penalty observed in this study, all acquisitions 
(especially axial acquisitions) should feature a start angle of 1800 to avoid 
imparting this dose penalty on superficial radiosensitive organs (e.g., breast, 
testes, and thyroid), which are more prevalent on a patient's anterior. 
4.1. INTRODUCTION 
In axial scan mode, the x-ray tube rotates around one section of the 
patient while the patient table is stationary. To image the next section, the patient 
table either moves forward or backward and another rotation is performed. In 
helical scanning, the x-ray tube continuously rotates as the patient table 
simultaneously moves through the scanner. Rather than tracing consecutive 
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rings around the patient (as in axial mode), the x-ray beam traces a spiral path in 
helical mode. In order to reconstruct the spiral data into planar images up to the 
specified image length, additional helical rotations are acquired at the beginning 
and end of a pass for interpolation. This is called z-axis overranging and refers to 
the difference between the user-specified image length (as entered on the 
scanner console) and the actual scan length including these additional 
rotations. 141 The additional rotations performed during helical scanning result in a 
dose penalty compared to axial acquisitions.142, 143 MC simulations of an MDCT 
scanner have estimated that overranging produces up to 35.8% higher doses in 
helical chest scans (pitch = 1) of a mathematical adult anthropomorphic phantom 
than in axial scans simulated at the same technique; 144 even greater MDCT dose 
penalties (up to 70%) were observed in mathematical pediatric anthropomorphic 
phantoms. 145 
Many studies have explored the effect of CT scan parameters (e.g., kVp, 
mAs, beam collimation, etc.) on radiation dose, but few have directly examined 
the dose effect of axial versus helical scan mode (outside the scope of z-axis 
overranging).146 Although contiguous axial and contiguous helical (i.e., pitch = 1) 
scan protocols using the same scan techniques have traditionally been 
considered to deliver equivalent radiation doses,147 several studies have 
revealed higher point doses in axial versus helical scanning.148-151 For instance, 
McDermott et al. observed organ doses an average of 13%, but as much as 
25%, higher in a pediatric anthropomorphic phantom when scanned in axial 
versus helical mode (with the same kVp and effective mAs [i.e., mAs/pitch]) on 
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a GE LightSpeed VCT scanner. 149 Even larger discrepancies, as high as 53%, in 
axial versus helical doses were observed by Pitman et al. when scanning an 
adult anthropomorphic phantom on a SDCT scanner. 151 McNitt-Gray et al. 
reported dose differences of between 3% and 14% in a 32-cm CTDI phantom 
scanned on a SDCT scanner using contiguous axial versus helical acquistions. 15o 
Differences between axial and helical scanning may explain the 
observation of higher doses, despite using equivalent techniques, in axial mode 
compared to helical mode. Specifically, differences in the frequency of rise and 
fall time events across scan modes may lead to dose discrepancies. Prior to 
acquisition in either scan mode, the x-ray tube output rises from zero to reach 
maximum exposure; after acquisition is finished, the tube output falls back to 
zero. Since acquisition is continuous in helical mode, the rise time (at the 
beginning) and fall time (at the end) only happen once during each helical pass. 
In contrast, rising of the x-ray tube output occurs before each axial rotation; the 
same is true when the x-ray tube output falls to its off state. The exposure 
delivered during the rise and fall time contributes to patient dose but is not 
typically used for image reconstruction. This phenomenon has been referred to 
as overscanning, which means that the beam-on time extends beyond the data 
acquisition time. 152 Overscanning due to the rise and fall, for example, would 
occur 20 more times when scanning 40-cm of a patient on a scanner with a 2-cm 
beam width in axial mode than during a single helical pass. The increased 
frequency of rise and fall time events may result in an inherent dose penalty in 
axial compared to helical scanning. However, the specific rise and fall time 
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durations and their dose contributions depend on the CT scanner make and 
model. 
The purpose of this study was to quantify the dose penalty associated with 
overscanning in CTDI phantoms during axial scanning. Additionally, the effect of 
phantom size, phantom centering, and rotation time on this/the dose penalty was 
also quantified. 
4.2. MATERIALS AND METHODS 
4.2.1. PHANTOM MEASUREMENTS 
All scans in this study were performed using a 64-channel MDCT scanner 
(LightSpeed VCT, GE Healthcare). Before data acquisitions on the GE 
LightSpeed VCT scanner, there is a 10-ms rise and stabilization time (i.e., the 
time required for the x-ray tube output to reach and remain stable at the 
prescribed value) that occurs for all scans regardless of the rotation time; fall time 
at the end of acquisition is negligible «1 ms) (determined via personal 
communication with Jiang Hsieh of GE Healthcare; 11/30/2009). Therefore, for a 
single axial rotation, exposure is delivered during the rotation time as well as the 
10 ms rise and stabilization time that occurs prior to data acquisition. 
A kVp meter (Radcal 4083; RadCal Corporation) was used measure kVp 
versus time on a GE LightSpeed VCT scanner to characterize the rise and fall 
time durations. According to the LightSpeed VCT technical reference manual, 
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rise time is the time elapsed before attaining 75% of the selected high voltage 
value and fall time is the time required to fall below 75% of the selected 
voltage. 153 Based on these definitions, the measured kVp versus time waveforms 
(data not shown) revealed that the high voltage rise and fall time lasted less than 
1 ms each. However, the measured exposure time (i.e., the time when kVp > 0) 
lasted between 1010 ms and 1011 ms for 1-s nominal exposure times. 
Therefore, the stabilization time, rather than the rise or fall time, constitutes the 
majority of the overscanning. 
The dose penalty due to overscanning is expected to increase when the 
path length between the x-ray tube and the exposure measurement location is 
minimized. Simulations performed by Nickoloff et al. showed that dose at the 
12:00 position in a CTDI phantom was higher for a stationary x-ray tube 
positioned at 0° (i.e., the top of the gantry), which has the shortest path to 12:00, 
than at any other tube angle. 154 Therefore, because overscanning occurs 
immediately prior to data acquisition, any additional dose contribution from 
overscanning would most likely be detected near the start acquisition angle of the 
x-ray tube. This was evaluated by measuring dose at a fixed position (e.g., 
12:00) inside CTDI phantoms while varying the x-ray tube start angle. 
Additionally, other factors affecting the path length between the x-ray tube and 
the dose measurement location, including the phantom diameter and positioning 
of the phantom within the gantry, were also varied. Furthermore, because the 
percentage of overscanning increases as the rotation time decreases, the dose 
effect of the rotation time was also quantified. 
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4.2.1.1. crol PHANTOMS AT ISOCENTER 
Exposure was detected using a 10-cm pencil ionization chamber 
connected to an electrometer (RadCal Corporation). The ionization chamber was 
placed at the 12:00 peripheral chamber position inside CTDI phantoms of three 
different diameters: 10-cm, 16-cm and 32-cm (see Fig. 4.1). Exposure was 
measured at 12:00 because it is the position inside CTDI phantoms that is most 
representative of the location of breast tissue in patients. The phantoms were 
placed either on the patient table (16-cm and 32-cm phantoms) or in the patient 
head holder (10-cm phantom) and their central chamber holes were aligned to 
isocenter. 
FIGURE 4.1. 10-cm, 32-cm, and 16-cm CTDI phantoms were used in this study to 
assess the dose effect of overscanning in axial CT. 
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Exposure measurements were collected using various x-ray tube start 
acquisition angles, which were specified in the scanner's service mode; Figure 
4.2 depicts the 32-cm phantom scanned using a 45° start angle. The scans 
performed in service mode corresponded to single axial rotations (without patient 
table movement). Helical scanning was not be evaluated because the start 
acquisition angle could not be controlled in helical mode. Pediatric head and 
chest protocols were used to scan the 10-cm and 16-cm phantom, respectively, 
while an adult chest protocol was used to scan the 32-cm phantom; both 0.4-s 
and 1-s rotation times were used to scan the 16-cm and 32-cm phantoms. The 
scan techniques used for each phantom appear in Table 4.1. 
?? .... ::::.::~~~y ....... ...... ... -.: ~ .... ,. s2'>~'>:! 
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FIGURE 4.2. The 32-cm CTDI phantom was scanned using various tube start 
acquisition angles; a start angle of 45° is shown in this illustration. 
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TABLE 4.1. Each CTDI phantom was scanned (in service mode) for a single axial 
rotation using the following technique(s). 
Phantom Bowtie Exposure Focal Nominal diameter rnA time kVp beam width 
(cmf filter (s) spot size (mm)t 
10 Small 200 1 120 Small 40 
16 Medium 290 0.4, 1 100 Small 40 
32 Large 400 0.4, 1 120 Large 40 
• The 10-cm phantom was placed in the head holder, while the 16-cm and 32-cm 
phantoms were placed directly on the patient tabletop. 
t The detector configuration was 64 x 0.625 mm. 
Eight exposures were collected using a start acquisition angle of 2700 for 
each phantom; these eight measurements were averaged and then converted to 
CTDI using Eq. (1.4). The mean CTD1100, 12:00 for a 2700 start angle was 
compared to the CTDls calculated for all other start angles through their percent 
differences; 2700 instead of 1800 was used for comparison to avoid the effect of 
attenuation from the patient table. The %CV for the eight exposure 
measurements collected using a start acquisition angle of 2700 was also 
calculated to characterize precision of the measurements. 
4.2.1.2. CTOI PHANTOMS OFF-CENTER 
After performing the experiments with the phantoms properly centered 
within the bore of the scanner gantry, we studied the effect of moving the 
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phantoms off-center. Off-centering was primarily evaluated using the 32-cm CTDI 
phantom because, of the three phantoms, it had the highest dose penalty due to 
overscanning. Although the dose penalty at isocenter was less substantial for the 
16-cm phantom, because there is more opportunity for off-centering in smaller 
patients (who occupy less space in the gantry) the effect of off-centering was 
evaluated to a lesser extent using the 16-cm phantom. 
The effect of vertical off-centering was assessed in the 32-cm CTDI 
phantom by measuring exposure at 12:00 with the phantom moved vertically off-
center to the limits of the patient table's range of motion (i.e., from 6 cm below to 
12 cm above the table position where the phantom's central chamber hole was 
aligned at isocenter) in 3-cm increments. Vertical off-centering was also 
assessed in the 16-cm phantom with the patient table moved 3 cm above the 
position where its central chamber hole was aligned at isocenter. Horizontal off-
centering was emulated because the patient table did not allow for horizontal 
movement and it would have been difficult to move the phantom horizontally off-
center in a controlled manner. Therefore, a second ionization chamber was 
placed at the 9:00 peripheral chamber position, allowing both vertical and 
emulated horizontal off-centering to be simultaneously evaluated by adjusting 
only the patient table height. As Figure 4.3 illustrates, this manner of emulating 
horizontal off-centering (i.e., placing an ionization chamber at 9:00 and vertically 
moving the patient table) is geometrically equivalent, except for the location of 
the patient table, to placing a chamber at 12:00 and horizontally moving the 
phantom. 
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The phantoms were scanned using the techniques listed in Table 4.1 and 
O.4-s rotations were performed, except when the 32-cm phantom was moved 12 
cm above isocenter, in which case, both O.4-s and 1-s rotations were performed. 
Exposure measurements were collected using various start angles, converted to 
CTDI (using Eq. [1.4]), and then compared (through their percent difference) to 
the mean CTDI calculated from eight exposure measurements collected for a 
start angle of 270 0 (for vertical off-centering) or 90 0 (for emulated horizontal off-
centering). 
4.2.2. COMPUTER SIMULATION 
A simple computer model was created in Matlab R2008b (MathWorks Inc.) 
to better understand the results, specifically, why we observed percent 
differences in the CTDls that were greater than the percent contributions of 
overscanning to the total exposure times (i.e., 1 % for a 1-s rotation or 2.5% for a 
O.4-s rotation). In the computer model, the CTDI phantoms were represented as 
solid PMMA (i.e., the chamber holes were not specifically included) and the 
ionization chamber was represented as a point located 1 cm below the 
phantoms' surfaces. The x-ray fan beam was modeled as originating from points 
located around the circumference of the scanner bore (which had a 70-cm 
diameter), with the beam's central ray passing through gantry isocenter. 
"Exposure" was calculated for every central ray angle from 00 - 359 0 (in 10 
increments) as the intensity, after accounting for attenuation through the 
phantom and the inverse square law, of the primary beam ray passing directly 
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through 12:00 (i.e., the point modeled as the ionization chamber). If a ray within 
the 50-cm SFOV did not pass through 12:00, as was the case for some central 
ray angles when the phantom was very far off-center, the intensity for that central 
ray angle was set to O. The total "exposure" over a full rotation was calculated for 
every start acquisition angle as the area under the curve (using trapezoidal 
integration) from 00 - 360 0 plus the area under the curve from the angle where 
the rise and stabilization time began (e.g., for a O.4-s rotation, the rise and 
stabilization time begins go before the start acquisition angle) to the start 
acquisition angle (i.e., the overscan region). The "exposures" by themselves 
were meaningless, and so their percent differences relative to the "exposure" for 
a simulated start angle of 270 0 were calculated and used to assess the dose 
penalties from overscanning in the same manner as for the measured data. 
4.3. RESULTS 
4.3.1. CTOI PHANTOMS AT ISOCENTER 
The CTDls calculated from exposures detected at the 12:00 peripheral 
chamber positions in a 10-cm, 16-cm, and 32-cm CTDI phantom are shown in 
Figure 4.4 for various x-ray tube start acquisition angles. The dose penalty for the 
start angle with the highest CTDllOo, 12:00, relative to the mean CTD1 100, 12:00 for a 
270 0 start angle, increased from 1.0% to 1.6% to 4.4% as the phantom diameter 
increased from 10-cm to 16-cm to 32-cm, respectively. Although minor dose 
penalties were observed in the 10-cm and 16-cm phantom, these penalties were 
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considered to be meaningful given that the maximum %CV for exposures using a 
start angle of 270° was 0.11 %. For all three phantoms, the peak CTDI 100, 12:00 
was observed when using a start angle of approximately 0°; this observation was 
consistent with our expectations since the path lengths through the phantoms 
were shortest for 0° start angles. However, because overscanning occurs 
immediately prior to acquisition, the peak CTDI 100, 12:00 values were observed for 
start angles that were slightly shifted from 0°. The peak CTDI 100, 12:00 occurs when 
the overscan region is centered at 0° rather than when using a start acquisition 
angle of 0°; thus, for 1-s rotations, the 10-ms of overscanning begins 
approximately 4° before acquisition, and so the peak CTDI 100, 12:00 values were 
observed when using start acquisition angles of approximately 2°. As follows, 
when O.4-s rotations were used, the peak CTDI100, 12:00 was observed when the 
start acquisition angle was further shifted away from of 0°, as shown in Figure 
4.4(b). Furthermore, when the rotation time decreased from 1 s to 0.4 s, the dose 
penalty due to overscanning increased and peak CTDI 100, 12:00 values, relative to 
the mean CTDI 100, 12:00 for a start angle of 270°, of 4.1 % and 10.5% were 
observed in the 16-cm and 32-cm phantom, respectively. 
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4.3.2. CTOI PHANTOMS OFF-CENTER 
The CTDls calculated from exposures detected at the 12:00 and 9:00 
peripheral chamber positions in a 32-cm CTDI phantom are shown in Figure 4.5 
for various start acquisition angles and amounts of vertical and emulated 
horizontal off-centering. Overscanning had a greater effect on dose as the 
phantom moved "left," "right," and above the position where its central chamber 
hole was aligned at isocenter; the opposite was observed when lowering the 
phantom. As Figure 4.5 shows, the peak CTDI100, 12:00 values, relative to the 
mean CTD1100, 12:00 values for 2700 start angles, ranged from 6.0% to 26% when 
the phantom was moved from 6 cm below isocenter to 12 cm above isocenter, 
respectively. When using 1-s rotations, the peak CTD1 100, 12:00was11% when the 
phantom was 12 cm above isocenter (graph not shown). In the emulated 
horizontal off-centering cases, the peak CTD1100, 9:00 values, relative to the mean 
CTD1 100, 9:00 values for 900 start angles, ranged from 11 % when the phantom was 
3 cm "left" or "right" of isocenter to 16% when the phantom was 12 cm "right" of 
isocenter. For the same degree of emulated left and right off-centering, the 
CTD1 100, 9:00 versus start acquisition angle curves were roughly symmetric; 
asymmetries that was observed may be attributable to the location of the patient 
table relative to the dosimeter and may not have existed if dose had been 
measured at 12:00 while physically moving the phantom left and right. 
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In the 16-cm CTDI phantom, the peak CTD1 100. 12:00 when the phantom 
was 3 cm above isocenter was observed when using a start angle of 6° and was 
6.0% than the mean CTD1100. 12:00 for a 2700 start angle. For emulated horizontal 
off-centering in the 16-cm phantom when moved 3 cm to the "right" of isocenter, 
the peak CTD1 100. 9:00 was observed for a start angle of 295° and was 5.6% higher 
compared to the CTD1100. 9:00 when using a 90° start angle. 
In addition to changes in dose due to overscanning, the CTDls were also 
affected by off-centering. We compared our results to those reported by Li et 
al. 155 to characterize the dose effect of off-centering outside the scope of 
overscanning. In the Li et aL study, a 32-cm CTDI phantom was moved below 
isocenter and dose was measured at several peripheral chamber locations, 
including the top, side, and bottom of the phantom (i.e., 12:00, 9:00, and 6:00, 
respectively). While we did not measure dose at the bottom of the phantom 
(6:00), we did measure dose for a geometrically-equivalent scenario (besides the 
location of the patient table) by measuring dose at 12:00 with the phantom 
moved above isocenter. To compare our results to those reported by Li et aL, we 
calculated the ratio of CTDls with the phantom moved off-center to CTDls with 
phantom at isocenter. Since the Li et aL study was not related to overscanning, 
we used the CTD1100. 12:00 and CTD1100. 9:00 values for 270° and 90° start 
acquisition angles, respectively, as these CTDls were not affected by 
overscanning. Table 4.2 shows that our results were consistent with those 
observed by Li et aL, confirming that overall dose and not just the dose penalty 
from overscanning is affected by off-centering. 
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TABLE 4.2. The ratio of CTOls in a 32-cm CTOI phantom when the phantom was 
positioned at isocenter to when the phantom was moved below isocenter (for a 
given peripheral dose measurement location). To provide a source of comparison 
for our results, the results of a study by Li et al. 155 are also shown. 
Distance Ratio to isocenter dose * 
below This study Li et al. studi 55 isocenter 
(mm) Top Side "Bottom" t Top Side Bottom 
0 1.00 1.00 1.00 1.00 1.00 1.00 
30 1.19 0.97 0.84 1.18 0.96 0.85 
60 1.41 0.91 0.74 1.41 0.91 0.76 
'CTDI 100, 1200 values, which were calculated from the mean of eight exposures measured 
using 270 0 start acquisition angles, were used to determine the ratios for the top and 
"bottom" positions; for the side position, CTD1 100, 900 values, which were calculated from 
the mean of eight exposures measured using 90 0 start acquisition angles, were used to 
determine the ratios. 
tFor the current study, the phantom was moved above isocenter and measurements 
were collected at 12:00, which is geometrically equivalent to the phantom being moved 
below isocenter with the chamber placed at 6:00; the only difference is the location of 
the patient table. 
4.3.3. COMPUTER SIMULATION 
Figure 4.6 shows the results of the computer simulations for the dose 
penalties versus start acquisition angles. The corresponding measured data is 
also plotted in Figure 4.6 in terms of the percent differences in the CTD1 100, 12:00 
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values across start acquisition angles, compared the CTD1 100, 12:00 values using a 
270 0 start acquisition angle. Figures 4.6(a) and 4.6(b) show the dose penalties in 
the 10-cm, 16-cm, and 32-cm CTDI phantoms when placed at isocenter and 
scanned using 1-s rotations; Figures 4.6(c) and 4.6(d) show the dose penalties in 
the 32-cm CTDI phantom when moved vertically off-center for O.4-s rotation 
times. The data shown in Figure 4.4(a) and Figure 4.5(a) was used to construct 
Figures 4.6(a) and 4.6(c), respectively, while the computer model generated the 
data shown in Figures 4.6(b) and 4.6(d). Despite a gross simplification of the 
measurement conditions, such as not accounting for scatter, not modeling the 
shape of the bowtie filter, and not modeling the patient table, the computer model 
was able to closely predict the dose penalties due to overscanning. This 
indicates that the observed dose penalties were consistent with what would be 
expected based primarily on the geometry of the experimental setup used (i.e., 
phantom diameter, gantry diameter, scan field of view, etc.). 
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4.4. DISCUSSION 
In this study, we characterized the dose effect of overscanning, in the form 
of a 10-ms rise and stabilization time which occurs prior to data acquisition on 
GE scanners. Dose penalties of up to 26% were observed on a GE LightSpeed 
VCT scanner due to overscanning. Furthermore, overscanning was shown to 
have a greater impact on dose for larger phantoms, shorter rotation times, and 
for regions in closer proximity to the tube start angle. To the best of the authors' 
knowledge, no prior study has quantified the dose penalty due to overscanning. 
Based on the results of the off-centering portion of this study, moving 
patients above isocenter could be considered to be a breast dose-reduction 
strategy. However, moving a phantom above isocenter can affect TCM by 
magnifying the patient's size in an anteroposterior localizer, thus resulting in 
higher tube currents than necessary being used.156 Additionally, off-centering 
affects image quality because the bowtie filter is designed to match a patient's 
cylindrical shape, assuming the patient is properly centered within the gantry.157 
For these reasons, patient off-centering is not recommended for dose reduction. 
One of the objectives of this study was to pinpoint the 13% average 
decrease in point doses observed between axial and helical scan modes in the 
prior study by McDermott et al. 149 The McDermott et al. study featured a small 
phantom, 1-s rotations, and appropriate centering; thus, based on the results of 
this study, the dose penalty due to overscanning should have been less than 2% 
and does not explain the results of the McDermott et al. study. Additionally, 
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overranging was not considered to be a factor since the scan setup was such 
that any overranging would have occurred well beyond the location of the TLD 
point dosimeters. Instead, it is likely that the results observed in the McDermott et 
al. study can be explained by the use of TLDs to estimate point doses; issues 
with comparing point dose estimates obtained across scan modes due to 
differences in alignment of the z-axis radiation dose profiles in relation to the 
TLDs have been reported. 158 On the other hand, overscanning does explain 
reported inconsistencies in CTDI around the periphery of a CTDI phantom. For a 
single axial rotation, dose measured by a 10-cm pencil ionization chamber at the 
12:00 chamber position in a 32-cm CTDI phantom was reported to be 5% larger 
than dose at the 3:00 and 9:00 positions, which is consistent with the results of 
th is study. 159 
Helical dose estimates are commonly calculated from data collected in 
axial mode by scaling according to pitch. However, this conversion does not take 
into account the increased frequency of overscanning events that occurs in axial 
compared to helical scan mode. Although contiguous axial and helical (pitch = 1) 
scan protocols with the same scan parameters have traditionally been 
considered to deliver equivalent doses,150 the results of this study indicate that 
helical dose could be overestimated by as much as 26%. Because the dose 
penalty due to overscanning is not uniform within the scan plane and is largest 
near the tube start acquisition angle, it would not be easy to incorporate a 
correction for overscanning into standard dose estimates. 
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Because overscanning has been given little attention, to the best of the 
author's knowledge, efforts have not been made to reduce this penalty. We 
suggest that both axial and helical acquisitions feature a default start acquisition 
angle of 1800 (i.e., bottom of the gantry) because the dose penalty due to 
overscanning is largest near the x-ray tube start acquisition angle and superficial 
radiosensitive organs (e.g., breast, testes, and thyroid) are more prevalent on the 
anterior side of patients. Furthermore, the patient table would attenuate some of 
dose penalty due to overscanning if a 1800 start acquisition angle was used. 
While these results indicate that contiguous helical scanning (i.e., pitch = 
1) may provide a dose advantage over axial scanning (all other technique factors 
being equal) within the scan extent (not including helical overranging), helical 
scanning is also associated with a dose penalty. In some cases, helical scanning 
is expected to have increased dose compared to axial scanning because of 
overranging. Organs that are outside the scan extent and would not have been 
directly exposed in axial scan mode could potentially be exposed due to 
overranging in helical scan mode. Although the dose penalties reported from 
overscanning are generally less than from overranging, one scan mode does not 
display a clear advantage over the other. For instance, if the organs beyond the 
acquisition length are not sensitive, while organs within the scan length are, then 
helical scanning could provide an advantage over axial scanning. On the other 
hand, in cases where single images are acquired (e.g., delayed kidney and/or 
bladder in pediatric CT exams), axial mode would be preferred to avoid 
overranging. Thus, a general recommendation on which mode is preferable for 
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dose savings cannot be made; instead, the specific nature of the examination 
must be considered to determine which mode provides a dose advantage. 
4.5. CONCLUSION 
In light of the dose penalty observed in this study, all acquisitions 
(especially axial acquisitions) should feature a default start angle of 180 0 to avoid 
imparting the dose penalty from overscanning on superficial radiosensitive 
organs (e.g., the. breast, testes, and thyroid), which are more prevalent on the 
anterior side of patients. Furthermore, factors like patient centering are important 
across both acquisition modes. 
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CHAPTER 5 
-------------------------------------------
VARYING KVP AS A MEANS OF REDUCING CT BREAST DOSE 
TO PEDIATRIC PATIENTS 
PURPOSE: The radiosensitivity of breast tissue is relatively high (compared to 
other tissues) and inversely related to age at exposure. Therefore, young girls 
represent a high-risk patient population from radiation exposure during CT 
scanning. We investigated the possibility of reducing radiation dose to the breast 
tissue of pediatric female patients by using multiple tube voltages during a single 
CT examination. 
METHODS: The kVp was raised or lowered at angular positions (during the x-ray 
tube's 360 0 rotation) that corresponded to direct exposure of breast tissue; this 
strategy was called kVp splitting. kVp splitting is a novel strategy and thus has 
not been implemented in CT scanners. To evaluate of potential of kVp splitting, it 
was emulated when scanning anthropomorphic phantoms representative of a 5-
year-old, 10-year-old, and an adult female by using a different kVp over the 
anterior and posterior tube angles (for every pair of the available kVp options). 
Dose savings from kVp splitting were calculated relative to using a static kVp 
over all tube angles. MC simulations with and without kVp splitting (using the 
optimal anterior and posterior kVps determined in the anthropomorphic 
phantoms) were performed to estimate breast dose-savings in voxelized patient 
models constructed from the CT images of a small, medium, and large pediatric 
female. 
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RESULTS: Scans emulating kVp splitting in anthropomorphic phantoms revealed 
dose savings, relative to static kVp scans, when using 80 kVp over the posterior 
tube angles in all three phantoms, regardless of the anterior kVp. MC simulations 
of kVp splitting, which used 80 kVp over the posterior tube angles and 100 kVp 
(for the small and medium voxelized models) or 120 kVp (for the large voxelized 
model) over the anterior angles, revealed breast dose-savings of between 9.8% 
and 34%, compared to scans using the anterior kVp for the entire scan. 
CONCLUSION: kVp splitting was estimated to reduce absorbed dose to the breast 
tissue by between 9.8% and 34%. However, image reconstruction algorithms and 
the image quality of scans with kVp splitting must be further investigated before 
this strategy can be implemented clinically. 
5.1. INTRODUCTION 
An inverse relationship between a patient's age at the time of exposure to 
ionizing radiation and the patient's relative radiation sensitivity has been 
reported.43 Therefore, pediatric patients undergoing CT scanning are at higher 
risk for adverse health effects (e.g., cancer) than adult patients. Furthermore, 
according to the ICRP's most recent tissue weighting factors, female breast 
tissue is among the most radiosensitive tissues. 38 For these reasons, the risk of 
breast cancer is considered to be especially high for pediatric female patients 
undergoing CT procedures. 
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Many user-input scan parameters, including the kVp, tube current, and 
exposure time, influence the amount of radiation patients are exposed to during 
CT scanning. 146 The x-ray tube current and exposure time affect the number 
(quantity) of photons generated by the x-ray tube and are linearly proportional to 
radiation dose.6 The kVp affects both the quantity and energy (quality) of photons 
in the beam and dose is directly proportional to the 2.5 or 2.8 power of kVp.160 
Although both the tube current and kVp can be adjusted to reduce radiation 
dose, reducing the quantity of x-rays affects both the spatial resolution and image 
noise. 146,161 
Adjusting the x-ray tube current is the simplest and most predictable means of 
reducing dose.95 Thus, TCM is often employed, which enables CT scanners to 
vary the tube current throughout scanning according to a patient's anatomy.99 
TCM allows for dose reduction because only the photons needed to maintain a 
desired level of image quality are delivered to each anatomical region; TCM also 
makes it possible to maintain consistent image quality throughout the entire 
examination. In MC simulations of TCM on 30 voxelized female patient models, 
glandular breast dose was reduced by an average of 17% compared to scans 
using a static rnA; however, TCM was also shown to increase breast dose in 
some larger patients. 162 
A form of TCM specifically designed to reduce breast dose has recently 
been developed (X-Care; Siemens Healthcare). X-Care reduces direct exposure 
of the breast tissue by either greatly reducing or completely turning off the x-ray 
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tube current (i.e., 0 mA) over the breasts. A similar technology (HandCare; 
Siemens Healthcare) was tested in CT fluoroscopy and was shown to reduce 
breast dose by 47%, as measured using TLDs in an adult female 
anthropomorphic phantom, when the x-ray beam was turned off over the top 
1200 of the rotation. 163 Computer simulations have estimated breast dose 
reductions of nearly 50% using X-Care. 113 However, because posterior tube 
current was increased to maintain image quality (in the absence of anterior 
projection data), higher doses to the spine and bone marrow were also estimated 
in the simulations. 113 
Dose is roughly quadratically proportional to kVp, but only linearly 
proportional to tube current; therefore, varying the kVp during scanning may 
result in greater dose-savings than from either TCM or X-Care. However, the kVp 
affects both beam quality and quantity, and so the relationships between kVp, 
dose, and image quality are much complex than with tube current. kVp affects 
the image contrast and in order to achieve acceptable image quality, kVp 
reduction may require a compensatory increase in tube current. In pediatric 
patients, the compensatory tube current increase may be less important because 
reducing the kVp (for a fixed tube current) has been reported to have a lesser 
impact on image noise in smaller versus larger phantoms. 164 Likewise, in a study 
by Kim and Newman, diagnostic image quality was maintained when 
simultaneously reducing both the kVp and tube current across pediatric 
protocols. 165 Because increasing the kVp increases the beam's penetrability, 
which means that photons are less likely to be attenuated at the patient's surface 
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(breast tissue is a relatively superficial organ), breast dose reduction may be 
possible even with a compensatory increase in the tube current. 
We evaluated the possibility of reducing CT breast dose by changing the kVp 
at angular positions of the x-ray tube that would correspond to direct exposure of 
patients' breast tissue. Therefore, the kVp was either raised or lowered when the 
x-ray tube was over the breast; both options were tested in light of the complex 
relationship between surface dose and kVp. Because the kVp effectively "splits" 
into two values during rotations over the breasts (illustrated in Fig. 5.1) and then 
converges back to a single kVp once past the breasts, we will refer to this 
technique as "kVp splitting." Although kVp splitting involves the use two kVps 
within a single scan, it is not to be confused with dual-energy CT, which acquires 
data for a full rotation at each kVp. 
FIGURE 5.1. kVp splitting is a novel strategy for reducing CT breast dose by 
varying the kVp over the breast tissue. 
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The purpose of this study was to quantify the potential of kVp splitting for 
reducing CT breast dose. Because CT scanners currently do not allow for kVp 
splitting, the physical data that could be collected to assess this technique's 
effectiveness was limited. Therefore, MC computer modeling was employed to 
simulate kVp splitting on voxelized models generated from the CT images of 
female pediatric patients of different size and age. 
5.2. MATERIALS AND METHODS 
5.2.1. MEASURED DATA 
Before MC modeling was used, physical data was collected to guide the 
MC simulations using CTOI and anthropomorphic phantoms. CT01100. air and 
CT01 100. 12:00 (for a 16-cm and 32-cm CTOI phantom) were measured at all of the 
four available kVp options to determine how dose varies with kVp and thus how 
the tube current should be adjusted in scans with kVp splitting. The anterior and 
posterior kVps used in the MC simulations of kVp splitting were selected based 
on measured data collected in anthropomorphic phantoms. 
5.2.1.1. CTDI 
Adjustment of the tube current is typically needed to maintain constant CT 
image quality when the varying the kVp. However, because CT images could not 
be acquired with kVp splitting, image quality could not be directly evaluated. 
Therefore, we instead determined the tube currents that would keep CTOI 
141 
constant across kVps. Because of the reported inconsistencies in the powers of 
kVp which CTDI is proportional to,6, 160, 166 these powers were determined within 
the context of this study. 
To determine the powers of kVp that dose varies as, exposures were 
detected at 80 kVp, 100 kVp, 120 kVp, and 140 kVp using a 10-cm pencil 
ionization chamber (RadCal Corporation) connected to an electrometer. The 
ionization chamber was initially suspended free-in-air at the gantry isocenter, 
which allowed us to measure exposure without the effect of scatter from a 
phantom or the patient table. Next, the ionization chamber was placed at the 
12:00 peripheral chamber position inside a 16-cm and 32-cm CTDI phantom 
placed on the patient tabletop; the chamber was positioned at 12:00 because this 
position most closely represents the location of breast tissue in a patient. For 
both setups, data was collected on a LightSpeed VCT scanner (GE Healthcare) 
in axial scan mode using single 0.5-s rotations. Additionally, the small focal spot 
size, which was controlled by the tube current, and the "large body" SFOV, which 
employed the large bowtie filter option, were used to match the protocols for 
scanning pediatric patients at our facility. A LightSpeed VCT scanner was used 
for data collection because it is a state-of-the art CT scanner and thus was 
considered to be a good representative of a scanner that could incorporate kVp 
splitting in the future. 
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Because kVp splitting is a novel technique and thus has not been 
implemented in CT scanners, it was emulated by performing a series of 
stationary scans over the equivalent of a full rotation and changing the kVp at 
angular positions of the x-ray tube that would correspond to direct exposure of 
patients' breast tissue (shown in Figure 5.4). This approach was validated by first 
performing 0.5-s axial scans in service mode on a GE LightSpeed VCT scanner. 
Subsequently, a series of 0.5-s exposures were delivered with the x-ray tube 
held stationary at evenly-spaced angular positions over the equivalent of a 3600 
rotation. Each series consisted of 18 stationary scans performed at tube angles 
from 0 - 3400 (in 200 angular increments). The same scan techniques used to 
determine CTDI (i.e., 80, 100, 120, and 140 kVp, a small focal spot size, a 40-
mm nominal beam width, and a large bowtie filter) were also used in this portion 
of the study. Entrance exposures were measured using a Farmer ionization 
chamber (in conjunction with an electrometer; RadCal Corporation) placed on the 
surfaces of the anthropomorphic phantoms at the location representing the 
sternum. Exposures delivered by the stationary scans, which were calculated as 
the sum of the 18 individual exposure measurements in each series, and the 
rotating scans were normalized by exposure time and then compared. Across all 
three phantoms and all four kVps, the difference in the exposures delivered by 
the rotating scans and the series of stationary scans ranged from 0.07% to 
1.44%. 
Exposures delivered by both the stationary scans, which were calculated 
as the sum of the 18 individual exposure measurements in each series, and the 
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anterior ("kVp1" in Figure 5.1) and posterior ("kVP2" in Figure 5.1) tube angles 
(e.g., 80 kVp for the anterior angles and 100 kVp for the posterior angles). A 
single tube current was used for each phantom across all scans (regardless of 
kVp), and later the detected exposures were scaled according to the exponents 
of kVp determined free-in-air and in the CTDI phantoms. For example, if the 
exponent of kVp was 2.5 (for 80 kVp relative to 100 kVp) , the current for the 80-
kVp exposures would be scaled so that it was 1.75 times the current used for the 
100-kVp exposures. When estimating dose delivered by kVp splitting, the 
stationary exposures measured for the posterior tube angles (angles between 
80° and 280° [inclusive], where 0° is at the top of the gantry) and anterior tube 
angles (300°, 340°, 0°, 40°, 60°) were summed separately. To determine 
cumulative exposure from the equivalent of an entire rotation, we combined 
exposures measured for the posterior and anterior regions. To combine data 
collected at different kVps and maintain image quality comparable to that of a 
static kVp scan, we scaled the cumulative exposure for each region using the 
exponents of kVp; however, image quality could not be directly evaluated 
because images cannot be reconstructed from stationary scans. The cumulative 
posterior and anterior exposures were summed and compared to the cumulative 
exposure for a scan that used a static kVp across all 18 stationary scans. The 
static kVp scan, which the kVp splitting scans were compared to, was selected 
for each phantom based on the kVp used to scan the corresponding patient (i.e., 
the examinations for both the small and medium patients were performed at 100 
kVp, so 100 kVp was used in the comparison scan). Dose savings were 
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determined by calculating the percent difference in exposure between each kVp 
splitting scan (for all combinations of anterior and posterior kVps) and the 
relevant fixed kVp scan. 
5.2.2. MONTE CARLO DOSE ESTIMATES 
Three pediatric female patients, who were considered to be representative 
of small, medium, and large pediatric patients, were identified and used to 
construct voxelized models for MC modeling. MC modeling was employed 
because it provided a more accurate means of estimating breast dose to 
individual patients and also because it allowed for scans to be simulated that 
were unable to be physically performed because kVp splitting is not available on 
CT scanners (e.g., helical scanning with kVp splitting). MC simulations with and 
without kVp splitting were performed to estimate the amount of radiation dose 
deposited to the glandular breast tissue of three pediatric female voxelized 
models so that the breast dose-savings potential of kVp splitting could be 
evaluated. The anthropomorphic phantom results were used to determine the 
anterior and posterior kVps used in the simulations because acquiring physical 
measurements for all kVp combinations was much more time efficient than 
performing an equivalent number of MC simulations. 
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5.2.2.1. VOXELIZED MODELS 
After receiving institution review board approval, patient data used to 
construct the voxelized models was obtained from three pediatric female patients 
who had undergone positron emission tomography with CT (PETtCT) using a 
Discovery STE scanner (GE Healthcare) at our institution. PETtCT rather than 
diagnostic CT was used because it acquires a single, continuous set of images 
without intravenous or oral contrast, which could interfere with tissue 
identification and characterization. A potential disadvantage of using PETtCT 
images to construct the voxelized models is that they have a larger voxel size 
than diagnostic CT images; however, because the models generated from the 
images are typically somewhat coarse (even when detailed CT image data is 
available), the large voxel size was not considered to be an issue. 
Voxelized models of the three patients were developed by identifying those 
voxels in the patients' CT images that contained glandular breast or lung tissue; 
a pediatric radiologist was consulted to ensure proper identification of the 
patients' breast tissue. Lung tissue was also contoured because it is among the 
most radiosensitive organs (according to the ICRP tissue weighting factors) and 
is in the same scan plane as breast tissue. 38 Figure 5.2 shows contouring of both 
the lung and breast tissue in one CT image for each of the three patients; all 
images containing breast tissue were contoured individually. 
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5.2.2.2. SIMULATIONS 
Anterior and posterior kVps determined to reduce dose to the 
anthropomorphic phantoms were used in MC simulations of kVp splitting to 
estimate the amount of radiation dose deposited to the breast tissue of the three 
voxelized patient models. A Monte Carlo computer model that uses the MC N-
Particle code eXtended version 2.6d (MCNPX) was employed to estimate the 
amount of radiation dose deposited to the breast tissue for a given voxelized 
patient model (generated from the CT data of the small, medium, or large 
pediatric patient).116, 167 Breast dose has been previously quantified in patient-
based models (GSF; Neuherberg, Germany) using the MCNPX model. 168 To 
simulate kVp splitting, we performed two separate MC simulations and the 
results were summed in a manner similar to that used to sum the posterior and 
anterior exposures in the anthropomorphic phantom measurements. Because the 
normalization factors used to convert output of the MC model to dose are kVp-
dependent, output of a single simulation that has varying kVps cannot be 
converted to absolute dose. Therefore, angular regions of the scan performed at 
each kVp were simulated separately. The MCNPX model was validated for 
modeling kVp splitting within 6.1 % of the physical data collected on a GE 
LightSpeed VCT scanner in a 32-cm CTDI phantom using 120 kVp for posterior 
angles and 80 kVp for anterior angles (data not shown). Validation was done in a 
CTDI phantom rather than an anthropomorphic phantom based on prior 
validation 
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To assess the effectiveness of kVp splitting in a manner that was clinically 
representative of how it would be employed, we followed the protocols used 
when scanning the patients as closely as possible when performing the 
simulations. However, several factors were changed between the patient scans 
and the simulations including the scanner type and model, the scan extent, the x-
ray tube start angle, and the use of TCM. Although a Discovery STE PET/CT 
scanner, which contains a 16-slice CT scanner, was used to collect the patient 
data, a GE LightSpeed VCT was used in the simulations. This change was made 
in part because an equivalent-source MC model has not yet been built for the GE 
16-slice scanner used in the Discovery STE PET/CT scanner. To define where 
kVp splitting would be applied, we determined the anatomical location of breast 
tissue in the angular and z-directions from the CT images. The posterior and 
anterior regions were defined according to which x-ray tube angles directly 
exposed the breast tissue with the patient positioned "as is" within the 50-cm 
DFOV. Although the angular coverage for off-center patients was different than if 
the patient had been centered (as can be seen in Figure 5.5), the simulations 
were performed without adjusting the patients' position within the field of view. 
The scan extent used in the simulations was based on the z-axis locations where 
breast tissue could be visualized in the CT images plus one beam width (i.e., 40 
mm) before and one beam width after the region containing breast tissue; the 
additional beam widths were included to ensure complete coverage of the breast 
tissue. Figure 5.6 shows the z-axis coverage of the breast tissue as well as the 
one-beam-width border (40 mm), which make up the scan extent simulated for 
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the small and large patients. While performing the simulation over the breasts 
only is not clinically realistic in terms of the scan extent, it can be assumed that 
dose to anatomy beyond the breast region would be unaffected by kVp splitting 
since this technique would only be used over the breasts and thus dose 
elsewhere should be relatively constant. This assumption allowed for simulation 
times to be reduced by only simulating kVp splitting over the region 
encompassing the breast tissue. The angular position of the x-ray tube was set to 
equal 0° (i.e., the top of the gantry) at the z-axis location which corresponded to 
the center of the simulated scan extent; the start angle was then calculated 
based on the beam width, pitch, and the distance (along the z-axis) between the 
start and center of the simulated scan length. Because simulating TCM would 
add another layer of difficulty and was unnecessary for demonstrating the 
potential of kVp splitting, a single mA was used for each portion of the scan. The 
actual patient TCM schemes (taken from the raw data) were used to calculate 
the average current values over the simulated scan extent (as seen in Figure 5.7) 
and this value was used to scale the output of the MC simulations (the MC 
simulations did not directly account for current). For the small, medium, and large 
patients, the average currents over the scan extent simulated (i.e., images 
showing breast tissue with a border of one beam width) were calculated to be 65 
mA, 118 mA, and 108 mA, respectively. Table 5.2 lists the technical factors and 
other information relevant to the simulations. 
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TABLE 5.2. Techniques used in the MC simulations to assess the effectiveness of 
kVp splitting for the small, medium, and large patients; all simulations were 
performed using a GE LightSpeed VCT scanner. 
Patient Helical Rotation Beam 
model kVp rnA pitch time width (s) (mm) 
Small· 80 & 100 65 & 116 or 114 1.375 0.5 40 
Mediumt 80 & 100 118 & 209 or 206 1.375 0.5 40 
Large; 80 & 120 108 & 318 or 286 1.375 0.5 40 
• For the small patient, 100 kVp and 65 mA were used for the static kVp simulation. For 
the kVp splitting simulation, 80 kVp and 116 mA or 114 mA (depending on whether mA 
was scaled by CTDI 100• 12:00 or CTD1 100. air, respectively) was used over the posterior tube 
angle (from 115° to 245°, clockwise); 100 kVp and 65 mA were used over the anterior 
tube angles (from 245° to 115°, clockwise). 
t For the medium patient, 100 kVp and 118 mA were used for the static kVp simulation. 
For the kVp splitting simulation, 80 kVp and 209 mA or 206 mA (depending on whether 
mA was scaled by CTD1 100. 12:00 or CTD1 100. air, respectively) was used over the posterior 
tube angle (from 90° to 270°, clockwise); 100 kVp and 118 mA were used over the 
anterior tube angles (from 270° to 90°, clockwise). 
:j: For the large patient, 120 kVp and 108 mA were used for the static kVp simulation. For 
the kVp splitting simulation, 80 kVp and 318 mA or 286 mA (depending on whether mA 
was scaled by CTDI 100. 12:00 or CTDI 100. air, respectively) was used over the posterior tube 
angle (from 105° to 255°, clockwise); 120 kVp and 108 mA were used over the anterior 
tube angles (from 255° to 105°, clockwise). 
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Outputs from each of the two simulated scans (i.e., the scans over the 
anterior and posterior regions) were combined into a single dose by summing 
the dose obtained over each region (in mGy). Before the doses could be added, 
they were multiplied by the appropriate kVp normalization factors, weighted by 
their fraction of a 360° rotation (e.g., the output would be multiplied by 0.5 if the 
region covered 180°), and then multiplied by the current-exposure time product; 
the in-air exposure data were used to determine the normalization factors for 
each kVp. After determining dose for the kVp splitting scans, breast tissue dose 
estimates were also obtained for a static kVp protocol. To quantify the breast 
dose-savings potential of kVp splitting, we compared dose (through percent 
difference) for a full scan at a fixed kVp and tube current to the dose for scans 
with kVp splitting. 
5.3. RESULTS 
5.3.1. MEASURED DATA 
5.3.1.1. CTDI 
Because both the small and medium patients were scanned at 100 
kVp and thus 100 kVp was used in the static kVp simulations, the exponents of 
kVp for the 16-cm CTDI phantom were determined relative to 100 kVp only. 
Similarly, the kVp exponents for the 32-cm phantom were determined relative to 
120 kVp only. Table 5.3 lists the kVp exponents determined at the 12:00 
peripheral chamber position in CTDI phantom and free-in-air. 
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TABLE 5.3. Exponents of kVp calculated using Eq. (5.1) and the measured 
exposures collected free-in-air or at the 12:00 chamber position in the CTDI 
phantoms; exponents were only determined relative to 100 kVp for the 16-cm 
CTDI phantom or 120 kVp for the 32-cm phantom. The ratio of kVps can be 
raised to these powers to determine how to scale the tube current across 
different kVps for scans with kVp splitting. 
kVp CTD1100, air CTD1100, 12:00 CTD1100, 12:00 (16-cm phantom) (32-cm phantom) 
80 kVp 2.50 2.57 (relative to 100 kVp) 
80 kVp 2.40 2.66 (relative to 120 kVp) 
100 kVp 2.27 2.46 (relative to 120 kVp) 
120 kVp 2.27 2.28 (relative to 100 kVp) 
140 kVp 2.21 2.25 (relative to 100 kVp) 
140 kVp 2.13 2.22 (relative to 120 kVp) 
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5.3.1.2. ANTHROPOMORPHIC PHANTOMS 
The exponents of kVp determined free-in-air and in the CTDI phantoms 
were used to scale the current (by the ratio of the kVps raised to the appropriate 
power). Data collected in the 16-cm CTDI phantom were used to calculate the 
exponents for anthropomorphic phantoms representing a 5-year-old and a 10-
year-old (because they were more similar in size to the 16-cm phantom than the 
32-cm CTDI phantom); likewise, data collected in the 32-cm CTDI phantom were 
used to determine the scaling factors for the adult phantom. Table 5.4 lists the 
dose savings as a percentage for every kVp combination over the anterior and 
posterior tube angles using tube currents scaled either by CTDI1Qo, 12:00 or 
CTD1 100, air· 
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All exposure measurements were converted to CTOI using Eq. (1.4) and 
then the powers (exponents) of kVp that CTOI was proportional to were 
calculated according to the following equation: 
where kVpl/kVp2 is the base of the logarithm and CTDlkVpJ/CTDlkVp2 is the ratio of 
CTOls calculated from the exposures measured at kVPl and kVp2. 
5.2.1.2. ANTHROPOMORPHIC PHANTOMS 
Once the relationships for describing how dose varies with kVp were 
determined, kVp splitting was evaluated using anthropomorphic ATOM family 
dosimetry phantoms representative of a 5-year-old, 10-year-old, and an adult 
upper torso (with breast attachments) (CIRS, Norfolk, VA), which are shown in 
Figure 5.3. 
FIGURE 5.3. Anthropomorphic phantoms representing a 5-year-old, 10-year-old, 
and a (female) adult were used in this study. 
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rotating scans, were normalized by exposure time and then compared. Across all 
three phantoms and all four kVps, the difference in the exposures delivered by 
the rotating scans and the series of stationary scans ranged from 0.070/0 to 
1.44%. 
FIGURE 5.4. A series of 18 stationary scans were performed in 20° angular 
increments from 00 to 3400 to emulate a 3600 rotation with kVp splitting. The 
central ray of the x-ray fan beam at each angular increment is shown as red or 
blue arrows; the blue arrows represent scans at the anterior kVp (kVp1) while the 
red arrows represent scans at the posterior kVp (kVp2) . 
Because exposures measured using the stationary scan method were 
consistent with those measured for the rotating scans, the stationary scan 
method was considered valid for emulating kVp splitting . Therefore, every 
combination of the four available kVps (i .e. , 12 pairs) was tested over both the 
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FIGURE 5.2. Lung (teal) and glandular breast tissue (purple) were contoured for 
the (a) small, (b) medium, and (c) large pediatric patients. All of the images are 
shown with a 50-cm display FOV (OFOV), which allows for direct comparison 
and visualization of the difference in the patient sizes. 
The patients chosen to represent the small, medium, and large pediatric 
patients were 3 years old (height: 102.3 cm, weight: 14.8 kg), 10 years old 
(height: 144.0 cm, weight: 36.7 kg), and 17 years old (height: 174.5 cm, weight: 
72.3 kg), respectively, at the time of scanning. Patients with surgical defects 
(e.g., lung removal) or large tumors causing noticeable surface or anatomical 
deformity were excluded from the study. The 10-year-old patient had one leg 
amputated (at the thigh), but this did not affect the results of the MC simulations 
because breast dose was the focus of this investigation. The CT image data and 
raw data were collected for these three patients; from the raw CT data, the 
specific TCM schemes used on each patient were extracted. The techniques 
used to scan the patients are listed in Table 5.1. 
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FIGURE 5.5. The angular coverage of breast tissue for the small patient was 2300 
when centered "as is" within the 50-cm DFOV. However, if the patient had been 
properly centered, her breast tissue would have only covered a 1300 angular 
region . 
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FIGURE 5.S. Highlighting shows the z-axis coverage of the breast tissue (blue 
highlighted region) and the scan extent used in the simulations (lighter 
highlighted region) for the (a) small and (b) large pediatric patient. The dashed 
line in the middle of the scan extent is the z-axis position at which the x-ray tube 
angle was set to 0 0 • 
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FIGURE 5.7. Plot showing the TCM scheme used to scan the medium-sized 
pediatric patient superimposed on the patient's scout projection image (i.e., 
localizer image); the values used to construct this graph were obtained from the 
raw data. Because the Me simulation was performed over the breast region only, 
the average current over this region (enclosed between the dashed lines) was 
used in the simulation; for this patient, the average current was determined to be 
118 mAo 
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5.3.2. MONTE CARLO DOSE ESTIMATES 
Results from the anthropomorphic phantom study were used to dictate the 
MC simulations that were performed. The 5-year-old, 10-year-old, and adult 
anthropomorphic phantoms were intended to be matched with the small, 
medium, and large pediatric patients, respectively, when determining which kVps 
would be used in the simulations for each patient; Figure 5.8 shows the CT 
images of the patients and the anthropomorphic phantoms used to represent 
them. Rather than choosing the kVps that gave the greatest dose savings for 
each individual phantom, instead we followed a general rule that the kVp used 
during the static kVp scan was used over the anterior tube angles of the kVp 
splitting simulated scan and the lowest kVp available (Le., 80 kVp) was used over 
the posterior tube angles. Although using the combination of kVps specified by 
this rule definitively resulted in the greatest dose-savings in the pediatric 
phantoms, the results were less clear in the adult phantom and depended on 
whether current was scaled by the kVp exponents determined in the CTDI 
phantoms or free-in-air. However, to be consistent with the kVp splitting pattern 
used in the pediatric phantoms and because this pattern (Le., 120 kVp over the 
anterior region and 80 kVp over the posterior region) did indicate a dose savings 
in the adult phantom when scaled either way, this general rule was followed 
across all simulations. 
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Results of the Me simulations for all three patient models are shown in 
Table 5.5. Lung and breast dose are reported in the scans with and without kVp 
splitting along with the estimated percentage of dose savings from using kVp 
splitting. Scans simulated with kVp splitting had breast doses that were 9.8% to 
34% (depending on how the current was scaled) lower than scans with a fixed 
kVp while generally not affecting the lung dose (within the scan extent simulated, 
which did not necessarily include all of the patients' lung tissue). Although we 
expected the absolute doses measured in the anthropomorphic phantoms to 
differ from those estimated through Me modeling, calculated absorbed dose to 
the phantoms was within 12% or less of the Me breast dose estimates for static 
kVp scans (data not shown); the phantom doses were normalized to match the 
mAs and pitch used in the Me simulations. The difference in the dose estimates 
in phantoms and in the voxelized patient models increased to up to 39% in scans 
with kVp splitting. 
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5.4. DISCUSSION 
kVp splitting was estimated in this study to lower CT breast dose in pediatric 
females by between 9.8% and 34% while presumably maintaining constant 
image noise. A trend in breast dose-savings versus patient size was not 
observed. Although this study related to pediatric patients, the large pediatric 
patient was adult-sized, so we expect that dose savings could also be achieved 
in adult patients. However, additional research is needed to assess this 
possibility and to assess dose savings across a greater sample of pediatric 
patients. 
The discrepancy in the dose savings from kVp splitting between the phantom 
measurements and the simulated patient results (Le., 4% dose savings in 5-year-
old phantom versus 34% dose savings in the small patient model) is likely due to 
the fact that anthropomorphic phantoms do not fully represent human anatomy. 
However, it could also be related to differences between the scans and the 
simulations, including the angular position of the x-ray tube relative to the breast 
tissue, improper patient centering, of the added effect of helical scanning. 
Because the percentages of dose savings observed in the anthropomorphic 
phantoms were inconsistent with those observed in the MC, we cannot be sure 
that the optimal combinations of kVps were used in the simulations because 
these values were chosen based on the phantom results. Additional MC 
modeling could be performed to validate the anthropomorphic phantom study 
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results; this would give us a higher degree of confidence in the validity of the MC 
results. 
In the age-based protocols that were initially used to scan the three prediatric 
female patients, TCM allowed for specification according to overall patient 
anatomy. The addition of kVp splitting would allow for further patient specification 
by specifically accounting for differences in the amount and distribution of breast 
tissue across pediatric patients (whose breast tissue may not protrude as in adult 
patients and thus would be less likely to be detected by TCM). Organ-based 
dose adjustment is important because cancer typically develops in a specific 
organ. Although X-Care is geared specifically toward reduction of breast dose, 
the x-ray beam can only be turned off for 1800 minus the fan angle; on the other 
hand, kVp splitting does not have such limitations and could be implemented 
over any angular region according to specific anatomical location of each 
patient's breast tissue. Additionally, kVp splitting may produce better image 
quality than X-Care because it does not involve turning the beam off, and so data 
are sampled throughout the entire rotation. However, Vollmar and Kalender 
reported that X-Care has little effect on image quality compared to a static rnA 
scan and because the specifics of kVp splitting's effect on image quality are 
unknown, this would need further evaluation prior to implementation. 113 Dose 
savings at the same level as X-Care (which has been reported to achieve 45 -
48% breast dose-savings) may be possible through kVp splitting. If the lower 
tube current in the kVp splitting scheme (i.e., the current used over the anterior 
region, with the higher kVp setting) was used for the entire scan (rather than 
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scaling current according to the powers of kVp), dose to the breast and lung in 
the three voxelized models would be reduced by 42 - 60% and 15 - 26%, 
respectively. Not increasing the current to compensate for reducing the kVp may 
be reasonable for pediatric patients because the compensatory tube current 
increase is thought to be less important for maintaining image quality in smaller 
patients. 164 Another drawback of X-Care is that dose to the spine can increase. 
Although spine dose was not evaluated in this study, because it is expected to be 
increased by kVp splitting, spine dose should be evaluated in the future when 
considering implementation of the kVp splitting technique; this would require the 
spine to be contoured in the patient models. The effectiveness of kVp splitting 
could also be evaluated in the context of dose savings to other superficial 
radiosensitive organs (e.g., the lens of the eye and thyroid), which would require 
these organs to be contoured as well. 
Although tube voltage modulation has been mentioned in prior studies,159 
to the best of our knowledge, dose reduction has not been previously quantified 
for tube voltage modulation or kVp splitting (which is a form of tube voltage 
modulation). However, at least one study has addressed image reconstruction for 
tube voltage modulation. 169 While image quality could not be evaluated in this 
study with physical data, image reconstruction would likely pose the greatest 
challenge to implementation of kVp splitting. By applying an empirical cupping 
correction algorithm to the raw data, Ritschl et a/. showed that equivalent image 
quality was achieved compared to image acquired using a single kVp. However, 
this study did not specify the exact shift in the CT numbers between the 
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corrected image and the image acquired at a single kVp. Another potential image 
quality solution to implementation of kVp splitting would be to use a single kVp 
within each rotation (Le., to flip from one kVp to another rather than to split the 
kVp into two different values); this approach would be similar to z-axis TCM. In 
terms of dose savings, the results in anthropomorphic phantoms were 
inconsistent when "flipping" to a different kVp for the entire rotation exposing the 
breasts (dose savings was achieved using 80 kVp for the entire rotation in the 
pediatric phantoms, but not in the adult phantom; data not shown); MC 
simulations could be used for further evaluation. While flipping the kVp would 
resolve issues with image reconstruction, the CT numbers would vary across 
images, which could lead to problems with interpretation of these values over an 
entire exam. If the issues with reconstruction and CT number correction were 
resolved, kVp splitting with more than two kVps could be explored. 
In addition to addressing image reconstruction and CT number correction, if 
kVp splitting was eventually implemented in CT scanners, a means of identifying 
the breast tissue or other sensitive organs would be needed. To identify target 
tissues, technologists could locate and mark a specific anatomical landmark, 
possibly from the localizer image (as shown in Figure 5.9). Then, an appropriate 
age- or size-based preset could be selected to specify the kVps and region of 
coverage. Although only four kVp options are available on most scanners, and 
the minimum is 80 kVp (for the GE scanners involved in this study), in the future, 
additional kVp options (e.g., 60 kVp) could be added to scanners to expand the 
selection of kVp splitting schemes. 
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(a) (b) (c) 
FIGURE 5.9. (a) Anteroposterior and/or (b) lateral views could be used to identify a 
patient's breast tissue coverage, which could then be used to determine the (c) 
tube angles and patient table positions over which to apply kVp splitting. 
5.5. CONCLUSION 
Breast tissue is one of the most radiosensitive tissues in the human body. 
The results of this study indicate that CT breast dose could be reduced by as 
much as 34% in pediatric patients by varying the tube voltage during those 
rotations that directly expose breast tissue. The development of novel techniques 
like kVp splitting for reducing pediatric breast dose may decrease the incidence 
of radiation-induced breast cancer in adult women who underwent CT scans as 
children. 
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CHAPTER 6 
ORGAN-BASED BEAM FILTRATION: A NOVEL APPROACH TO 
REDUCING CT BREAST DOSE 
PURPOSE: We sought to assess the effectiveness of a novel CT radiation dose-
reduction strategy in which additional filtration was placed in between the x-ray 
beam and the breast area of three sizes of anthropomorphic phantoms. 
METHODS: Since dynamic organ-based x-ray beam filtration could not easily be 
added to the rotating x-ray tube, we emulated this technique by placing static 
filtration over the CT scanners' Mylar windows according to the location of the 
representative breast tissue of anthropomorphic phantoms. We initially scanned 
anthropomorphic phantoms representative of a 5-year-old, 10-year-old and an 
adult female without additional filtration using clinical TCM protocols with and 
without ASiR. We then scanned the phantoms with in-plane bismuth breast 
shielding placed over the phantoms' breast areas or copper foil or lead foil 
filtration placed over the scanners' Mylar windows. To detect entrance radiation 
exposure, we used a Farmer ionization chamber placed on the phantoms' 
surfaces at locations representing the sternum and left breast; at least 10 
measurements were collected at each location, and the mean dose was 
calculated. Dose reduction was then determined by calculating the percent 
difference between the mean dose in unshielded scans compared to the mean 
dose in scans shielded by bismuth or copper or lead foil filtration. Additionally, we 
sampled CT numbers and noise at regions representing the lung and the soft 
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tissue near the sternum, left breast, and spine in CT images of the phantoms 
during unshielded scanning compared to scanning with bismuth breast shielding, 
copper foil filtration, or lead foil filtration in place. 
RESULTS: In the TCM scans without ASiR, entrance dose reduction at the 
sternum and left breast in the three anthropomorphic phantoms ranged from 22% 
to 41%, from 28% to 42%, and from 54% to 60% when using in-plane bismuth 
breast shields, copper foil filtration, and lead foil filtration, respectively. The 
addition of 40% ASiR to the TCM protocols increased the dose reduction ranges 
to 51 - 68%, 53 - 66%, and 71 - 79% when using in-plane bismuth breast shields, 
copper foil filtration, and lead foil filtration, respectively. Copper foil filtration 
affected the CT image noise and CT numbers less than the bismuth breast 
shields and lead foil filtration (8.2% mean increase in noise versus 23% and 
32%, respectively). 
CONCLUSION: Breast surface dose-reductions between 28% and 66% were 
achieved in anthropomorphic phantoms with a minimal impact on image quality 
by placing copper foil filtration between the phantoms' breast areas and the x-ray 
beam. It is expected that similar dose reduction could be achieved in patients by 
incorporating a dynamic filter into CT scanners that covers the x-ray beam output 
port when passing over patients' breast tissue. 
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6.1. INTRODUCTION 
The breast tissue weighting factor published in a recent report by the ICRP 
increased substantially relative to the previously-published value (from 0.05 to 
0.12), and so breast tissue is now considered to be among the most 
radiosensitive organs in the body?S, 170 Breast tissue is incidentally exposed to 
radiation during many routine CT scans, including coronary angiography and 
thoracic CT, but is rarely the organ of interest. Because patients undergoing CT 
scanning may be at higher risk for developing breast cancer than previously 
thought, CT breast dose must be given additional consideration. While overall 
dose-reduction strategies (e.g., TCM and iterative reconstruction) have been 
implemented across CT scanner manufacturers, few organ-based strategies 
exist. 
X-care (Siemens Healthcare) is a strategy that was recently developed to 
reduce CT breast dose. In this method, the x-ray tube current is turned off (Le., 0 
rnA) or greatly reduced at angular tube positions where the beam is directly 
exposing the breast tissue. Disadvantages of X-Care are that the x-ray tube must 
sample data, and thus deliver radiation, over a minimum of 1800 plus the fan 
angle to reconstruct CT images, which limits the effectiveness of this technique in 
patients whose breast tissue extends beyond a 1800 region, and to date X-Care 
has only been implemented by one manufacturer. Another strategy specifically 
aimed at reducing CT breast dose is to cover the breast tissue with in-plane 
shielding during scanning.104 Breast tissue is relatively superficial (Le., there is a 
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lack of overlying tissue) and absorbs much of the radiation dose from the x-ray 
beam's low-energy photons, which are unlikely to penetrate through the patient 
and are instead likely to be attenuated upon entering the body. Thus, in-plane 
breast shields (typically bismuth-based) are used to partially attenuate the x-ray 
beam before it enters the body, reducing dose to the underlying tissue. Unlike X-
Care, bismuth breast shielding functions independently of the CT scanner and 
thus can be used universally across scanners of different models and from 
different manufacturers. In two studies of bismuth breast shielding, diagnostic 
quality CT images (with no difference in image quality between shielded and 
unshielded lung) were obtained in pediatric and adult female patients, and dose 
reductions of 29% and 41 %, respectively, were achieved in the corresponding 
phantom scans. 171 , 172 Another study revealed that combining bismuth breast 
shielding with TCM reduced dose to the representative breast tissue of a 
pediatric anthropomorphic phantom by 52%; however, this dose reduction was 
only achieved if the breast shield was placed on the patient after the localizer 
(also known as the scout) was acquired.173 
Although bismuth breast shields have been reported to reduce CT radiation 
dose to breast tissue, degraded quality of the CT images has also been reported, 
which has limited the acceptance of this technology by some medical 
physicists. 174 In one study, dose reductions of almost 50% achieved using 
bismuth breast shielding on a semi-anthropomorphic phantom (scanned with a 
thoracic CT protocol) were accompanied by increased noise and streak artifacts 
in the CT images.175 However, such artifacts, which have been observed in 
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images acquired with 1-cm or smaller gaps between the bismuth breast shield 
and the patient surface, may be eliminated by using additional foam padding to 
increase the gap between the shield and the patient; equivalent noise between 
shielded and unshielded regions can also be achieved by increasing the gap.176, 
177 Shifts in CT numbers have been associated with the use of bismuth breast 
shielding.177 The impact of breast shielding on CT numbers is important to consider 
because breast shielding could potentially be in place during cardiac CT and one 
use of CT numbers is for clinical interpretation of coronary calcium scoring. Another 
criticism of in-plane breast shields is that they attenuate the x-ray beam not only 
before it enters the patient (Le., when the x-ray tube is facing the patient's 
anterior), but also after the beam exits the patient (Le., when the tube is facing 
the patient's posterior); Figure 6.1 shows the entrance and exit beam. This is 
problematic because the exit beam "carries" information about the patient's 
anatomy to the detectors, which hinders image quality by reducing the number 
and increasing the average energy of transmitted photons that reach the 
detectors. This results in more image noise and a further shift in CT numbers, 
and can also lead to artifacts. Furthermore, shielding the exit beam does not 
reduce patient dose since the beam has already been transmitted through the 
patient. 
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Entrance 
beam 
FIGURE 6.1. The entrance beam versus the exit beam for an anteroposterior 
projection through a patient. 
Incorporating organ-based beam filtration into CT scanners may resolve 
several of the drawbacks of in-plane breast shielding and X-Care while 
maintaining their dose-saving benefits. Similar to in-plane breast shielding, a 
physical filter made of a dense material (e.g., lead, copper, etc.) could be placed 
in the x-ray beam's path when it is directly exposing a patient's breast tissue (as 
shown Fig. 6.2). Filtering an x-ray beam preferentially removes low-energy 
photons, which are thought to contribute to patient dose but not image quality, 
consequently increasing the beam's penetrability, and thus reducing absorbed 
dose to the breast tissue. 6 On the other hand, reducing the number of photons 
may increase image noise, and increasing the mean energy of photons in the 
beam may reduce image contrast. 178 However, the effect of organ-based beam 
filtration on image quality remains unclear. 
176 
FIGURE 6.2. Direct exposure of radiosensitive breast tissue occurs over a portion 
of the x-ray tube's 360 0 rotation around a patient. During this portion of the 
rotation , filtration could be placed over the x-ray beam to reduce CT breast dose. 
The purpose of this study was to investigate the effect of organ-based beam 
filtration on CT dose and image quality. Since the proposed technology (i.e. , 
organ-based beam filtration) has not yet been implemented in CT scanners, we 
emulated the technology by securing lead and copper foil over a portion of the 
scanners' Mylar windows. Pediatric and adult anthropomorphic phantoms were 
then scanned using clinical chest TCM protocols with and without ASiR to 
evaluate the potential of organ-based beam filtration in combination with existing 
dose-reduction strategies. 
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6.2. MATERIALS AND METHODS 
6.2.1. PHANTOMS AND CT SCANNERS 
Two state-of-the-art CT scanners and three anthropomorphic phantoms 
were used in this study to evaluate the proposed breast dose-reduction strategy 
of organ-based beam filtration across phantoms representative of patients of 
different sizes. A LightSpeed VCT scanner and a Discovery CT750 HD scanner 
(GE Healthcare) were used to scan anthropomorphic ATOM family dosimetry 
phantoms representative of a 5-year-old, 10-year-old, and an adult upper torso 
(with breast attachments) (CIRS). Each phantom was placed on the patient 
tabletop and centered within the bore of the scanners' gantries using the 
scanners' built-in laser lights, as shown in Figure 6.3; the CT images were used 
to verify centering. 
FIGURE 6.3. Phantoms were centered within the scanners' bores using the built-in 
laser lights. The 10-year-old phantom is shown within the bore of the Discovery 
CT750 HD scanner's gantry. 
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6.2.2. SCANNING TECHNIQUES 
After each phantom was properly centered, the TCM schemes were 
determined from the scout scans, which were acquired without any added 
filtration or shielding. A technique of 10 mA and 80 kVp was used for the 
pediatric phantom scouts, while 10 mA and 120 kVp were used for the adult 
phantom scout. All scouts were acquired using a 1800 scout plane (i.e., a 
posteroanterior projection). The phantoms were then scanned with a helical pass 
from the chin to roughly the diaphragm using the clinical TCM protocols listed in 
Table 6.1; the scout images in Figure 6.4 show the specified image lengths for 
each phantom. For the GE scanners involved in this study, we specified both a 
noise index (NI) and the range (i.e., minimum and maximum) of x-ray tube 
currents within which the tube current could be modulated. 153 Using the scout, 
the scanner then calculated the TCM scheme that achieved the target noise in 
each reconstructed image (as indicated by the NI). On the Discovery CT 750 HD 
scanner, 40% ASiR was also employed during the scans (the 40% level was 
chosen on the basis of the recommendations from Karen Procknow of GE 
Healthcare [via personal communication, 3/4/2011 D. The TCM protocols were 
adjusted to account for ASiR by scaling the noise index by a factor of 1.3.179 
Because ASiR was not installed on the LightSpeed VCT scanner, it was not used 
during those scans. 
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FIGURE 6.4. Localizer (scout) images showing the image lengths used when 
scanning the (a) 5-year-old, (b) 10-year-old, and (c) (female) adult 
anthropomorphic phantoms. The scout images shown here were acquired on the 
LightSpeed VCT scanner, but the same image lengths were also used for the 
Discovery CT750 HD scanner. 
TABLE 6.1. The TCM protocols used when scanning the pediatric and adult 
anthropomorphic phantoms; 40-mm beam coverage, 2.5-mm helical image 
thickness, 0.984 pitch, and 0.4-s rotation times were used for all scans. 
Phantom Noise index * mA kVp DFOV SFOV 
range (em) 
5-year-old 21 or 27.3 35 - 230 80 25 Pediatric body 
1 O-year -old 21.5 or 27.95 35 - 300 100 29 Ped iatric body 
Adult 22 or 28.6 35 - 360 120 50 Medium body 
"The higher NI listed was used for scans with ASiR (performed on the Discovery CT750 
HD scanner only) whereas the lower NI was used for scans without ASiR. 
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6.2.3. UNSHIELDING SCANNING 
The phantoms were initially scanned and exposures were detected 
without any added filtration or shielding, using the protocols listed in Table 6.1. 
6.2.4. IN-PLANE BISMUTH BREAST SHIELDING 
Scanning was repeated (using the protocols in Table 6.1) and exposure 
measurements were collected with in-plane bismuth breast shields (AttenuRad 
CT breast shield system; F&L Medical Products, Vandergrift, PA) placed on the 
phantoms' surfaces (see Fig. 6.5). The approximate dimensions of the breast 
shields used on the 5-year-old, 10-year-old, and adult phantoms were 28 cm x 8 
cm, 33 cm x 10 cm, and 25 cm x 20 cm (per side), respectively. The breast 
shields used on the pediatric phantoms and adult phantom contained 0.5 mm of 
bismuth (0.03-mm lead equivalence) and 1 mm of bismuth (0.06-mm lead 
equivalence), respectively, impregnated in synthetic rubber. Each shield was 
mounted to a 1-cm foam base. 
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FIGURE 6.5. Placement of appropriately-sized bismuth breast shields on the (a) 5-
year-old , (b) 10-year-old, and (c) (female) adult phantoms. 
6.2.5. ORGAN-BASED BEAM FILTRATION 
Subsequently, scanning was repeated with high-purity (~ 99.9%) copper 
or lead foil placed over the scanners' Mylar windows, as shown in Figure 6.6, and 
exposures were recorded (using the protocols listed in Table 6.1). Copper and 
lead are commonly used in radiological applications and could be acquired 
relatively inexpensively in high-purity forms with the desired dimensions. Width of 
the copper and lead foils (i.e. , 76.2 mm) matched that of the Mylar window; the 
lengths of the foils were sized to match the angular region covered by the in-
plane bismuth breast shields, which was approximately 1400 for the 5-year-old 
and adult phantoms and 1500 for the 10-year-old phantom (see Fig. 6.7). 
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FIGURE 6.6. The lead and copper foil tape covered a 1400 arc of the CT scanners' 
Mylar windows when scanning the 5-year-old and adult phantoms and a 1500 arc 
when scanning the 10-year old phantom. As shown here, the lead foil is placed 
over the Mylar window of the GE LightSpeed VCT scanner. 
FIGURE 6.7. An arc of approximately 1500 was covered by the bismuth breast 
shield when scanning the 10-year-old phantom, therefore the top 1500 of the 
Mylar window was covered with lead or copper foil when scanning the 10-year-
old phantom. 
183 
6.2.5.1. TRANSMISSION MEASUREMENT 
Radiation transmitted through the bismuth breast shields, copper foil, and 
lead foil was determined using the same setup as for HVL estimation; this setup 
is described in 2.2.1. and shown in Figure 2.1 (a).123 However, instead of 
aluminum filters, the breast shields and varying thicknesses of the copper foil and 
lead foil were placed at the bottom of the gantry, covering the x-ray tube output 
port. The transmission percentages (for a 120 kVp beam) were calculated 
relative to the exposure measured for an unattenuated beam (Le., nothing at the 
bottom of the gantry). The calculated transmission percentages were used to 
determine the thicknesses of copper foil that would give roughly the same 
transmission as through the bismuth breast shields. 
6.2.5.2. COPPER FOIL FILTRATION 
Based on the results of the transmission measurements, four and eight 
layers of 0.0356-mm thick copper foil (CFL-5A copper foil tape; JV. Converting 
Company, Inc., Fairless Hills, PA) were placed over the Mylar window when 
scanning the pediatric phantoms and the adult phantom, respectively. 
6.2.5.3. LEAD FOIL FILTRATION 
Because the 0.127-mm thickness of the lead foil (LF-5A lead foil tape; JV. 
Converting Company, Inc.) was greater than the lead equivalence of bismuth in 
the breast shields, one layer of lead foil was placed over the Mylar window for all 
three phantoms. 
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6.2.6. DOSE ANALYSIS 
Radiation entrance (skin) exposures were measured without added beam 
filtration or shielding, with in-plane bismuth breast shielding, with copper foil 
beam filtration, and with lead foil beam filtration. A Farmer ionization chamber 
connected to an electrometer (RadCal Corporation) was used to detect 
exposure. The Farmer chamber was placed on the phantoms' surfaces at 
locations representing the sternum and left breast, as shown in Figure 6.8. For 
the 5-year-old and 10-year-old phantoms, the active detection region of the 
Farmer chamber was placed approximately 4 cm and 5 cm, respectively, to the 
left of the sternum; for the adult phantom, the active detection region was placed 
at the nipple. Ten exposure measurements were collected at each location and 
averaged. Exposures (in units of R) were converted to doses (in units of mGy) by 
using an exposure-to-dose conversion factor (f-factor) of 0.94 rad/R, which is the 
appropriate f-factor for tissue dose estimates, and then multiplying by 10.136 
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FIGURE 6.8. Entrance exposure was measured using a Farmer chamber placed at 
the sternum and left breast of a (a) 5-year-old, (b) 10-year-old, and (c) (female) 
adult anthropomorphic phantom. As shown, the Farmer chamber is placed at the 
sternum for the pediatric phantoms and at the left breast for the adult phantom. 
Dose reductions were calculated as the percent differences between the 
mean doses with bismuth breast shielding, copper foil beam filtration, or lead foil 
beam filtration compared to scans without shielding or filtration (for each 
phantom, scanner, and dose measurement location). While all scans included 
TCM, the scans on the Discovery CT750 HD also incorporated ASiR; for both 
scanners, dose reductions were calculated relative to the unshielded scan with 
TCM only (i.e., without ASiR). Dose reductions for the unshielded scans with 
TCM and ASiR were also calculated to determine the dose savings from ASiR 
alone. 
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6.2.7. IMAGE QUALITY ANALYSIS 
To assess image quality, regions of interest (ROls) were sampled in the 
CT images in the anterior soft tissue adjacent to the sternum and in the left 
breast, in the posterior soft tissue near the spine, and in the lung; Figure 6.9 
shows the sizes and specific locations of these four ROls for each phantom. We 
compared the CT numbers and noise level across the unshielded scans, scans 
with in-plane bismuth breast shielding, and scans with lead or copper foil 
filtration. The mean percent difference in the noise and shift in the CT numbers 
among the three phantoms, both scanners, and the four ROls were determined 
for each shielding/filtration scenario compared to for the unshielded scan. While 
the relative percent differences in the noise values across shielding conditions 
can be directly calculated, because percent difference depends on the baseline 
value of the comparison, absolute differences in the CT numbers were 
considered. For example, the relative percent difference between the CT 
numbers 2 and 10 is 400%, but the difference between 200 and 208 is 4%, even 
though the absolute difference between them is the same. Furthermore, when 
considering the effect of shielding or filtration on the CT number, we are 
concerned with the magnitude of the shift, particularly in relation to the noise 
level. The CT number shift was not considered to be substantial if the CT number 
was within the noise (i.e., one standard deviation) of the mean CT number in an 
unshielded scan (e.g., if the mean CT number is 400 and the noise is 15, then 
CT numbers between 385 and 415 were not considered to be substantially 
different). 
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6.3. RESULTS 
6.3.1. TRANSMISSION MEASUREMENTS 
The percentages of radiation transmitted through the bismuth breast 
shields, the copper foil filtration, and the lead foil filtration are shown in Table 6.2. 
When we folded the adult breast shield in half in order to cover the x-ray beam 
with two layers of the shield (i.e., 0.12 mm lead equivalence), the beam 
attenuation was slightly more than that achieved with one layer of 0.127-mm 
thick lead foil. 
TABLE 6.2. Percentages of exposure transmitted through bismuth breast shields 
and foil filtration. The transmission percentages were calculated relative to 
exposure measured for an unattenuated beam. 
Filtration or shielding 
5-year-old bismuth breast shield 
10-year-old bismuth breast shield 
Adult bismuth breast shield 
Adult bismuth breast shield 
(folded over [i.e., 2 layers]) 
Lead foil tape (1 layer) 
Lead foil tape (2 layers) 
Copper foil tape (1 layer) 
Copper foil tape (4 layers) 
Copper foil tape (8 layers) 
189 
Transmitted exposure 
(%) 
71 
73 
54 
34 
38 
19 
91 
72 
55 
6.3.2. DOSE ANALYSIS 
The radiation doses and percentages of dose reduction achieved for all 
phantoms and shielding conditions on the LightSpeed VCT and Discovery CT750 
HD scanners are given in Table 6.3. The reduction in entrance dose achieved 
with lead foil filtration ranged from 54% to 80% across all phantoms, both 
scanners, and both measurement locations (sternum and left breast); in every 
case, lead foil filtration achieved the greatest reduction in entrance dose. The 
range of dose savings from the copper foil filtration (28 - 66%) was roughly the 
same as that of the bismuth breast shields (22 - 68%). Across all shielding 
scenarios and phantoms, dose reduction was higher for the scans performed on 
the Discovery CT750 HD than those performed on the LightSpeed VCT because 
of the added effect of ASiR, with dose reductions due to ASiR alone ranging from 
30% to 44%; these dose reductions agreed with expectations based on the ASiR 
level chosen, which was expected to reduce dose by 40%. Despite several 
differences between the two scanners (e.g., the Discovery CT750 HD scanner 
uses gemstone detector technology, while the LightSpeed VCT does not), the 
detected radiation doses and the rnA values used in scanners' TCM schemes 
(without ASiR) were similar. 
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6.3.3. IMAGE QUALITY ANALYSIS 
Table 6.4 lists the CT numbers and noise in the CT images. Although the 
lead foil filtration resulted in the highest dose reduction, it also caused the 
greatest shift in CT numbers compared to unshielded scans. The mean absolute 
shifts in CT numbers (relative to unshielded scans) across the four ROls, three 
phantoms, and two scanners were 18.3, 10.3, and 32.4 HU for scans with 
bismuth breast shields, copper foil filtration, and lead foil filtration, respectively. 
For the most part, the shift in the CT numbers produced by the presence of 
copper foil filtration was within one standard deviation of the CT number of the 
unshielded scans. The mean percentages of increase in the noise (across ROls, 
phantoms, and scanners) compared to the noise in the unshielded scans were 
23%, 8.2%, and 32% for the breast shields, copper foil, and lead foil, 
respectively. Across only the two anterior ROls (left breast and sternum), the 
mean absolute shifts in CT numbers were 31.4, 11.6, and 38.5 HU for scans with 
bismuth breast shields, copper foil filtration, and lead foil filtration, respectively; 
the corresponding mean percentages of increase in noise were 36.4%, 7.7%, 
and 39.4%, respectively. The mean shift in the CT numbers in scans with ASiR 
compared to scans without ASiR was less than 1 HU, and the images 
reconstructed with ASiR had 6% less noise on average than the images 
reconstructed without ASiR. 
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The CT images reconstructed for the 5-year-old, 10-year-old, and adult 
phantoms appear in Figures 6.10 - 6.12 for the GE LightSpeed VCT scanner and 
Figures 6.13 - 6.15 for the GE Discovery CT750 HD scanner. Streak artifacts 
appeared in the CT images of the adult phantom when in-plane bismuth breast 
shielding was used. Although streak artifacts also appeared in the CT images of 
the adult phantom when copper or lead foil filtration was used, the artifacts were 
at the edge of the DFOV in the images, beyond the anatomy of the phantom. 
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FIGURE 6.10. CT images (mediastinum window level) of the 5-year-old phantom 
scanned on a GE LightSpeed VCT scanner with (a) no shielding, (b) bismuth 
breast shielding, (c) copper foil beam filtration, and (d) lead foil filtration; the 
phantom was scanned using the clinical pediatric chest protocol listed in Table 
6.1. 
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FIGURE 6.11. CT images (mediastinum window level) of the 10-year-old phantom 
scanned on a GE LightSpeed VCT scanner with (a) no shielding, (b) bismuth 
breast shielding, (c) copper foil beam filtration, and (d) lead foil filtration; the 
phantom was scanned using the clinical pediatric chest protocol listed in Table 
6.1. 
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FIGURE 6.12. CT images (mediastinum window level) of the (female) adult 
phantom scanned on a GE LightSpeed VCT scanner with (a) no shielding , (b) 
bismuth breast shielding, (c) copper foil beam filtration, and (d) lead foil filtration ; 
the phantom was scanned using the clinical adult chest protocol listed in Table 
6.1. Notice the artifact caused by the breast shield in image (b) and by the lead 
foil in image (d). 
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6.4. DISCUSSION 
Traditionally, x-ray beam filtration has been constant within a given CT 
examination; however, if the technology proposed in this study (Le., organ-based 
beam filtration) was implemented into scanners, it would enable beam filtration to 
be dynamically adjusted during scanning. To the best of our knowledge, no prior 
study has evaluated the effect of organ-based filtration of the primary x-ray 
beam. We found that copper foil filtration reduced the radiation dose by 28 - 66% 
while increasing the CT image noise by 8.2% on average. Therefore, copper foil 
beam filtration yields roughly the same dose reduction as that achieved with in-
plane bismuth breast shielding but has a lesser impact on image quality 
(particularly the anterior image quality). 
In our study, in-plane breast shielding resulted in a mean shift in CT 
number of 18.3 HU, with a maximum observed shift of 69.3 HU (across all 
measurement conditions), and a mean increase in noise of 26.5%. Our results 
can be compared to those obtained in a study by Kalra et a1. 177 Kalra et al. 
reported that bismuth breast shields with a 1-cm foam offset resulted in a shift in 
CT number of almost 100 HU and a 53.5% increase in the noise at the surface of 
a 30-cm anthropomorphic chest phantom. Inconsistency in the noise and CT 
number shift reported in our study and the Kalra et al. study could be attributed to 
the fact that we used GE scanners while Kalra et al. used a Siemens scanner. In 
our study, copper filtration yielded a dose reduction that was roughly the same as 
for the bismuth breast shielding; this is consistent with Kalra et al.'s finding that 
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dose did not significantly change when the distance between the shield and 
phantom was increased. Although both bismuth breast shields and copper foil 
beam filtration produced roughly the same dose reductions, the improved image 
quality (Le., less shift in the CT numbers and less noise) from using copper foil 
compared with bismuth breast shields may also be explained by Kalra et aI., who 
reported less shift in the CT numbers and less image noise when increasing the 
offset between the shield and phantom surface. Although both the current study 
and that of Kalra et al. noted that using breast shielding with a 1-cm foam offset 
resulted in streak artifacts in CT images, in the current study, neither the lead foil 
or copper foil filtration caused streak artifacts within the phantom anatomy. 
The current study had several potential limitations. For example, both the 
lead foil and copper foil used in the study had an acrylic adhesive and a paper 
liner. Although that did not affect demonstration of proof of concept, the specific 
dose reduction might have been different if pure lead and copper (without 
adhesive) had been used. Presence of the adhesive and paper may explain why 
the bismuth shielding, which had a lead equivalence of 0.12 mm, had a lower 
percentage of transmission than 0.127 mm of lead; however, the fact that 
attenuation properties vary across the energy spectrum (and thus limit the 
meaning of the term "lead equivalent") could also account for this 
inconsistency.18o Furthermore, differences in the amount of precision specified 
for the lead equivalence of the bismuth shield and the thickness of the lead foil 
may provide another explanation. 
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Another potential limitation of the current study was that we did not 
compare dose reductions from TCM with those of a static mA scan. Although 
TCM was used, we did not specifically quantify the effect of TCM on dose 
reduction because the same TCM schemes were used across scans and thus 
the same reductions would have been observed if static mA protocols had been 
used. The best attempt at comparison would be to use the maximum mA 
specified by the TCM protocol (to ensure dose reduction, the GE LightSpeed 
VCT scanner manual153 recommends setting the maximum mA in TCM protocols 
to the mA used in the static protocol) or the maximum observed mA (from the 
actual TCM scheme for each phantom). Because the mean mA over the active 
detection region of the Farmer chamber was at least 20% less than maximum 
mA used in the actual TCM scheme and 45% less than maximum mA specified 
in protocol (across all phantoms and both scanners), dose from using TCM would 
be at least 20% lower than from a static mA scan. When applying this additional 
dose reduction, a total breast dose reduction of at least 65% could be achieved 
by combining TCM, ASiR, and copper beam filtration. The dose reduction from 
TCM compared to a static mA scan would likely be even higher if the scout was 
performed using a plane of 0° (Le., with the x-ray tube at the top of the gantry, 
which corresponds to an anteroposterior projection) rather than 180°. After data 
collection, we discovered (via personal communication with Karen Procknow of 
GE Healthcare [7/27/2010]) and confirmed with measured data that the mA 
values in the TCM scheme were generally lower when a scout plane of 0° was 
used, unless the mA values were close to the maximum or minimum of the TCM 
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range, in which case the scout plane did not matter. Although using a 1800 scout 
plane did not specifically affect the conclusions of this study because all scans 
used the same TCM scheme within a phantom and scanner type, and we did not 
determine dose reduction relative to a static mA scan, the absolute doses would 
have likely been lower if a 00 scout plane had been used. 
Despite the limitations of this study, our findings indicate that organ-based 
beam filtration (if incorporated into CT scanner design) would likely improve upon 
a number of the drawbacks typically associated with in-plane bismuth breast 
shields, including issues with timing of shield placement relative to scout acquisition 
and streak artifacts within the anatomy. While organ-based beam filtration may 
cause a small shift in CT numbers, this shift could be addressed by implementing 
correction algorithms or by using less attenuating beam filtration (although this 
would also result in less dose reduction). In addition, the shifts in CT numbers due 
to the copper foil filtrations were generally less than those caused by the bismuth 
breast shields, and radiologists are accustomed to reading images that have been 
affected by breast shields. Furthermore, if organ-based beam filtration were 
incorporated into CT scanners, the CT number shift would likely be smaller than 
that reported in the study because only the entrance beam would be filtered, 
whereas both the entrance and exit beam were filtered in the current study. 
Organ-based beam filtration could be incorporated into CT scanners such 
that a physical filter made of a dense material (e.g., lead, copper, etc.) could be 
used to filter the primary x-ray beam when the beam is directly exposing a 
patient's breast tissue. To implement this technology, a filter that can be quickly 
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placed and removed during scanning would have to be developed. One 
approach to filter design would be to use an aperture that opens and closes like 
the shutter on a camera at the output port of the x-ray beam; the aperture would 
close at a given angular position of the x-ray tube and then re-open at a second 
angular position based on the location of breast tissue. To allow for patient 
specificity, two aperture layers could be included in the design, thus enabling the 
use of two filter thicknesses. Because transmission depends on the beam 
energy, and because pediatric patients are typically scanned for 80 kVp or 100 
kVp while adult patients are scanned for 120 kVp or 140 kVp, adding two 
thicknesses would allow for roughly the same percentage of dose reduction for 
all patients. When choosing the filter material, several factors need to be 
considered, including the photoelectric attenuation coefficient. 18o While some 
studies have recommended the use of copper filters, the criteria for organ-based 
filtration would be different than the criteria used to determine inherent or bowtie 
filter materials since organ-based filtration would only be used to filter the beam 
while it is directed at breast tissue. 181 , 182 In addition, since the filter would need to 
be placed and removed quickly while it rotates with the x-ray tube, a material that 
provides the desired level of dose reduction without being too thick (heavy) or 
thin (flimsy) should be selected to prevent strain on the scanner. Therefore, 
although copper was the better of the two filtration options evaluated in the 
current study in terms of balancing dose reduction and image quality and 
overcame many of the issues associated with bismuth breast shields, copper is 
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not necessarily the optimal filtration material to use when implementing dynamic 
filtration into scanners. 
Another issue that would need to be addressed when considering 
implementation is the method of specifically targeting beam filtration to the breast 
tissue. Using the patient's posteroanterior or anteroposterior scout, a technologist 
could outline the breast tissue (Fig. 6.16); from the outline, the start and stop z-
axis locations, and thus the number of rotations over which to apply the filter, 
could be determined. This would enable the use of patient-specific organ shielding 
(in contrast to in-plane organ shielding, which is available in standard sizes). The 
angular region over which to apply the beam filter (within the xy-plane) could be 
calculated by the technologist outlining the breast on the patient's lateral scout, 
or preset angular coverage regions could be employed. However, if the lateral 
scout were used for this purpose, the order of the scout acquisitions could be an 
issue since the TCM scheme is determined from the last scout performed. 
FIGURE 6.16. The anteroposterior scout of the adult anthropomorphic phantom, 
which has the breast tissue outlined; outlining the breast tissue on the scout 
could be used to identify the location of breast tissue (along the z-axis) as the 
target for selective application of x-ray beam filtration. 
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Before dynamic organ-based beam filtration can be incorporated into CT 
scanner design, further analysis is needed to evaluate the effect of this 
technology on image quality in patients. The application of selective beam 
filtration for other superficial radiosensitive organs such as the eyes, thyroid, and 
testes should also be considered. 
6.5. CONCLUSION 
In this study, we found that copper foil beam filtration reduced entrance breast 
dose by 28 - 66% across three sizes of anthropomorphic phantoms, which was 
roughly the same dose reduction as that achieved with in-plane bismuth breast 
shielding. Furthermore, copper foil beam filtration was shown to have a lesser 
impact on image quality than in-plane bismuth breast shielding compared to 
scans without any added filtration or shielding (10.3 mean HU shift and 8.2% 
mean increase in noise for copper foil beam filtration versus 18.3 mean HU shift 
and 23% mean increase in noise for in-plane bismuth breast shielding); this was 
particularly true when considering image quality in the phantoms' anterior soft 
tissue and no streak artifacts were observed within the phantom in the scans with 
copper foil beam filtration. This study supports the development of new strategies 
to reduce CT radiation dose to breast and other radiosensitive tissues. 
Additionally, these findings support the combination of multiple strategies 
(including TCM and ASiR) to maximize dose reduction without impairing 
diagnostic image quality. 
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CHAPTER 7 
SUMMARY AND FUTURE WORK 
7.1. SUMMARY 
The primary contributions of this thesis are as follows: 
• An empirical model for describing CT attenuation was developed and 
validated (R2 > 0.99). This model can be used to estimate the HVL and 
QVL, which are the most common metrics used to describe the 
penetrating ability of an x-ray beam. 
• The precision of dosimetry-related data, including the HVL, CTDI1oo, air, 
and CTDlw, was evaluated over the course of one year using three 
different models of CT scanners and was found to be well within 5%. 
• The dose penalty from overscanning, due to stabilization of the x-ray tube 
output prior to scanning, was determined for three sizes of CTDI 
phantoms. Dose penalties ranging from 1 % to 26% were observed when 
dose was measured near the angular position of the x-ray tube where 
acquisition began. Therefore, it is recommended that CT acquisitions 
begin with the x-ray tube at the bottom of the gantry to avoid imparting this 
penalty on radiosensitive tissues near patients' anterior surfaces (e.g., 
breast tissue). 
• Monte Carlo modeling estimated that CT dose absorbed by the glandular 
breast tissue of pediatric females was reduced by up to 34% (while 
presumably maintaining constant image noise) from using kVp splitting 
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compared to scans using a static kVp. kVp splitting is a novel strategy in 
which kVp is varied during rotations when the x-ray beam is directly 
exposing the breast tissue. 
• Placing copper foil filtration over CT scanners' Mylar windows, in between 
the x-ray beam and the representative breast tissue of pediatric and adult 
anthropomorphic phantoms, resulted in entrance (skin) dose reductions 
(at the left breast and sternum) ranging from 28% to 66%. These doe 
reductions were accompanied by an average increase of 8.2% in the CT 
image noise. 
7.2. FUTURE WORK 
The novel methods evaluated in this thesis for reducing CT breast dose 
showed promise; however, more research is needed to assess such strategies 
before implementation in CT scanners could be recommended. Additional dose 
quantification of both kVp splitting and organ-based beam filtration could be 
obtained through MC modeling. Specifically, the dose-saving potential of these 
strategies across scanners of different makes and models, which have different 
geometries and filtration, and thus which emit different levels of radiation (even 
for the same scan parameters) could be quantified through MC modeling. 
Furthermore, patient studies could be performed to evaluate the effect of organ-
based beam filtration on image quality. 
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Besides the three voxelized patient models used to simulate kVp splitting, 
22 additional models were developed from female pediatric PETtCT patient data 
(with institutional review board approval) during the course of this thesis. MC 
simulations of both kVp splitting and organ-based beam filtration could be 
performed using these 22 models to evaluate breast dose-savings. Additionally, 
simulations could be performed when combining the two strategies and also with 
the added effect of TCM or bismuth breast shielding. The TCM schemes of all 22 
patients were obtained from the raw data, and thus could be included in future 
simulations. Most of the patients had bismuth breast shields in place during 
scanning; the breasts shields were contoured in the patient images (see Fig. 7.1) 
so that they could either be modeled as bismuth or "removed" from simulations 
by labeling them as air. Two of the patients had bean bag toys and these were 
also contoured (as shown in Fig. 7.2) so that they could be labeled as air if 
necessary (i.e., if they affect the dose estimates). 
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FIGURE 7.1. A CT image of one of the 25 pediatric female patients used to 
construct voxelized patient models, which shows the contoured breast shield 
(light green), glandular breast tissue (purple), and lung tissue (teal). 
FIGURE 7.2. (a) The localizer image of one of the pediatric patients, whose CT 
images were used to construct voxelized patient models, shows the patient 
holding a bean bag toy during scanning; (b) the toy was contoured so that its 
effect could be "removed" from future MC simulations if necessary. 
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Performing additional MC analysis is important because of the limited 
physical data that can be collected to assess kVp splitting. Furthermore, the kVp 
splitting results obtained up to this point showed inconsistent dose reductions 
across patients, and so more data is needed to assess this technology's 
potential. MC modeling of organ-based beam filtration is also needed because 
the doses that we measured at the breast surface of anthropomorphic phantoms 
will likely differ from patient breast dose estimates obtained through MC modeling 
(as was the case in the kVp splitting study). This is because anthropomorphic 
phantoms cannot account for the broad range in the amount and distribution of 
breast tissue across patients (even patients of similar size and age). Figure 7.3 
shows such differences in the breast tissue across two of the 25 pediatric female 
patients whose CT images were used to construct the voxelized patient models. 
Additionally, anthropomorphic phantoms may not accurately represent modern 
patient sizes in light of the increasing rates of obesity and the multicultural 
composition of the U.S. population.183 
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FIGURE 7.3. The CT images of a (a) 13-year-old (height: 156.1 cm; weight: 50.7 
kg) and (b) 16-year-old (height: 159.0 cm; weight: 61.0 kg), which show the 
difference in the amount of glandular breast tissue across these patients. MC 
modeling allows for such differences in internal anatomy to be taken into account 
when estimating dose. 
Breast tissue and lung tissue were the only organs contoured in the 
voxelized patient models as part of this thesis; however, full-body scans were 
performed on many of the patients and all scans at least covered the anatomy 
from mid-skull and to the bottom of the knee. Therefore, the voxelized patient 
models could be expanded in the future to include other superficial radiosensitive 
organs, like the lens of the eye and the thyroid. Furthermore, organs within the 
same scan plane as these radiosensitive tissues could also be contoured. For 
instance, dose to the spine could be checked when implementing strategies over 
the breasts to ensure that the technology designed to decrease breast dose does 
not have the opposite effect on spine dose. Finally, because patients' arms are 
raised above the head in routine CT examinations, the arms of the voxelized 
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patient models, which were positioned next to the trunk, could be contoured and 
set to air to remove their effect on dose (due to attenuation and scatter). 
New strategies for CT dose reduction are continually emerging, including 
the novel breast dose-reduction strategies of kVp splitting and organ-based 
beam filtration proposed in this thesis. While optimization of CT dose is ongoing, 
such advances in technology move us closer towards full realization of the 
ALARA principle. 
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CHAPTER 8 
APPENDICES 
8.1. APPENDIX A: DERIVATION OF EQ. (2.5) 
Initially, Eq. (2.4) was substituted into Eq. (2.1) for ~: 
I = IDe -( JlO+A(~))X (8.1) 
Eq. (8.1) was rearranged to achieve separation of variables: 
Both sides of Eq. (8.2) were multiplied by Ax. 
Term uwas created such that: 
U = AX (t) (8.4) 
Substituting u into Eq. (8.3): 
(8.5) 
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By definition of W, Eq. (8.5) becomes: 
Setting Eq. (8.4) equal to Eq. (8.6) and rearranging: 
(2.5) 
8.2. APPENDIX B: EQUATIONS FOR CALCULATING HVL AND QVL 
Rearranging Eq. (8.1): 
Taking the natural logarithm of both sides of Eq. (8.7): 
In (t) = - (tlo + At) x (8.8) 
Rearranging Eq. (8.8): 
-In (f-) 
X = ~ (8.9) 
JLo+il.iO 
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Eq. (8.9) can be written as the HVL or QVL by substituting ~ or~, respectively, 
2 4 
for (t): 
(8.10) 
(8.11 ) 
where 110 and A are calculated as follows for a two-point Lambert W interpolation 
of measured data points (xv ~) and (XlI ~): 
(8.12) 
(8.13) 
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